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SUMMARY
Several variables associated with the assimilation of
histamine by the guinea pig basophil have been studied.
The experimental model has been an in vitro technique which
measures the uptake of radiolabelled histidine and histamine,
and the synthesis of new histamine from the isotopic histidine
incorporated. The cell preparations used were prepared by
modifications of previously published procedures for
obtaining large numbers of basophils from the bone marrow
of the guinea pig.
Using this technique it was found that only the guinea
pig basophil, when compared to eosinophils, neutrophils and
mononuclear cells, incorporated appreciable amounts of
14
C-histidine and converted it to new histamine. In contrast,
histamine was taken up by all these cell types, but in very
small concentrations. Histidine uptake and the amount of
histamine formed de novo was directly related to the number
of basophils, the time of incubation and the substrate
concentration. In addition, the uptake of radiolabelled
histidine was dependent on the integrity of a number of
biochemical pathways. Thus agents which inhibited glycolysis,
oxidative phosphorylation, protein synthesis and RNA synthesis
14
decreased the amount of C-histidine incorporated in a dose-
dependent fashion. In contrast, conversion of isotopic
histidine to histamine within the cell was not affected by
these agents. This part of the study suggested that
histidine is preferentially incorporated into the basophil
by an active mediated process but that once the histidine is
taken up these requirements do not apply to the formation of
new histamine. In contrast, histamine appears to enter the
cells by passive mediated transport and in relatively small
amounts.
Histamine and the prostaglandins, PGE^, PGEg and PGF2a -
pharmacological mediators known to be released during type I
hypersensitivity reactions in the guinea pig - increased the
14 14
amounts of C-histidine incorporated and C-histamine
formed de novo. By the use of histamine receptor antagonists
the enhancement by histamine was shown to involve HI receptors
The histamine metabolites, imidazoleacetic acid and 1,4-
methylimidazoleacetic acid, were also capable of increasing
14 14
C-histidine uptake and C-histamine formation, although
to a lesser extent than histamine. However, a number of
other pharmacological mediators, including bradykinin,
5-hydroxytryptamine, and the human ECF-A tetrapeptides (Val-
Gly-Ser-Glu and Ala-Gly-Ser-Glu), several anti-inflammatory
drugs and the anti-allergy agent, disodium cromoglycate,
were without effect. Apart from histamine and some of its
14
major catabolites all these agents had no effect on C-
histamine uptake. Thus histamine and prostaglandins may play
a bioregulatory role in the events accompanying the uptake of
histidine by histamine forming cells.
When actively sensitized basophils were challenged with
specific antigen they were still capable of incorporating
14C-histidine and forming "^4C-histamine de novo. Indeed,
there was a time-dependent increase in 44C-histidine uptake
and 14C-histamine formation by these challenged cells when
compared to unchallenged controls. Thus the release of
histamine and the presence of extracellular histamine and
prostaglandins might stimulate basophils to replenish their
stored histamine by increased amine formation de novo.
Studies on the effects of eosinophils on histamine
replenishment were also performed. Eosinophils had no
14
effect on either the amount of C-histidine incorporated
14
or C-histamine formed by antigen stimulated or unchallenged
basophils. Therefore, using this in vitro model the
eosinophil was apparently unable to influence basophil
histamine replenishment.
In summary, this study has attempted to provide insight
into the mechanisms of histamine assimilation within the
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CHAPTER I - INTRODUCTION
SECTION I - IMMEDIATE-TYPE (TYPE I) HYPERSENSITIVITY
1-° INTRODUCTION
Mast cells and basophils were first described at the
end of the nineteenth century (reviewed by Michels, 1938)
although it was not until 1941 that the first reference to
mast cell damage in anaphylaxis was reported (Jaques and
Waters, 1941). The concept that a membrane receptor might
play a role in anaphylactic reactions was, however, proposed
by Dale (1913) and Weil (1913) long before the role of mast
cells in this reaction or the nature of the immunoglobulin
involved was appreciated.
The fact that allergic serum contained a humoral factor
which upon passive transfer may cause allergic symptoms in a
healthy individual was first observed by Ramirez in 1919 and
further extended by the classical experiments of Prausnity
and Kilstner in 1921 (reviewed by Prausnity, 1955). The
studies of Ishizaka and Ishizaka during the 1960?s clearly
established that immunoglobulin E (IgE) was the reagin
implicated in the pathogenesis of atopic allergy (reviewed
by Ishizaka and Ishizaka, 1975).
The first observations of antigen-induced degranulation
or histamine release from isolated mast cells and basophils
was reported at the end of the 1950's (reviewed by Mongar and
Schild, 1962). Since then the molecular basis of histamine
storage, the presence and structure of various other pharmaco¬
logical mediators and the biochemical events associated with
ft
their release have been determined in a variety of species.
2.0 PRIMARY TARGET CELLS
Tissue mast cells develop from undifferentiated mono¬
nuclear mesenchymal cells in the perivascular areas of
connective tissue (Asboe-Hansen, 1973). They are ubiquitous
in the loose connective tissues of higher vertebrates and, in
general, are distributed along blood vessels. Mast cells,
along with the basophil leucocyte (see Section II) have the
capacity to bind IgE on to their surface. Subsequent inter¬
action between specific antigen and bound IgE results in
degranulation with mediator release.
5
3•0 immunoglobulins associated with mast cell and
basophil pegranulation
Immunoglobulin molecules capable of interacting with
homologous or closely related cell membrane receptors and
generating a trigger for antigen-induced noncytotoxic,
complement-independent release of intracellular granular
constituents such as histamine are functionally defined as
homocytotropic (Becker and Austen, 1966).
The IgE class of antibody which has been studied
extensively in man and is found in many other species, fits
this definition. However, recently certain immunoglobulin
subclasses have been described in several species which
possess the same biological properties.
3.1 Immunoglobulin E
In man, IgE is a glycoprotein of molecular weight 188,000
containing 12% carbohydrate. Electrophoretically it migrates
as a globulin (Johansson and Bennich, 1967), circulates as
a minor component of normal blood, 0.1 to 0.4 pg.ml and
like all other immunoglobulins it is produced-by plasma cells.
IgE is composed of two light and two heavy chains and is
probably divalent. It has a short half life in the serum of
about 2-3 days (Waldmann, 1969); by contrast T-§- of IgG is
25 days. It does not "fix complement" via the classical
pathway when reacting with antigen but can activate the
alternative pathway (Ishizaka and Ishizaka, 1975).
The fixation of IgE to human basophils has been
demonstrated by autoradiography and electron microscopy
(Ishizaka et aT, 1970a; Sullivan et al, 1971). The
functional presence of IgE, i.e. to release histamine,
constitutes indirect evidence for the existence of a receptor.
This approach has been used to show that binding occurs via
the Fc portion of the molecule (Ishizaka et aT, 1970b) and
that it is this part which is heat labile. IgE is distribu¬
ted over the entire basophil surface, as judged by immuno¬
fluorescence and immunoferritin electron microscopy, but can
be redistributed with anti-IgE to form patches or "caps" in
a manner analogous to "capping" observed with lymphocytes
and other cell types (Taylor et. al, 1971).
The affinity of IgE for the cell surface is normally
-8 -9
very high at physiological pH, of the order 10 to 10
moles. 1 ^ for human basophils (Ishizaka et £uL, 1973).
3
Normally each cell is thought to possess about 10-40 x 10
molecules of bound IgE but this may be increased three- to
seven-fold by exposure to high concentrations of IgE. It
3
has been estimated that there are 30-100 x 10 receptor sites
for IgE on a normal basophil and that in an atopic individual
the vast majority may be filled. The binding between IgE
and the cell surface is reversible and does not involve a
covalent bond (Ishizaka and Ishizaka, 1974; Ishizaka e_t al,
1973).
3. 2 Non-IgE homocytotropic antibodies
Reagin IgE antibodies of man and IgE-like antibodies
of animals normally occur in very small amounts in normal
serum, are heat labile and can confer passive sensitization
for several weeks. Some species have anaphylactic antibodies
of two immunoglobulin classes, IgE and a subclass of IgG.
The non-IgE antibodies have certain characteristics in
common. They have a gamma electrophoretic mobility, belong
to an immunoglobulin class present in mg amounts in serum,
have a sedimentation coefficient of 7S and have a relatively
rapid turnover (Stechschulte, 1978). In contrast to IgE
they are relatively heat stable, resistant to sulphydryl
reagents and involve complement in selected reactions.
Rat IgGa, mouse IgG-^, sheep IgS, guinea pig IgG^ and
rabbit IgGa have all been identified as homocytotropic anti¬
bodies (Stechschulte, 1978; Esteves e_t aT, 1974). Recently
IgG^ has been implicated as an anaphylactic IgG antibody in
man (van der Giessein et aT, 1976; Shakib et aT, 1977)
8
4.0 BIOCHEMICAL MECHANISMS OF MEDIATOR RELEASE
The interaction of fixed tissue mast cells or circulating
basophils with a variety of stimuli results in the secretion
of a number of mediators which play a prominent role in the
inflammatory process.
4.1 Immunoglobulins in mediated secretion
Of the wide variety of stimuli known to initiate
secretion from mast cells, the reaction of cell-bound IgE
with antigen has major biological relevance. It has been
demonstrated to occur in vitro and iri vivo and represents an
integral component of acute allergic reactions.
It appears that the initial signal for mediator release
is generated by the cross-linking of surface IgE by antigen
(Ishizaka and Ishizaka, 1975). Studies in a variety of
in vitro model systems have revealed that the release process
is non-cytotoxic and essentially a selective secretion. The
antigen-induced release of histamine from IgE-sensitized human
basophils occurs without loss of intracellular K+ ions
(Lichtenstein and Osier, 1966), impairment of- vital dye
exclusion (Lichtenstein and Osier, 1964) or loss of motility
under phase contrast microscopy (Hastie, 1971).
The mechanism of anaphylactic histamine release from
mast cells was first investigated by Mongar and Schild (1957a;
1957b; 1958) using actively sensitized guinea pig lung
fragments. Later the biochemical reactions involved were
also studied in the mast cells from other species including
rats (Uvnas and Thon, 1961), mice (Prouvost-Danon et al, 1966)
and man (Kaliner and Austen, 1973) and in human, rabbit and
guinea pig basophils (Lichtenstein and Osier, 1964; Greaves
and Mongar, 1968a, b; Greaves and Burdis, 1968).
Once the mast cell is perturbed, a cascade of steps
including calcium ion influx, the activation of a serine
esterase, an energy requiring phase, a second calcium
dependent event and a fall in intracellular cyclic-3?,5'-
adenosine monophosphate (cAMP) occurs (reviewed by Austen,
1974). This cellular activation results in the release of
preformed, primary mediators such as histamine and ECF-A in
a fully active form and the generation and release of unstored
factors such as SRS-A and PAF.
The degranulation process has been studied in the
electron microscope (Uvnas, 1974; Chan, 1972). Following
antigen challenge of sensitized cells the appearance of the
granules changes and adjacent granules fuse to form vacuoles
which eventually join with the plasma membrane. This creates
open channels between the granules and extracellular space
which permits the release of partially dissolved granules.
Discharged granules reside in the tissue until they are
removed by phagocytes.
The main constituent of the mast cell granule is a
complex between basic polypeptides and the acidic polymer
heparin. This complex is thought to be responsible for the
cationic binding properties of the granules (Uvnas, 1974).
The release of certain primary mediators, including histamine
and 5"-hydroxytryptamine, has been explained as a simple
cationic exchange between granule amines and extracellular
cations, mainly sodium ions. While acetyl-(B-D-glucosaminadase
exhibits partial releasibility from the discharged or isolated
granules and heparin and chymase are not released from mast
10
cell granules until it undergoes dissolution in high salt
concentrations (Yurt ej; al, 1977).
The secondary mediators are a growing group of
substances which are derived from the action of primary
mediators upon other cell types in the immediate environment
(Austen and Orange, 1975).
It is now well established in studies with human lung
fragments and peripheral blood leucocytes enriched with
basophils that mediator release is controlled by the levels
of cAMP. Agents capable of stimulating adenyl cyclase,
such as (3-adrenergic catecholamines (Orange et al, 1971),
histamine (Grant et al, 1974) and E series prostaglandins
(Tauber ej; al, 1973) increase the concentration of cAMP and
inhibit mediator release. Inhibitors of phosphodiesterase,
the enzyme responsible for cAMP breakdown to AMP, such as
methylxanthines, also block mediator release (Bourne ert al,
1971b). Conversely, imidazole stimulates phosphodiesterase
lowering the cellular concentration of cAMP and enhances the
release of both histamine and SRS-A (Kaliner and Austen,
1974). The release of chemical mediators is also enhanced
by a-adrenergic agonists and low concentrations of prosta¬
glandin F0 which decrease cAMP levels (Orange et al, 1971;£ cc
Kaliner ej; al, 1972). Thus there appears to be an inverse
relationship between cAMP levels and the degree of mediator
release. The presence of a- and p-adrenergic receptors and
receptors for histamine and prostaglandins on the target
cells is also implied by these observations.
Cholinergic stimulation of sensitized lung fragments
with acetylcholine or carbamylcholine chloride results in
enhancement of the IgE-dependent release of chemical
mediators. The enhancement is not associated with a
decrease in cAMP concentrations (Kaliner et aJ, 1972) and
is blocked by the addition of atropine, indicating that the
cholinergic receptors on the target cells in human lung
tissue are of the muscarinic type. Cholinergic stimulation
results in an increased tissue concentration of cyclic-3*,5'-
guanosine monophosphate (cGMP) (Lee £t aJL, 1971), and the
addition of 8-bromo-cyclic GMP to human lung fragments effects
a dose-dependent enhancement of histamine release and SRS-A
generation (Kaliner et al, 1972).
The opposing effects of cAMP and cGMP, the so-called
"Yin Yang" effect (Goldberg et aJ, 1973), have also been
observed in other tissues and cells (Turner et al, 1972;
George ejt al, 1970). However, it is important to emphasize
that there is no evidence that altering cAMP or cGMP levels
can initiate secretion of mediators from mast cell or
basophils per se.
Histamine can be released from rat mast cells (Kaliner
and Austen, 1974) and human basophils (Ishizaka ejt al, 1971)
by antibody directed against IgE immunoglobulin. The cross-
linking of cell-bound IgE molecules by antibody triggers
mediator release in a similar noncytotoxic manner as antigen.
An identical release reaction has been reported by Siraganian
and Siraganian (1975) using concanavalin A to induce secretion
►
from human leucocytes. This lectin is thought to act by
cross-linking the IgE molecules on the surface of the
basophil since its action is inhibited by Fab anti-IgE
specific for the Fc portion of the immunoglobulin molecule
(Magro, 1974). Keller (1973) observed that concanavalin A
induced release of histamine from parasite infected rats but
not unsensitized animals. However, Bach and Brashler (1975)
suggest that these interactions may be complex in the sense
that histamine was released by some lectins but not others.
All the above mechanisms are noncytotoxic processes.
Anti-mast cell antibody in the presence of the second and
sixth components of complement induces histamine release
(Valentine £t al, 1967). This reaction was shown to be
cytotoxic but it has also been demonstrated that histamine
was released to a greater extent than were cytoplasmic
constituents.
4.2 Other stimulants of mediator release
Activated serum has been shown to initiate the release
of histamine from perfused guinea pig lungs (Roch e Silva et al
1951). Cochrane and Mtiller-Eberhard (1968) demonstrated that
activated C3 had anaphylatoxin activity and induced the non¬
cytotoxic release of histamine from isolated rat peritoneal
mast cells. Further studies revealed that the activity was
associated with a low molecular weight cleavage fragment of
C3, C3a, and that C5a was also capable of initiating histamine
release (Johnson ejt al, 1975).
A number of relatively low molecular weight polypeptides
from the venom of several insects and reptiles have the
capacity to cause the release of amines from mast cells
(reviewed by Habermann, 1972). A cationic protein from
cobra venom, cobra venom activator (CVA), which initiates
histamine release from rat peritoneal mast cells, has been
described (Morrison et_ ad, 1975a).
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Polymyxin B (Norton and DeBeer, 1955) and compound 48/80
(Uvnas and Thon, 1961) are able to initiate the noncytotoxic
release of histamine from rat mast cells.
Studies by Morrison ejt al (1975b) have provided evidence
that polymyxin B and compound 48/80 induce the release of
amines from mast cells by a common biochemical pathway that
is distinct from the mechanism utilized by CVA protein and C3
fragments.
Several antibiotics have been described which have the
capacity to transport mono and divalent cations across
membranes (Caswell and Pressman, 1972). A23187 has been
2+
used extensively to examine the role of Ca ions in the
release of amines from mast cells. Foreman et, ad (1973)
were the first to establish that this ionophore had the
capacity to induce degranulation and release histamine from
rat peritoneal mast cells. Recently human basophils from
normal and allergic individuals have also been shown to be
stimulated by A23187 to release mediators (Lichtenstein, 1975).
The mechanism of ionophore mediated release appears to share
some, but not all, of the pathways of other noncytotoxic mast
cell/basophil activation. The available evidence suggests
2+
that the antibiotic causes an influx of Ca ions which is a
critical event in the triggering of the secretion reaction.
This step appears to occur after the modulation by cAMP and
before that requiring metabolic energy (Garland and Mongar,
1976).
Several other stimuli have been reported which induce
histamine release from mast cells and/or basophils. These
include low molecular weight cationic polypeptides extracted
from the granules of various leucocytes (Kelly and White, 1973,
Ranadive and Cochrane, 1971), dextran (Garland and Mongar,
1976), adenosine-5*-triphosphate (Diamant and Krilger, 1967)
and various enzymes (Uvnas and Antonsson, 1963).
5•0 PHARMACOLOGICAL MEDIATORS OF HYPERSENSITIVITY
The association of numerous mediators of immediate-type
hypersensitivity with mast cells and basophils has been
inferred from data provided by iri vivo and iii vitro models
in several mammalian species. The interaction of specific
antigen with IgE on the surface of mast cells and basophils
results in the release of preformed basic amines and acidic
peptides and the generation and release of at least three
newly formed substances; slow reacting substance of
anaphylaxis (SRS-A), platelet activating factor (PAF) and
lipid chemotactic factors. Secondary to this, other
substances such as prostaglandins and bradykinin are produced
by the action of the primary mediators upon other cell types.
5.1 Histamine
The histamine present in most tissues is formed from
L-histidine by a specific L-histidine decarboxylase which
requires pyridoxal-5-phosphate as coenzyme. Following
synthesis the histamine is stored in cytoplasmic granules
within mast cells and basophils and is normally only released
slowly from tissues, the half-life being about 50 days
(Schayer, 1952).
Histidine decarboxylase has a pH optimum at 6-7
depending on the substrate concentration; it shifts towards
the alkaline side as the concentration of substrate decreases
and is accompanied by a decrease in enzyme activity (Hakanson,
1967a). The affinity of the enzyme for its substrate also
varies with pH, At neutrality the affinity for histidine
is higher than in more acid pH (Hakanson, 1963b). It is
also probable that the enzyme attacks the anionic form of
histidine for which the percentage concentration is inversely
related to (ifakanson, 1967b). Therefore, at low pH the
enzyme is more active but there is less histidine available
and the concentration of the anionic form of histidine is a
limiting factor for histamine production. At more alkaline
pH the amount of available substrate is higher but the enzyme
activity is lower; thus the enzyme activity becomes the
limiting factor. It is, therefore, possible that pH varia¬
tions, depending on substrate concentration and the effect of
pH on K^, might be one of the mechanisms of autoregulation
for histamine synthesis.
The enzyme may also be controlled through its coenzyme
pyridoxal 5'-phosphate which under certain conditions may
react irreversibly with amines and amino acids. In such
reactions Schiff's bases are transformed into cyclic compounds
depending on the reacting amino acids. Pyridoxal 5?-phosphate
reacts with l-amino-2-imidazole compounds, such as histidine
and histamine, to form imidazoletetrahydropyridines (Heyl et al,
1952) and with 3-hydroxyphenylaline cyclic compounds of the
tetraisoquinoline type are formed (Schott and Clark, 1952).
It also reacts with cysteine (Buell and Hansen, 1960) to form
a thiazolidine derivative, a reaction which does not proceed
via Schiff's base formation.
The formation of these compounds leads to the inactiva-
tion of the coenzyme and may be of importance in the process
of inhibition of enzymatic reactions involving pyridoxal 5'-
phosphate. Histidine, histamine, other amines and amino
acids may, in certain conditions, form these compounds and
inhibit histidine decarboxylase.
Nearly all tissues have the capacity to catabolise
histamine (Schayer and Reilly, 1974). In man, histamine is
largely methylated to form l-methyl-4-(p-aminoethyl)-imidazole
(methylhistamine) which is then deaminated by monoamine
oxidase to form l-methylimidazole-4-acetic-acid. A second
route involves the oxidation of histamine by diamine oxidase
to imidazole-4,5-acetic acid which is then conjugated and
excreted as l-riboxyl-imidazole-4-acetic acid (Schayer, 1959).
The studies of Ash and Schild (1966) and Black ejt al
(1972) have demonstrated the presence of at least two classes
of histamine receptor. The receptors involved in histamine-
induced contraction of the smooth muscle of various organs
including the gut and bronchus are Hl-dependent. Histamine
also stimulates gastric acid secretion, increases heart rate
and relaxes the rat uterus; these effects are sensitive to
H2-receptor antagonists.
Circulating leucocytes including basophils, neutrophils
and at least certain thymus-derived lymphocytes also appear
to possess H2 receptors and indeed histamine has been shown
to inhibit IgE-mediated histamine release, lysozomal enzyme
release and allogeneic cell killing by these respective cell
types (Bourne et al, 1971; Zurier ei: aT, 1974; Plaut et al,
1973).
5.2 Preformed chemotactic factors
Eosinophil chemotactic factor of anaphylaxis (ECF-A)
was first described by Kay et al (1971) and shown to attract
eosinophils selectively in modified Boyden chambers.
This preformed mediator from human lung is composed of
at least two tetrapeptides, alanine-glycine-serine-glutamic
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acid and valine-glycine-serine-glutamic acid (Goetzl and
Austen, 1975). The chemotaxis to these tetrapeptides is
thought to involve the binding of a hydrophobic domain of
an eosinophil receptor with the N-terminal and activation
of an ionic domain with the glutamic acid C-terminal (Goetzl
and Austen, 1976).
In addition to the low molecular weight ECF-A, two other
groups of preformed chemotactic factors have been extracted
and/or immunologically released from human lung fragments and
rat peritoneal mast cells. Eosinophil chemotactic oligo¬
peptide with a molecular weight of 1200-2500 (Austen et al,
1976) also preferentially attracts eosinophils in vitro. A
neutrophil chemotactic factor (NCF) has also been described
in human leukaemic basophils (Lewis e_t al, 1975) and human
lung fragments (Austen et al, 1976).
5•^ Slow reacting substance of anaphylaxis
The chemical structure of slow reacting substance of
anaphylaxis (SRS-A) is not known (Orange and Austen, 1969)
although it is thought to be an acidic sulphur-containing
lipid of molecular weight 300-400 daltons (Orange et al, 1974).
Its activity is measured by bioassay on an atropinized anti¬
histamine treated guinea pig ileum (Brocklehurst, 1962).
SRS-A is generated and released by antibody-mediated immuno¬
logical reactions and by calcium ionophore. A small amount
of SRS-A is present in a preformed state (Turnbull et al,
1976). Although other mediators may be released concomitantly
evidence suggests that the release of preformed mediators and
the pathway leading to the SRS-A release involves both common
and different steps (Austen and Orange, 1975).
The studies of Schild elt aT (1951) and Brocklehurst
(1962) clearly implicate SRS-A as a potentially important
mediator of human allergic bronchoconstriction. SRS-A
also increases vascular permeability upon intracutaneous
injection (Orange £t al, 1969) and decreases pulmonary
compliance independent of a cholinergic mechanism when
injected intravenously in the guinea pig (Drazen and Austen,
1975).
5.4 Platelet activating factor
Platelet activating factors (PAF) are a family of
substances released by immunological activation of basophils
and mast cells from a variety of tissues (Austen and Orange,
1975). They release 5'-hydroxytryptamine from, and in some
cases aggregate, homologous platelets and are thought to be
lipid-like materials (Kater ejt al, 1976).
5.5 Lipid chemotactic factors
Lipid factors which chemotaetically attract neutrophils
are released from sensitized human lung fragments and rat
peritoneal mast cells following antigen challenge (Valone and
Goetzl, 1978). These factors are chromatographically distinct
from SRS-A and PAF and could be derived from arachidonate
metabolism.
5.6 Other potential mediators
Macromolecular heparin, having a molecular weight of
750,000, has recently been'shown to be released from rat mast
cells by an IgE-dependent mechanism (Yurt et aT, 1977) as has
arylsulphatase A (Orange and Moore, 1976).
Antigen challenge of IgE sensitized human lung fragments
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and peripheral leucocytes (Newball et al, 1975b) results
in the release of a chymase capable of hydrolysing synthetic
substrates such as N-benzyl-L-tyrosine ethyl ester. Super-
natants from antigen challenged human leucocytes also appear
to contain a kallikrein activity which cleaves bradykinin
from its natural substrate, kininogen (Newball et al, 1975a).
Whether these two activities are the same or different
enzymes remains to be established.
In addition, antigen challenge of sensitized human
(Piper and Walker, 1973) and guinea pig (Dawson e_t a_l, 1976)
lung results in the release of various prostaglandins and
thromboxanes.
SECTION II - THE BASOPHIL LEUCOCYTE
1•0 historical background
The basophil leucocyte was first observed in the blood
of patients with chronic myeloid leukaemia by Paul Ehrlich
(1891). He recognized them as a form of polymorphonuclear
granulocyte derived from the bone marrow, distinct from
tissue mast cells which he had previously described and
differentiated from the plasma cells of Waldeyer (1875).
The major problem in the study of blood basophils is their
relative paucity and lack of obvious function. Prior to
1953, when the first direct chamber counting method was
developed by Moore and James (1953), very little information
on the chemistry and pharmacology of these cells was availabl
However, when reviewed by Michels (1938) their morphology and
distribution in many organisms had been studied in depth,
along with their variation under numerous pathological
conditions.
Interest in basophils has been stimulated in the last
decade by findings that implicate them in both immediate and
delayed types of hypersensitivity. Ishizaka and Ishizaka
(1971) demonstrated that basophils specifically bind homo-
cytotropic antibody, thus sensitizing them for antigen
induced mediator release. It is possible, therefore, that
basophils as well as mast cells participate in atopic
allergic disease. The application of modern histological
methods for fixing and processing tissue has implicated
basophils in several forms of delayed type hypersensitivity
(Dvorak et, al, 1971).
2•0 ORIGIN AND DIFFERENTIATION
The basophil is a polymorphonuclear granulocyte which
differentiates in the bone marrow. The mature form
circulates in the blood of most vertebrates including man
(Michels, 1938) where its life span is 8-12 days.
Basophil differentiation has not been studied in man
but several studies have been carried out on the guinea
pig (Winqvist, 1963; Terry £t aT, 1969; Dvorak £t aT, 1972)
Early myelocytes are the first cell in which basophil-
specific granules appear. These cells have a prominent
Golgi apparatus and abundant rough endoplasmic reticulum.
Basophil granules arise as small vesicles which pinch
off from the Golgi cisternae. These granules subsequently
aggregate to form larger, but still immature, structures
lying in the peripheral cytoplasm. They show reticular,
mottled or loose lamellar ultrastructure and have only a
thin hole around the matrix in contrast to the broad rim
surrounding the majority of the definitive granules. With
further development the granule precursors organise to form
the highly ordered patterns characteristic of mature granules
The origin of basophil granules from the Golgi apparatus is,
therefore, comparable to that of the secretory granules of
neutrophils, eosinophils and other cells including mast cells
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3.0 DISTRIBUTION AND FREQUENCY
The distribution and frequency of basophils varies
in certain physiological and pathological conditions.
3.1 Normal
Basophils, which account for less than 1% of the
circulating leucocytes and about 0.3% of the nucleated cells
of the bone marrow, are the least numerous human granulocyte
(Juhlin, 1963a). Slight variations in basophil frequency
have been reported with age and sex. Their percentage is
somewhat lower in children (Mitchell, 1958) while young
adult females have the highest basophil counts (Thonnard-
Neumann, 1963).
With few exceptions a 0.5-1.0% level is maintained in
most mammalian species. However, in rabbits and camels
basophils have been reported to account for up to 10% of
the circulating leucocytes. In lower vertebrates, as a
rule, basophils comprise a much larger percentage, 7-33%,
while in most fish they are extremely rare (Michels, 1938).
3.2 Variations
Basophil counts are altered by a variety of hormones.
Cortisone and adrenocorticotrophic hormone induce a fall in
the number of circulating basophils in man, but to a lesser
extent than eosinophils (Keleman and Bikich, 1956).
Boseila et al (1959) have suggested that the numbers of
basophils may be controlled by the action of circulating
thyrotrophin and thyroid hormone. L-thyroxin depresses
basophil numbers whereas metabolically inert D-thyroxine
increases basophil levels, possibly by inhibiting thyrotrophin
secretion.
Sex hormones influence the number of circulating
basophils which also vary during the menstrual cycle
(Boseila, 1959). Their numbers are increased under the
influence of oestrogens and decreased by luteal or
progesterone action. In the rabbit a fall in the number
of circulating basophils occurs at the time of ovulation;
simultaneously an accumulation of basophils takes place in
ovaries and oviduct vessels and around the recently ruptured
follicles (Zachariae £t al, 1958).
Physiological variations in the number of basophils
in man were studied by Rorsman (1962) who noted that food
intake, moderate exercise and mechanical lesion of the small
blood vessels did not influence the levels of circulating
basophils.
Variations in basophil numbers have been reported in
a variety of diseases. They can be dramatically increased
in myeloproliferative disorders, particularly chronic
granulocytic leukaemia where they may number more than
s* 1
90 x 10 .ml- (Youman e_t al, 1973) and can account for over
90% of the circulating leucocytes (Austen et aT, 1974).
Elevation in the blood basophil count has also been reported
in ulcerative colitis, myxoedema, chronic sinusitis, small¬
pox, chicken pox, polyerythaemic vera and in various atopic
states (Fredricks and Maloney, 1959; Juhlin, 1963b;
Shelley and Parnes, 1965). Peripheral basophil numbers
are low in urticaria, acute infection, following x-radiation
or chemotherapy and immediately following anaphylaxis
(Rorsman, 1962; Shelley and Juhlin, 1961).
In certain experimental animals the number of basophils
can be greatly increased by the administration of various
antigens. In the guinea pig substantial elevation of bone
marrow and circulating basophils can be achieved by repeated
injection of large quantities of heterologous serum or blood
(Ringoen, 1923; Chan and Yoffey, 1960; Winqvist, 1960).
This phenomenon has been used by Dvorak <3t ajL (1974) to
prepare large numbers of purified basophils. The mechanism
responsible for the increased basophilopoiesis has not been
established but the basophil response is highly selective
in that there is little change in the overall blood leucocyte
or bone marrow nucleated cell count. The number of eosino¬
phils may also increase but the increment is smaller and
slower to develop (Albanus and Winqvist, 1961).
In 1923 Ringoen described a pronounced basophil
granulocytic exudation in the subcutaneous connective
tissues of guinea pigs 4-8 days after the injection of egg
white. Since then basophil leucocytes have been reported
to infiltrate certain tissues in various diseases, without
the presence of a peripheral basophilia.
Basophils are characteristically present in reactions
of delayed type hypersensitivity, including allergic contact
dermatitis, skin allograft and tumour rejection and hyper¬
sensitivity to protein antigens (Dvorak and Mihm, 1972;
Dvorak, 1971; Wolf-Jtlrgensen, 1966). Their presence has
also been reported in other diseases of the skin where a
component of cell-mediated hypersensitivity may exist,
including eczema, psoriasis and drug reactions, dermatitis
herpetiformis, insect bites and photo—contact dermatitis
(Juhlin, 1963c; Aspegren £t aJ, 1963b; Fregert and Rorsman,
1964). Felarca and Lowell (1971) described basophil
infiltration into allergen-specific skin window sites in
some patients with atopic disease.
Basophils have also been reported in other tissues.
Colvin ejt al (1974) observed their presence in drug-related
allergen interstitial nephritis. They are also a component
of the inflammatory infiltrate in renal allografts undergoing
active cellular rejection (Colvin and Dvorak, 1974).
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4.0 MORPHOLOGY
Basophils from various species have been studied in the
electron microscope and substantial differences in their
ultrastructural appearance have been described. Again,
such studies on normal human basophils have been hampered
by their paucity in peripheral blood and susceptibility
to damage. However, the use of animal models, especially
the guinea pig, has provided a great deal of information on
their nuclear and cytoplasmic structure.
In vital films studied by phase-contrast microscopy,
human basophils measure 10-14 pm in diameter and are the
smallest of the granulocytes (Ackerman and Bellios, 1955).
4.1 Nucleus
Basophils have a band or bilobed nucleus with dense
irregular condensations of chromatin along a thin nuclear
membrane. The nucleus is quite similar to that of the
neutrophil and eosinophil although the segmentation of the
nuclear lobes is less pronounced.
4.2 Granules
The characteristic cytoplasmic granules of the human
basophil are electron dense, round, oval and angular shaped,
membrane-bound structures that measure up to 1.2 pm in
their largest dimensions (Zucker-Franklin, 1967). The sub¬
structure of basophil granules is composed of dense particles
embedded in a less dense matrix. Those particles, present
within a single granule, can vary in size and are generally
rounded but have irregular peripheral borders. Some granules
contain complex collections of membranes. A second set of
smaller granules is generally found between the lobes of the
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nucleus (Hastie, 1974). These are bound by thinner membranes
and contain uniform, lightly dense material.
The granules of the guinea pig basophil on average
measure slightly more than 0.5 by 1.0 jam but occasionally
even 1 by 2 [am. According to the plane of the section
o
they appear oval or spherical and may show a repeating 130 A
banded pattern, a hexagonal array or a rectangular lattice
(Terry et aJL, 1969; Winqvist, 1963). Some granules contain
only uniform, finely granular material with no discernible
repeating pattern. Whatever the substructure, the granules
are frequently surrounded by a hole of varying breadth.
This rim is not entirely empty but contains material of low
electron density that sometimes forms concentric or radical
filaments and separates the granule matrix from the membrane.
Rabbit basophil granules are composed of very dense
particles which may be arranged in a regular array (Wetzel,
1967).
4.3 Other organelles
The cytoplasm of the guinea pig basophil contains small
vesicles and vacuoles, some of which are in continuity with
cytoplasmic granules. Relatively few mitochondria and
ribosomes are present. The former are long and slender,
about 0.3 by 1.5 jam, with numerous transverse cristae.
The Golgi apparatus, usually situated in the central part
of the cell, and an endoplasmic reticulum are present in
mature cells but these, along with ribosomes, are more
abundant in immature elements. One or two centrioles have
been observed between the nucleus and the Golgi apparatus
(Winqvist, 1963). Microfilaments and microtubules have
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been identified. The plasma membrane is thin, about 11 nm,
and frequently shows short surface villi and large blunt
pseudopodal processes.
Similar organelles have been described in other species,
including man. In all species studied the mature cells
contain large numbers of glycogen particles which are often
closely associated with the cytoplasmic granules and
vesicles.
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5.° BIOCHEMISTRY AND PHARMACOLOGY
The elusiveness of the basophil has, until recently,
complicated the analysis of its biochemical constituents.
In fact, much of the available data has been derived from
studies using extremely impure cell populations and will
require further confirmation. However, cytochemical
evidence, when available, is much more reliable.
5.1 Pharmacological mediators
Several low molecular weight substances are released
from leukaemic basophils following an anaphylactic reaction.
These include at least four substances, histamine, SRS-A,
ECF-A and PAF (Lewis et al, 1975) which are also found in
mast cells.
5.1.1 Histamine
Since Dale (1913) first described histamine as a
mediator of immediate-type hypersensitivity there has been
increasing evidence that the basophil is the site of
storage of this amine in blood. Histamine content was
found to correlate with basophil frequency in both normal
volunteers and patients with chronic myelogenous leukaemia
(Ehrich, 1953; Valentine et aT, 1955). Graham et al (1955)
originally estimated that half of the blood histamine was
confined to basophils. The release of histamine from human
basophils was conclusively demonstrated by Ishizaka and co¬
worker (1972) and it is now generally accepted that virtually
all the histamine present in human and guinea pig blood is
contained within basophils. In contrast, rabbit basophils
account for only one-quarter of the blood histamine, the
remainder being associated with the platelets (Code, 1952).
Assuming that all the histamine is present within
basophils it can be estimated that in man each cell contains
1-2 pg (Graham et ad, 1955). Cell disruption studies have
revealed that the majority of the histamine present within
human basophils is located within the cytoplasmic granules
(Pruzansky and Patterson, 1967).
Basophils are capable of synthesizing histamine from
L-histidine, the reaction being catalysed by a histidine
decarboxylase which has been detected in blood (Hartman
et al, 1961; Ackerman, 1963). As the rate of histamine
formation was proportional to the number of basophils
(Lindell ejt al, 1961), the enzyme is presumably in these
cells. Indeed, guinea pig basophils have been reported to
take up very little extracellular histamine (Galli et al,
1976) although Day ejt al_ (1974) have claimed that human
basophils do incorporate this amine and store it in their
granules. Galli et ad (1976) have also provided evidence
that circulating guinea pig basophils are capable of
histamine synthesis.
5.1.2 Other mediators
Both normal and leukaemic human basophils have been
shown to release SRS-A (a mediator which is largely pre¬
formed, the majority being generated in the course of
immediate hypersensitivity reactions (Grant and Lichtenstein
1974; Clark et al, 1976)) and ECF-A (Parish, 1972).
Rat leukaemic basophils, like rat peritoneal mast cells
may contain 5-hydroxytryptamine, but human basophils
apparently lack this substance (Humphrey and Jaques, 1954).
PAF has been identified in rabbit (Siraganian and
Osier, 1971) and human (Benveniste, 1974) leucocytes.
That the source of this chemical mediator is the basophil
is indicated by the fact that PAF can be released from
suspensions of human leukaemic basophils upon interaction
with calcium ionophore (Lewis et, eLL, 1975).
Several other possible pharmacological mediators have
been reported to be present in human basophils or to be
released from them by antigen challenge. These include a
kallikrein activity (Newball et aJL, 1975a) and a chemotactic
factor selective for neutrophils (Lewis ejt al, 1975).
5. 2 Acid mucopolysaccharides
Basophils from all mammalian species studied exhibit
metachromatic colouration of their granules following
staining with certain basic dyes, such as toluidine blue,
thionine and methylene blue (Ackerman, 1963). On this
basis, basophil granules have been thought to contain
sulphated acid mucopolysaccharides or proteoglycans and,
by analogy with mast cells, this was presumed to be heparin
(Lagunoff ejt al, 1964).
Several workers have reported the presence of
chondroitin sulphate in rabbit and human basophils (Olsson,
1971; Olsson elb aJ, 1968). Recently Orenstein and co¬
worker (1978) have characterized the acid mucopolysaccharide
present in guinea pig basophils i_n vivo and iri vitro, using
»
35S labelling. They found that the majority of these
macromolecules was a mixture of chondroitin sulphate,
dermatan sulphate and small amounts of heparin sulphate.
No heparin was detected.
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5.3 Enzymes and other constituents
The other cellular constituents have been poorly
characterized. As measured cytochemically, basophils are
said to lack hydrolytic enzymes such as alkaline phosphatase,
aminopeptidase and non-specific esterases (Ackerman, 1963).
Recently, Dvorak et al (1977) using biochemical and ultra-
structural techniques demonstrated proteolytic enzyme
activity in purified guinea pig basophil granules. These
preparations contained a mixture of neutral esterases:
proteases including caseinolytic activity and both trypsin-
and chymotrypsin-1ike serine hydrolyases were identified.
Peroxidase activity has been reported in human basophil
granules but it is normally lacking in basophils from the
rabbit and guinea pig (Ackerman, 1963; Ackerman and Clark,
1971). Guinea pig basophils have plasminogen activator
activity associated with their plasma membrane (Dvorak ert al,
1978).
A variety of oxidative enzymes, including diaphorases
and several dehydrogenases are present in human basophils
(Balogh and Cohen, 1961; Ackerman, 1963). Human leukaemic
basophils are capable of generating and releasing superoxide
radicals after immunological or non-immunological stimulation
and also contain superoxide dismutase (Henderson and Kaliner,
1978).
Glycogen particles are abundant in the cytoplasm, often
in close approximation to and sometimes within the granules,
of all species studied (Dvorak and Dvorak, 1975).
6-° STORAGE AND RELEASE OF PHARMACOLOGICAL MEDIATORS
The cytoplasmic granules of the basophil hold large
stores of potentially important pharmacological agents.
Under a variety of conditions, including hypersensitivity
reactions, these mediators are released and others formed.
The processes and reactions involved have been described
in Section I (part 4) and are essentially the same as for
mast cells.
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7.0 PHAGOCYTOSIS AND PINOCYTOSIS
Basophils have been reported to ingest sensitized
erythrocytes and antigen-antibody complexes but not
colloidal carbon (Sampson and Archer, 1967; Dvorak £t al,
1972). However, their phagocytic ability is appreciably
less than that of neutrophils and eosinophils and it does
not seem to be one of their major functions.
In contrast, basophils have a substantial capacity for
pinocytosing certain solutes. Neutral red, toluidine blue
and thionine are all ingested by basophils (Sabin, 1923;
Chan and Yoffey, 1960). In an electron microscopic study
Dvorak et aT (1972) demonstrated that horseradish peroxidase
is transported to the cytoplasmic granules by a pinocytotic
process.
S.O CHEMOTAXIS
Human and guinea pig basophils have been shown to be
responsive chemotactically to "lymphokines" elaborated from
sensitized lymphocytes cultured with specific antigen and
products of complement activation (Boetcher and Leonard,
1973; Ward et ajL, 1975). In addition, diffusates from
lung fragments challenged with allergen, the plasma enzyme
kallikrein and an additional complement component, C567,
have been found to be weakly chemotactic for human leukaemic
basophils (Kay and Austen, 1972). Guinea pig basophils are
also attracted by products present in bacterial culture
supernatants (Ward et al, 1975).
The chemotactic response of basophils is not specific
since other cell types respond to the same agents. However,
the kinetics of the basophil migration is distinct, they
respond rapidly and reach a plateau as early as 1 hr whereas
neutrophils and macrophages do not achieve such levels for
2 and 3-5 hr respectively.
9.0 CUTANEOUS BASOPHIL HYPERSENSITIVITY
Several forms of delayed onset, lymphocyte mediated
hypersensitivity are characterized by an extensive
infiltration of basophil leucocytes (Dvorak and Dvorak, 1974)
Such reactions have been termed cutaneous basophil hyper¬
sensitivity or CBH. These were first observed in guinea
pigs with so-called "Jones-Mote" hypersensitivity, a form
of cell mediated reactivity to protein antigens following
sensitization without the use of mycobacterial adjuvants.
In contrast to classic, tuberculin-type delayed hyper¬
sensitivity CBH skin reactions are relatively non-indurated,
are characterized by extensive infiltration of basophils
(one-third to one-half of total infiltrates), contain
substantial amounts of histamine, are affected by lymphocytes
which are difficult to tolerize and lack extensive fibrin
deposits (Dvorak and Hammond, 1978).
CBH reactions may be elicited by skin testing as early
as 4 or 5 days after sensitization and are maximal by 6 to 7
days (Richerson et; al, 1970); after two or more weeks CBH
reactivity often wanes and may be superseded by the
appearance of "late reactions", complex lesions comprised
of sequential but overlapping components of cutaneous
anaphylaxis, Arthus reactivity and a residual basophil
component (Colvin e_t aT, 1973).
While the expression of CBH has been most carefully
studied in the skin of guinea pigs, cell mediated reactions
rich in basophils also occur in other organs and species
(Dvorak and Dvorak, 1974). Examples include peritoneal
rejection of ascites tumour cells in guinea pigs,
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experimental allergic encephalomyelitis in rats and
immunity to parasites (Ogilvie, 1974). Significant
species differences exist in the frequency with which
basophils participate and basophil infiltration is
generally greater in guinea pigs than in other species
studied.
Sensitized lymphocytes are essential to the induction
and expression of these reactions (Dvorak and Dvorak, 1974)
and it is likely that basophils are attracted to local skin
test sites by lymphocyte products. Askenase (1973) has
claimed passive transfer of CBH with immune serum although
other attempts to implicate antibody in the pathogenesis
of these reactions have been unsuccessful.
Basophils have also been described in the cellular
infiltrates in various forms of delayed skin reaction by
the use of skin window techniques (Aspegren et al, 1963a).
Recently they have been identified in human tissue sections
from patients with allergic contact dermatitis and classical
delayed hypersensitivity reactions to microbial antigens
(Dvorak and Mihm, 1972).
Degranulation of the type seen in anaphylaxis has only
rarely been observed in basophils infiltrating CBH lesions in
the guinea pig. However, basophils participating in cell
mediated reactions in man and certain forms of CBH in guinea
pigs (Dvorak et al, 1973) regularly exhibit striking altera-
tions in their cytoplasmic granules which develop progressively
over a period of days as the reaction evolves.
10.0 BASOPHILS AND MAST CELLS
In various species there is a reciprocal relationship
between the number of mast cells and basophils (Michels,
1938). Thus rats, mice and many types of fish, in which
basophils are extremely rare, have numerous fixed tissue
mast cells whereas the opposite is true of the rabbit.
This relationship has supported the widely held view that
the two cell types complement each other and have similar
or even identical functions. In some lower vertebrates
it is impossible to distinguish basophils from mast cells.
Differences occur among mast cells of different species
although this does not seem so marked for basophils.
There is, however, a danger of drawing too close an
analogy between the two cell types. Basophilic leukaemia
and systemic mastocytosis are discrete afflictions involving
the two cell types independently of each other. Therefore,
different mechanisms must be involved in controlling their
numbers and the cells have been shown to arise from
different precursors. Nevertheless, they have a number of
structural features and activities in common.
Basophils and mast cells are the only cell types with
receptors for homocytotropic antibody through which the
release of histamine and other pharmacological mediators
can be activated by antigen and other stimuli. Both cell
types can decarboxylate L-histidine and bind the resultant
histamine in their granules which also contain zinc (Smith
et al, 1969). The granules are metachromatic but that of
the basophil is more labile, a property that can be used
to differentiate the two cell types (Padawer, 1959). In
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man, basophil granules are water soluble whereas mast cell
granules are not. Mast cells contain heparin; however,
the acid mucopolysaccharide of basophils has been shown to
be a mixture of chondroitin, dermatan and heparin sulphate.
Recently Galli et ad (1978) developed a specific anti-
basophil serum which caused histamine release from basophils
but also reacted with mast cells. Therefore, there are
antigenically similar structures on the surface of both cell
types.
Apart from its motility, the chief morphological features
which distinguish the basophil from the mast cell are its
smaller size, more rounded shape, its relatively scanty cyto¬
plasm and usually obscured segmented nucleus. Ultrastructur-
ally human basophil granules display either homologous or
coarsely stripped appearance in the electron microscope.
In contrast, mast cell granules show complex and abundant
whorls. Within any one species the morphology of mast cells
differs from that of the basophil, but the basophil of one
species can resemble the mast cell of another, and vice versa.
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11.0 POSSIBLE ROLE OF THE BASOPHIL LEUCOCYTE
The function(s) of basophils are poorly understood
but they are probably related to the release of mediators
contained within their cytoplasmic granules. The
physiological role of the mast cells is also unknown
although it is presumably not present only to undergo
hypersensitivity reactions. Asboe-Hansen (1973) has
postulated that mast cells participate in all diseases of
connective tissue and that no new formation of such tissues
takes place without a demonstrable activity of mast cells.
Mast cells have also been associated with the host defence
against parasites (Ogilvie and Jones, 1971) where IgE
antibody is also involved.
Norman (1975) has suggested that mast cell degranulation
serves to facilitate an influx of high molecular weight IgG
and IgM from the vasculature for complexing with antigens
extravascularly. This theme has been developed by Padawer
(1978) to incorporate the basophil. He speculates that the
basophil coated with IgE, moves into tissues in response to
chemotactic attraction, not as Norman suggests to transfer
IgE to the mast cell but to release its mediators upon
interaction with extracellular antigen. This would cause
oedema accompanied by influx of IgG, IgM and unbound IgE.
As events proceed, the unbound IgE could interact with mast
cells triggering a second response, leading to the further
involvement of antibody and the attraction of various
inflammatory cells.
This is partly supported by the work of Dvorak and
Dvorak (1974) on CBH. The release of vasoactive amines
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may be responsible for certain features of these reactions
including vasodilation and hence erythema and increased
vascular permeability leading to compaction, oedema and
leakage of fibrinogen and other clotting factors. By
releasing ECF-A, basophils could also be responsible for
attracting eosinophils which are regularly present in these
reactions.
It is still possible that the mast cell and basophil
are complementary. The long-lived sessile mast cells on
site ready to respond instantaneously and the basophil able
to migrate to areas of need. Mast cells in all tissues
being virtually responsible for repair after injury or
infection, with basophils playing their part when required.
During evolution as organisms developed parasites, IgE was
developed as a possible answer to the problem. In the
presence of an infection, parasite specific IgE bound to
mast cells or basophils could be activated, mediators
released and the parasite expelled. The fact that mast
cells and basophils are able to take part in anaphylactic
reactions is a failure to limit their proper response
which leads to disease.
CHAPTER II - AIMS OF THE PRESENT STUDY
There is increasing evidence suggesting a regulatory
role for the eosinophil leucocyte in immediate type (type I
or anaphylactic) hypersensitivity reactions. They may be
involved at all stages of the allergic response, i.e.
mediator release, mediator inactivation and mediator
replenishment.
Eosinophils have been shown to accumulate at the site
of allergic reactions following antigen challenge (Kay,
1970a; Samter et aT, 1953; Fowler and Lowell, 1966).
This accumulation is directed by the release of ECF-A from
mast cells (Kay and Austen, 1971). Recently, histamine and
imidazoleacetic acid have also been shown to be selectively
chemotactic for human (Clark ejt al, 1975; Turnbull and Kay,
1976) and guinea pig eosinophils (Jones and Kay, 1977).
Following an anaphylactic reaction an eosinophil-
derived inhibitor of histamine release (EDI) may inhibit
further mediator release (Hubscher, 1975a). This factor
is thought to be a prostaglandin (Hubscher, 1975b).
The eosinophil's relatively high content of histaminase
(Zeiger and Colten, 1977) and arylsulphatase (Wasserman et al,
1975) may have a biological role in the inactivation of
histamine and SRS-A, respectively. Other antihistamine
effects have been reported in a variety of experimental
models. The first evidence that eosinophils could exert
an antihistamine action was proposed by Kovacs (1950) when
he showed that an eosinophil-rich leucocyte suspension,
injected intraperitoneally, could lessen the effect of
histamine-induced bronchospasm in guinea pigs. Vercauteren
and Peeters (1952) and Vercauteren (1953) demonstrated that
preparations of horse eosinophil granules and arginine
suppressed the effect of histamine on guinea pig ileum.
They suggested that the arginine-rich proteins from the
granules could have antihistamine properties. Archer (1960)
noted that the weal expected after an intradermal injection
of histamine was inhibited if the skin site was previously
injected with a suspension of eosinophils. The same author
reported that injections of horse eosinophils protected
guinea pigs from an histamine aerosol (Archer et al, 1962).
Eosinophils may also influence the repair process which
leads to mediator replenishment. It was shown that when
guinea pigs were depleted of eosinophils, by anti-eosinophil
serum, histamine reaccumulation at the site of passive
cutaneous anaphylaxis was considerably accelerated (Jones
and Kay, 1976); thus suggesting that eosinophils may
inhibit mast cell regranulation. An alternative possibility
is that they suppress the maturation or differentiation of
new mast cells.
Therefore, eosinophils may provide a homeostatic
function, "dampening" and "curtailing" the effects of
pharmacologically active mediators by influencing their
release, inactivation and replenishment.
Apart from its regulatory role in type I hypersensitivity
reactions the eosinophil has been shown to affect mast cells
in other ways. Histamine release is thought to involve the
exposure of membrane-free granules, either by expulsion or
retention in vacuoles connected to the outside, to cation-
containing extracellular fluids which cause amine release by
simple cation exchange (Uvnas, 1974). Eosinophils have been
seen to phagocytose mast cell granules (Welsh and Geers,
1959). Components of eosinophil granules have also been
reported to cause mast cell disruption (Archer and Jackas,
1965). Archer and McGovern (1968) investigating the role
of the eosinophil in parasite infections in rats observed
changes in mast cell populations. As the eosinophilia
developed the mast cells degranulated and after about
10 days new mast cells were forming.
These observations involve the "interaction" between
eosinophils and cells of the mast cell/basophil series.
To investigate these interactions a single cell system was
developed to study aspects of histamine storage and
synthesis. The eventual aim was to determine whether
histamine metabolism was altered in a cell which had
undergone an anaphylactic reaction and if eosinophils or
eosinophil-derived products influenced that metabolism.
Histamine is not the only mediator released from
basophils or mast cells during a type I hypersensitivity
reaction. However, its synthesis is possibly the simplest
to study since it is formed from a single molecule,
histidine, and it is easily detected and measured. Other
pharmacologically active mediators are present in preformed
or precursor states. Their molecular structure is more
complicated and they are more difficult to measure and
quantify.
Guinea pig ECF-A is probably an acidic peptide or
series of peptides similar to the human forms which have
been sequenced (Goetzl and Austen, 1975). It is unlikely
that the basophil or mast cell possess specialized transport
systems for all its constituent amino acids since the amino
acid pool within the cell is probably capable of supplying
all that is required. The structures of the other primary
mediators, SRS-A and PAF, are not known. SRS-A is thought
to be an acidic sulphate ester and PAF a phospholipid
(Austen and Orange, 1975). Therefore, modulations of
their metabolism would be difficult to measure.
Prostaglandins, secondary mediators, have been measured
in sensitized guinea pig lung diffusates (Dawson et al,
1976). However, their detection is very complicated,
requiring gas liquid chromatography and mass spectrometric
analysis. Therefore, histamine is the logical pharmaco¬
logically active mediator to use as a measure of mediator
variations within the basophil.
The histamine found within mast cells and basophils
could be derived from two sources. It could be the result
of direct uptake of histamine from the extracellular fluids
particularly after an anaphylactic reaction when high
concentrations of histamine could be present in the micro-
environment surrounding the cells. Furano and Green (1964)
have supported this concept by showing that isolated rat
mast cells take up and store histamine. Basophils and
mast cells are also capable of forming histamine by the
decarboxylation of L-histidine (Schayer, 1956; Lindell
ejt al, 1961). Therefore, the intracellular histamine
could also be derived from'the uptake of exogenous histidine
and its decarboxylation within the cells.
The development of a method by which guinea pig
basophils can be obtained in relatively high concentrations
(Dvorak ejt al, 1974) afforded the possibility of an
experimental model which could be used to study mast cell/
basophil function. In the present thesis this model has
been developed and utilized to study histidine and
histamine uptake and histamine formation from exogenously
incorporated histidine.
The guinea pig is and has been a useful experimental
animal to use in the study of anaphylaxis. It can be
easily sensitized to a variety of antigens either actively
or passively. The whole animal or some of its organs
respond very strongly to an antigen challenge permitting
the study of quantitatively graded allergic reactions.
Perhaps more importantly the immunologically released
mediators and mechanisms of release are almost identical
to those encountered in man.
Therefore, the uptake of histidine and histamine and
histamine synthesis de novo by guinea pig basophil leucocytes
was used to study variations in histamine storage.
Before the effect of eosinophils on histamine replenish¬
ment after an anaphylactic reaction could be examined the
experimental model had to be investigated. To this end
the uptake of histidine and histamine and histamine synthesis
de novo was examined in depth. If an insight into the control
of these processes could be obtained then the influence of the
eosinophil on these controlling factors may provide an
explanation of the "dampening" effect of eosinophils on
histamine replenishment.
CHAPTER III - MATERIALS AND METHODS
SECTION I - BUFFERS AND REAGENTS
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1.0 BUFFERS
All chemicals were analytical grade obtained from BDH
Chemicals Ltd., Poole, Dorset, unless otherwise stated.
1.1 Tyrode's buffer
Tyrode's buffer was composed of the salts as originally
described (Tyrode, 1910). It was prepared by mixing 40 ml
Tyrode's "A" (see below), 1.0 g glucose, 1.0 g NaHCO^,
1.0 ml 20% CaCl2 and 0.4 ml 25% MgCl2 and making the volume
up to 1 litre with distilled water. The pH was adjusted to
7.25-7.4.
Tyrode's "A" was composed of 200 g NaCl, 5 g KC1, and
1.62 g NaHgPO^^I^O dissolved to a final volume of 1 litre
with distilled water.
1.2 Phosphate buffered saline (PBS)
This was prepared by mixing 6.8 g NaCl, 1.48 g Na2HP04
and 0.44 g KP^PO^ and adjusting the volume to 1 litre with
distilled water.
1.3 PBS/HSA
PBS/HSA is a buffered salt solution composed of phosphate
buffered saline supplemented with 0.3 mg.ml human serum
albumin (a gift from the South-East Scotland Regional Blood
Transfusion Service) and 0.1% EDTA and adjusted to pH 7.3.
1.4 Modified phosphate buffered saline
Modified PBS was prepared by dissolving 6.8 g NaCl,
1.48 g K2HPC>4, 0.43 g KH2P04 and 1 g glucose up to 1 litre
with distilled water.
Choline substituted modified PBS was prepared as above
but adding 16.3 g choline chloride in place of the NaCl.
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1.5 Eagle's Minimal Essential Medium without histidine
This contained the constituents as described by Eagle
(1959) with the exception of L-histidine. It was prepared
as a ten times concentrate by dissolving the constituent amino
acids in 95 ml ten times concentrated Eagle's balanced salt
solution with Earle's salts and 10 ml one hundred times con¬
centrated Minimal Essential Medium Vitamins (both from Gibco
Bio-Cult Ltd., Paisley, Renfrewshire; amino acid from Sigma
Chemical Co., Poole, Dorset). The L-tyrosine was dissolved
in 10 ml of the balanced salt solution at pH 10 before being
added to the rest of the solution. The medium was sterilized
by filtration and kept at 4° until required. To use, the
prepared medium was diluted 1 in 10 with distilled water or
distilled water with sufficient guinea pig serum to give a
final concentration of 10% and 0.29 mg.ml * L-glutamine added.




A differential basophil count can be carried out in a
Neubauer haemocytometer using the stain developed by Cooper
and Cruickshank (1966) with the addition of guinea pig serum
at a final concentration of 10%.
The stain was prepared by mixing 25 ml of 0.5% cetyl-
pyridinium chloride, 25 ml of distilled water and 20 ml of
0.8% toluidine blue in 5% (Al)2 (SO^)^. The solution was
filtered regularly and to use 1 part cell suspension was added
to 8 parts stain and 1 part guinea pig serum.
2.2 Trypan blue
1% aqueous trypan blue was added 1:1 with the cell
suspension.
2.3 White cell diluting fluid
A stock was prepared by adding 0.1 g gentian violet to
100 ml of 1% acetic acid. To use, the stock was diluted
1:10 with 1% acetic acid and 1 part cell suspension added
to 9 parts stain.
3.0 REAGENTS
3.1 Toluene based scintillator
The liquid scintillator used to measure the amounts of
radioisotope present on the chromatograms was prepared by
dissolving 4 g 2,5-diphenyloxazole (PPO) and 0.2 g 1,4-di-
2-(5-phenyloxolyl)-benzene (POPOP) in 1 litre toluene (Koch
Light Laboratories Ltd., Colnbrook, Bucks.).
3.2 Chromatogram stain
The positions of the authentic standard histidine and
histamine on the developed chromatograms were identified by
diazotised sulphanilic acid (Ames and Mitchell, 1952). The
dried chromatograms were first sprayed with a mixture of
5 parts ice-cold 5% NaNC^ and 1 part 0.9% sulphanilic acid
in 9% HC1 and then with 5% NagCOg using a laboratory spray
gun (Shandon Scientific Co. Ltd., London).
3. 3 Preparation of antigens
The sheep's blood used for injections was obtained every
two weeks by venepuncture and collected into sterile Alsever's
solution (1:1). The sheep's blood cell lysate used as the
antigen for anaphylactic histamine release was prepared when
required by centrifuging 10 ml of sheep's blood at 150 g for
10 min and resuspending the pelleted cells in 5 ml distilled
water.
The ovalbumin used to stimulate a basophilia was a
-1
50 mg.ml solution of ovalbumin (crude powder grade II,
Sigma Chemical Co., Poole, Dorset). For anaphylactic
histamine release albumin, chicken egg five times crystal¬





Basophils from the bone marrow and peripheral blood
were purified by the method of Dvorak et al^ (1974) with some
minor modifications.
1.1 Bone marrow derived cells
Basophilia was induced in 250-400 g Dunkin-Hartley guinea
pigs of either sex by 12 daily intraperitoneal injections of
1 ml sheep*s blood or ovalbumin (see Section I, part 3.3).
The day after the final injection the animals were killed by
dislocation of the vertebrae, the neck opened and the blood
collected in a glass universal container. The blood was
allowed to clot and the serum removed for use later in the
purification or stored at -70° until required. After
exsanguination the bone marrow was harvested from the femora,
tibias and humeri by flushing the shaft with Eaglets minimal
essential medium (Wellcome Reagents Ltd., Beckenham, Kent),
pH 7.3-7.4. A cell suspension was prepared by gentle
pipetting and fatty material and pieces of broken bone removed
by filtration through a plastic sieve. A differential cell
count was performed on the cell suspension obtained from each
animal and those containing less than 5% basophils were
discarded.
Pooled, basophil-rich bone marrow preparations, usually
from two animals, were centrifuged at 100 g for 10 min at 4°
and resuspended in 30 ml of a mixture of 1 part Eagle's
minimal essential medium and 1 part normal guinea pig serum,
pH 7.25-7.4. The cells were incubated with 10 mg.ml 1
ex-carbonyl iron particles (Koch-Light Laboratories Ltd.,
Colnbrook, Bucks.) in a shaking water bath at 37° for 30 min.
Phagocytic cells, mainly neutrophils and monocytes, and
residual iron particles were removed by passing the cell
suspension six times through a piece of tubing fixed in a
magnetic field.
The phagocyte-free suspension was centrifuged at 100 g
for 10 min at 4°, resuspended in 8 ml PBS/HSA and layered on
to a continuous Ficoll density gradient. The gradient was
prepared by placing 5 ml of 43% Ficoll 400 (Pharmacia (G.B.)
Ltd., London) in PBS/HSA into a 100 ml round-bottomed glass
centrifuge tube and layering on to this 10 ml of decreasing
concentrations (10.5-5.5%) of Ficoll in PBS/HSA in 1% steps.
The tube was allowed to equilibrate overnight at 4°.
The linearity of the gradient was confirmed using a
Bellington and Stanley "Abbe 60" refractometer, and comparing
the refractive angle of each fraction to a standard curve of
Ficoll solutions of known concentration and density.
The gradient was centrifuged at 85 g for 15 min at 4°
and 4 ml fractions collected from a point immediately above
the 43% Ficoll cushion using a glass capillary tube connected
to a peristaltic pump. Each fraction was centrifuged at 100
for 10 min at 4°, washed with Tyrode's buffer and resuspended
in 8 ml of the same buffer. Differential cell counts were
performed to identify the basophil containing fractions which
were pooled and adjusted to the required concentrations.
1.2 Peripheral blood derived cells
Basophil enriched cell suspensions were purified from
the blood of sheep's blood treated guinea pigs using the same
technique as for the bone marrow derived cells with a few
modifications to remove the red cells.
The blood was collected in plastic universals containing
sufficient heparin (Weddel Pharmaceuticals Ltd., London) to
provide a final concentration of 10 units.ml-"'". Because of
the low number of leucocytes present the ex-carbonyl iron
step was omitted since it resulted in the loss of a large
number of cells.
The blood from 8-10 animals was pooled, diluted 1 in 4
with 0.15 M saline and centrifuged in 100 ml aliquots at
150 g for 10 min at 4°. The diluted plasma was removed and
the cell pellet resuspended in the final drop of liquid.
Seventy-five ml of deionized distilled water at 4° was added,
the tubes inverted and 25 ml of 0.6 M saline added immediately.
The cells were centrifuged at 80 g for 10 min at 4°, washed and
pooled with Tyrode's buffer before being resuspended in 4 ml
of PBS/HSA. The cells were then treated as for the bone
marrow derived cells except that the gradient and fraction
volumes were halved.
In experiments where basophils derived from the blood and
bone marrow were compared, a sample of bone marrow was taken
from each animal and treated as for the blood cells.
2.0 PREPARATION OF OTHER GUINEA PIG LEUCOCYTES
Eosinophils, neutrophils and macrophages were collected
from the peritoneal cavity of Dunkin-Hartley guinea pigs of
either sex. Bone marrow from untreated animals was also
used. Cell counts were performed using white cell diluting
fluid.
2.1 Eosinophil leucocytes
Eosinophils were obtained by the peritoneal lavage of
animals which had received weekly intraperitoneal injections
of horse serum (Wellcome Reagents Ltd., Beckenham, Kent) for
six weeks (Kay, 1970b). The preparations were purified by
centrifugation on cushions of sodium diatrizoate (Hypaque,
Winthrop Laboratories, Surbiton-upon-Thames, Surrey) (Gleich
and Loegering, 1973). A 45% Hypaque solution was diluted to
the required density of 1.140 at 20° with 0.15 M saline and
EDTA, to give a final concentration of 0.1%, added.
2.2 Neutrophil leucocytes
Neutrophils were harvested from the peritoneal cavity,
3 hr after the intraperitoneal injection of 20 ml of 1 mg.ml
glycogen (ex oyster pure AR, Koch-Light Laboratories Ltd.,
Colnbrook, Bucks.) (Jones et aT, 1977).
2.3 Macrophages
Peritoneal macrophages were obtained by lavage 3 days
after the intraperitoneal injection of 20 ml of 1 mg.ml ^
glycogen and purified by ceptrifugation on Ficoll-Hypaque
gradients (density: 1.077 g.ml ^) (English and Anderson,
1974). The Ficoll-Hypaque used contained EDTA at a con¬
centration of 0.1%.
2.4 Normal bone marrow
The bone marrow from an untreated guinea pig was
collected as described in part 1.1 of this section. After
a cell suspension was prepared, the cells were centrifuged
at 100 g for 10 min at 4° and resuspended in Tyrode*s buffer
at the required concentration.
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3.0 PURIFICATION OF RAT PERITONEAL MAST CELLS
Mast cells were isolated by the method of Yurt et al
(1977) with minor modifications. The cells of 20 Sprague-
Dawley rats of either sex weighing 200-400 g were collected
by lavage of the peritoneal cavity of each rat with 25-30 ml
of Tyrode's buffer containing 0.1% gelatin and 10 units.ml-^
heparin. The cells were pooled and washed twice with Tyrode's
buffer containing 0.1% gelatin and 30 [ig.ml-^ deoxyribonuclease 1
(Sigma Chemical Co., Poole, Dorset). One ml aliquots
7
containing 3-7 x 10 cells in the same buffer were layered
on 2 ml cushions of 22.5% metrizamide (Sigma Chemical Co.,
Poole, Dorset) and centrifuged at 85 g for 15 min at 20°.
The mast cells in the pellet and, if required, the interface
containing mainly mononuclear cells, were washed with Tyrode's
buffer and resuspended in the same buffer at the required
concentration. The basophil stain, containing 10% guinea
pig serum, was used to identify and count the mast cells.
SECTION III - MEASUREMENT AND MODULATION OF




1.0 measurement of c-histidine uptake and its conversion
to 14c-histamine
1.1 Basophil enriched cell suspensions
One ml volumes of basophil enriched cell suspensions
6
containing 3-4 x 10 nucleated cells/ml in TyrodeTs buffer
were incubated in triplicate with 10 pi of L- [ring-2-
histidine (10 pCi.ml-"^ : 55 mCi.mmole *) (Radiochemical
Centre, Amersham, Bucks.) in 15 ml plastic conical centrifuge
tubes in a shaking water bath at 37°. The suspensions were
diluted to 10 ml with ice-cold Tyrode's, centrifuged at 150 g
for 5 min at 4°, the supernatants discarded and the cell
pellets washed twice with 10 ml ice-cold Tyrode's. The
washed cells were resuspended in 3 ml of Tyrode's buffer and
0.3 ml transferred to 6 ml scintillation vials. Three ml
of Unisolve 1 (Koch-Light Laboratories Ltd., Colnbrook, Bucks.)
were added to each vial and the amount of radioisotope present
measured by liquid scintillation counting. All results were
corrected by counting internal standards of known activity.
The remaining cells from each set of triplicates were
pooled and centrifuged at 150 g for 5 min. The supernatant
was decanted and the pellet of cells resuspended in the
remaining solution before lysis by multiple (four times)
freeze-thawing in an ethanol/dry ice bath, The resulting
lysate was centrifuged at 250 g for 10 min at 4° and the
supernatant applied to pre-coated cellulose sheets (Eastman
Kodak, Kirby, Liverpool) scored into 1 cm wide strips.
The chromatograms were developed in ethanol:diethyl
ether:NH40H:H20 (8:10:1:2) until the solvent front had
migrated 16 cm. Twenty pi of a mixture of authentic
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L-histidine and histamine (1 mg.ml of each) were used as
markers, similarly chromatographed and identified by diazotized
sulphanilic acid (Section I, part 3.2).
Areas of the lysate strips corresponding to the L-
histidine (Rf 0.06 ± 0.004) and histamine (Rf 0.493 ± 0.01)
containing regions were cut out and placed in vials containing
3 ml of toluene-based scintillation fluid (Section I, part 3.1).
14
The amount of C-histamine present in each strip was expressed
as a percentage of the total radioactivity in that strip and
the amount of histamine formed calculated from the total amount
of histidine taken up by the cell suspensions.
1.2 Rat peritoneal mast cells
14
The uptake of C-histidine and the amount of histamine
formed was assessed by the method outlined above for basophil
containing cell suspensions. In this case, however, 0.5 ml of
6 — 1
purified mast cells containing 2-3 x 10 cells.ml were
14
incubated with 5 pi of C-histidine. After the final wash
the cells were resuspended in 1 ml of Tyrode's buffer; 0.3 ml
of this being used to measure the uptake and the rest subjected
to chromatography.
1.3 Other cell types
Initial experiments were carried out as described in
part 1.1. above. However, eosinophil enriched, neutrophil
enriched, macrophage enriched and normal bone marrow cell
suspensions were incapable pf forming measurable amounts of
14 14
C-histamine from the incorporated C-histidine. Therefore,
following the final wash the cells were resuspended in 0.3 ml
14
of Tyrode's buffer, all of which was used to assess C-
histidine uptake.
2.0 MEASUREMENT OF 14C-HISTAMINE UPTAKE
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2.1 Guinea pig derived cells
One ml samples of the cell suspensions were incubated
in triplicate with 10 pi |_ring-2-44cQ histamine dihydrochloride
(10 pCi.ml 4 : 57 |_iCi.mmole 4) (Radiochemical Centre, Amersham,
Bucks.) in 15 ml plastic conical centrifuge tubes as described
14
in part 1.1 for C-histidine. Following the final wash the
cells were resuspended in 0.3 ml Tyrode*s buffer, all of which
was transferred to the scintillation vials. Three ml of
14
Unisolve 1 was added to each vial and the amount of C-
histamine present measured by liquid scintillation counting.
2.2 Rat peritoneal mast cells
The mast cell suspensions were treated as detailed above
for guinea pig cells except that 0.5 ml of cells were incubated
14
with 5 |il C-histamine.
3.0 MEASUREMENT OF 14C-LEUCINE UPTAKE
14
The uptake of C-leucine was investigated with guinea
pig cells only. One ml samples were incubated in triplicate
with 10 |il L- £l-^cT) leucine (10 ii.Ci.ml-"'' : 59 mCi.mmole-^)
14
and treated as described for C-histamine (Section III, part
2.1).
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4.0 effect of amino acids on 14c-histidine uptake and
14c-histamine formation
The following amino acids were used: L-alanine, L-
arginine hydrochloride, L-aspartic acid, L-asparagine,
L-cysteine hydrochloride, L-cystine, L-glutamic acid,
L-glutamine, glycine, D-histidine hydrochloride, L-
histidine, DL-isoleucine, DL-leucine, L-lysine monohydro-
chloride, DL-methionine, L-proline, DL-phenylalanine,
L-serine, DL-threonine, DL-tryptophan, L-tyrosine and
DL-valine (all from Sigma Chemical Co., Poole, Dorset).
0.9 ml samples of cells were added to 15 ml plastic
conical centrifuge tubes containing 0.1 ml of amino acid
or control solution (i.e. medium in which amino acid was
14
dissolved) and 10 jj.1 C-histidine. The cell suspensions
were incubated for 90 min at 37° before being washed and
treated as described in part 1.1 above.
Incubations containing cysteine also included dithio-
threitol at a final concentration of 10 mmoles.l ^ to prevent
cysteine oxidation. Tubes containing dithiothreitol were
included as controls.
-2 -1
Cystine was insoluble at 10 moles.1 and, therefore,
-3 -1
it was dissolved at 1.1 x 10 moles.1 . In this case,
0.9 ml of cystine or control solution was added to the
centrifuge tubes and 0.1 ml of a ten times concentrated cell
suspension was added.
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5.0 EFFECT OF METABOLIC INHIBITORS. PHARMACOLOGICAL
MEDIATORS AND DRUGS ON 14C-HISTIDINE AND 14C-HISTAMINE
UPTAKE AND 14C-HISTAMINE FORMATION
The materials were obtained as follows. Metabolic
inhibitors: actinomycin D, antimycin A, colchicine, cyclo-
heximide, cytochalasin B, 2-deoxyglucose, 2,4-dinitrophenol,
iodoacetamide, mitomycin C, ouabain and sodium fluoride
(Sigma Chemical Co., Poole, Dorset); 4, bromo-3-hydroxy-
benzylosyamine dihydrogen phosphate (NSD 1055) (Sandev Ltd.,
Harlow, Essex).
Pharmacological mediators: histamine acid phosphate
(BDH Chemicals Ltd., Poole, Dorset); bradykinin triacetate
and 5-hydroxytryptamine creatinine sulphate complex (Sigma
Chemical Co., Poole, Dorset); ECF-A tetrapeptides were a
gift from Dr. R. Camble (ICI Ltd., Pharmaceuticals Division,
Alderley Park, Macclesfield, Cheshire); prostaglandins E][,
E0 and F„ were a gift from Dr. J. Pike (Upjohn Company,£ (X
Kalamazoo, U.S.A.).
Drugs: hydrocortisone, indomethacin and aspirin were
a gift from Dr. F.R. Mangan (Beecham Pharmaceuticals, Research
Division, Harlow, Essex); disodium cromoglycate ("Intal") was
a gift from Fisons Pharmaceuticals Ltd., Loughborough, Leics.
Imidazoleacetic acid hydrochloride (Sigma Chemical Co.,
Poole, Dorset); 1,4-methylhistamine dihydrochloride, N-
acetylhistamine and l-methyl-4-imidazoleacetic acid (Calbiochem
Ltd., San Diego, California, U.S.A.); mepyramine maleate (May
and Baker Ltd., Dagenham, Essex); chlorpheniramine (Allen and
Hanburys Ltd., London); burimamide, metiamide, 2-(2-aminoethyl)
thiazole dihydrochloride, 4-methylhistamine dihydrochloride,
and S- [_3- (N, N-dimethyl amino ) propyl]] isothiourea dihydro-
chloride ("Dimaprit") were a gift from Smith, Kline and French
Laboratories Ltd., Welwyn Garden City, Herts.
All these compounds were dissolved in Tyrode's buffer
except for cytochalasin B which was dissolved in dimethyl
-3 -1
sulphoxide at 10 moles.1 and hydrocortisone, indomethacin
-2 -1
and aspirin which were dissolved in ethanol at 10 moles.1
These were then diluted to the required concentration with
Tyrode's buffer before use and compared to the appropriate
controls.
0.9 ml cell suspensions were added to 15 ml plastic
conical centrifuge tubes containing 0.1 ml of agent or control
solution and preincubated in a shaking water bath at 37° for
14 14
40 min. Ten |il of C-histidine or C-histamine were then
added and the cells incubated for a further 90 min before
being treated as described above (parts 1.1 and 2.1).
5.1 Effect of sodium ions
To assess the effect of sodium ions, basophil enriched
cell suspensions were washed five times with modified PBS or
choline substituted modified PBS (Section I, part 1.4).
6
The cells were resuspended in the same buffers at 3-5 x 10
14
nucleated cells/ml, and incubated with C-histidine or
14
C-histamine as described above (part 1.1 and 2.1).
5.2 Time courses
0.9 ml of cell suspensions in triplicate were incubated
with 0.1 ml of ouabain (10~4 moles.I-1), antimycin A (10 ^
moles.I-1), histamine (10~2 moles.I"1) or diluent control for
40 min at 37° in a shaking water bath and then incubated for
14
various times with 10 |il C-histidine. The cells were
washed and treated as described above (part 1.1).
To study the effect of increased exposure to histamine,
_ o
0.9 ml of cells were incubated with 0.1 ml histamine (10
moles.1 or diluent control for various times before the
14
addition of C-histidine and then treated as for other time
courses. In experiments where the histamine was removed
14
before the addition of the C-histidine the cells were
washed twice with 10 ml of ice-cold Tyrodefs buffer. After
the final wash the cells were resuspended in 1 ml of the same
14
buffer for incubation with C-histidine as for other time
courses.
5.3 Effect of histamine antagonists on the enhancement of
histidine uptake and histamine formation
0.8 ml of basophil enriched cell suspensions were added
to a 15 ml plastic conical centrifuge tube containing 0.1 ml
antagonist for 20 min at 37° in a shaking water bath. 0.1 ml
-2 -1
of histamine (10 moles.1 ) or diluent control was added for
14
a further 20 min and then 10 pi C-histidine. The cell
suspensions were incubated for 90 min and treated as
described above (part 1.1).
The effect of the antagonists was expressed as the
percentage decrease of enhancement:
% decrease of enhancement =
(value for antagonist
_ value for )
100 - ( + histamirfe antagonist x 100)
(value for histamine - value for )
( antagonist )
6.0 EFFECT OF ANAPHYLAXIS
6.1 Endogenous histamine content
Total endogenous histamine was extracted from guinea
pig basophil enriched cell suspensions and purified rat mast
cells by multiple (four times) freeze-thawing in an ethanol/
dry ice bath. Histamine was measured by bioassay using
guinea pig ileum suspended in oxygenated atropinized Tyrode's
solution (0.05 |i moles atropine. 1 "*") in a 2 ml capacity organ
bath maintained at 37° by a continuous flow water jacket
(Brocklehurst, 1960).
6.2 Measurement of anaphylactic histamine release
0.9 ml of basophil enriched cell suspensions, in
duplicate, were incubated at 37° for 15 min prior to the
addition of 0.1 ml antigen (Section I, part 3.3) or control,
which were also incubated at 37°, for a further 15 min. The
cells were centrifuged at 150 g for 5 min at 4° and the super¬
natant removed. The pelletted cells were resuspended in 1 ml
Tyrode's buffer and lysed by multiple (four times) freeze-
thawing to release the residual histamine. "The released
and residual histamine were measured by bioassay as described
above for endogenous histamine content.
The amount of histamine released was expressed as a
percentage of the endogenous content prior to challenge:
% histamine released =
Amount of histamine released .
x
Amount of histamine released + Amount of residual
histamine
6.3 Effect of anaphylactic histamine release on the uptake
of 14C-histidine and 14C-histamine formation
Sheep's blood treated animals were used as the source of
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the basophils and sheep's blood cell lysate as the antigen.
A set of tubes were included to measure the amount of
histamine released as a control to test the cells and
antigen.
Immediately after challenge: cells were challenged in
triplicate with various dilutions of antigen as described in
part 6.2. The cells were washed twice with Tyrode's buffer
and then resuspended in 1 ml of the same buffer for incubation
14
with C-histidine for 90 min as described above (part 1.1).
Twenty-four hours after challenge: 4.5 ml of pre-
warmed basophil enriched cell suspensions in Tyrode's buffer
were challenged with 0.4 ml of antigen or control solution for
15 min at 37° in sterile plastic universal containers. The
cells were washed twice with the same buffer and resuspended
in 10 ml Eagle's minimal essential medium without histidine
(Section I, part 1.5) containing 10% fresh guinea pig serum
and incubated at 37° for 24 hr with continual gentle mixing.
The cells were then washed with 20 ml Tyrode's buffer, re¬
suspended in 4 ml of the same buffer and a cell count
performed. One ml aliquots were added in triplicate to 15 ml
14
plastic conical centrifuge tubes and incubated with C-
histidine for 90 min as described above (part 1.1).
Time course: 22.5 ml of pre-warmed cell suspensions
rich in basophils were challenged with 2.5 ml antigen or
control solution as detailed above (24 hr after challenge).
After the washes they were resuspended in 25 ml Tyrode's
o 14
buffer at 37 , a cell count performed and 0.25 ml of C-
histidine added. At each time point, triplicate 1 ml samples
were removed and the amount of C-histidine incorporated and
histamine formed determined as described above (part 1.1).
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7.0 EFFECT OF VARIOUS CELL TYPES ON THE UPTAKE OF 14C-
HISTIDINE AND 14C-HISTAMINE FORMATION BY BASOPHIL
ENRICHED CELL SUSPENSIONS
7.1 On unchallenged basophils
After 40 min incubation: centrifuge tubes were set up
in triplicate containing 0.5 ml basophil enriched cell
0 __ ^
suspension, 8-10 x 10 nucleated cells.ml" , and 0.5 ml of
the cell type being investigated, at the highest concentration
0
possible (in practice 10-12 x 10 cells.ml ) or 0.5 ml of
either cell type and 0.5 ml Tyrode's buffer. The cells were
mixed and incubated at 37° for 40 min before the addition of
14 14
C-histidine for a further 90 min. The amount of C-
14
histidine incorporated and C-histamine formed was determined
as described above (part 1.1).
In two sets of experiments the eosinophils were incubated
with horse serum for 15 min at 37° and washed twice with
Tyrode's buffer prior to mixing with the basophil enriched
cell suspensions or Tyrode's.
After 18 hr incubation: 3 ml of basophil containing cell
suspensions plus 2 ml of eosinophil enriched cell suspensions
or the two cell populations alone were added to sterile plastic
universal containers. The cells were centrifuged at 100 g for
10 min at 4°, the pelletted cells resuspended in 10 ml Eagle's
minimal essential medium without histidine containing 10%
fresh guinea pig serum and incubated at 37° for 18 hr with
14
continuous gentle mixing. The uptake of C-histidine and
14C-histamine formation was assessed as in part 6.3 (24 hr after
challenge).
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7.2 On challenged basophils
Three ml of a basophil containing cell suspension plus
2 ml of a cell suspension rich in eosinophils, or each cell
type alone (concentrations as in part 7.1), were added to a
sterile plastic universal container. The cells were centri-
fuged at 100 g for 10 min at 4° and resuspended in 4.5 ml
Tyrode?s buffer. After equilibration for 40 min in a 37°
shaking water bath they were challenged with antigen or control
solution and treated as described in part 6.3 (24 hr after
challenge) except that they were cultured for only 18 hr.
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8.0 EFFECT OF EOSINOPHIL DERIVED PRODUCTS ON 14C-HISTIDINE
UPTAKE AND 14C-HISTAMINE FORMATION
Purified human eosinophil cationic protein and lysozyme
were a gift from Dr. Per Venge, University of Uppsala, Sweden.
The guinea pig eosinophil granule extract was prepared by
the method of Gleich et al (1973). Eosinophils were obtained
as described in Section II, part 2.1. The cells from five
guinea pigs were pooled, washed twice in Tyrode*s buffer and
resuspended in 10 ml 0.34 moles.1 ^ sucrose. The cells were
lysed by numerous vigorous passages out of a 20 ml syringe.
The resultant suspension was centrifuged at 400 g for 10 min
at 4° to remove cell debris and any intact cells. The super¬
natant was then subjected to 5000 g for 20 min at 4° and the
pelletted granules solubilized with 0.5 ml 0.01 moles.1 * HC1.
The effect of the purified cationic proteins, lysozyme and
14 14
the crude granule preparation on C-histidine uptake and C-
histamine formation was studied as in part 5.0 above.
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9.0 ANAPHYLACTIC RELEASE OF 14C-HISTAMINE AND 14C-HISTIDINE
14
Cells were incubated with C-histidine in the presence
or absence of NSD 1055 as detailed above (part 5.0). After
the final wash one triplicate of each treatment was processed
14
as described for the determination of C-histidine uptake and
14
C-histamine formation. The rest were resuspended in 0.45 ml
of Tyrode's buffer and challenged with 0.05 ml antigen or control
solution, after equilibration at 37°, for 15 min. The cells
were centrifuged at 150 g for 5 min at 4° and the supernatants
removed. 0.05 ml of this were transferred to a scintillation
vial to which was added 0.25 ml distilled water and 3 ml
Unisolve 1. The amount of radioisotope present was determined
by liquid scintillation counting. A further 0.1 ml was stopped
on a chromatogram scored in 2 cm strips and processed as
described in Section III, part 1.1 to determine what proportion
14
of the radioisotope present corresponded to C-histidine and
"^C-histamine.
14
The amount of C-histamine released was expressed as a
percentage of that present within the cells prior to challenge.
14
The amount of C-histidine released was expressed as a
percentage of that present in the supernatant of cells which
were incubated with control solution instead of antigen.
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10.0 STATISTICS
Measurements from triplicate incubations for uptake
14
studies and single values for C-histamine formation determina¬
tions from at least three separate experiments were pooled,
the mean and standard errors calculated and the observations
compared using the student's t-test. Such pooling was
considered to be statistically valid since in the present
study the variation within each experiment was similar to the
variations between individual experiments as previously
observed (Clark et al, 1975).
CHAPTER IV - RESULTS
SECTION I - HISTIDINE AND HISTAMINE UPTAKE AND
NEW HISTAMINE FORMATION BY BASOPHILS:
OPTIMAL CONDITIONS, SPECIFICITY AND COMPARISON
WITH OTHER LEUCOCYTES
1.0 INTRODUCTION
The basophil leucocyte is known to participate in both
immediate and delayed type hypersensitivity reactions
(Ishizaka and Ishizaka, 1971; Richerson et al, 1970).
Until recently there were difficulties in the study of
basophil function and the elucidation of its role in the
immune response because of the paucity of numbers that
normally circulate in the peripheral blood. Although
partial purification of both human and guinea pig basophils
has been achieved by a number of workers (Sampson and
Archer, 1967; Pruzansky and Patterson, 1970; Wilson and
Coombs, 1971), the first reliable method for obtaining large
numbers of purified basophils was not developed until more
recently (Dvorak et al, 1974). Basophil-enriched cell
suspensions obtained by a slight modification of this method
have been used to study several biological variables, viz.
14 14
the uptake of C-histidine and C-histamine and the
14
formation of C-histamine de novo, which may be relevant
to histamine synthesis and storage.
This section describes the attempts which were made to
study the mechanism of transmembrane movement of histamine
and its precursor, histidine, by determining some of the
factors which may influence their uptake. To this end
the effects of variations in the time of incubation, extra¬
cellular concentration, temperature and pH and inter-amino
ft
acid competition were investigated. Also, attempts were
made to compare other leucocytes, with basophils, in terms
of histidine and histamine uptake and histamine synthesis.
2.0 PURIFICATION OF BONE MARROW BASOPHILS
The mean purification data for 417 sheep's blood
treated, 52 ovalbumin treated and 21 stock guinea pigs is
shown in Table I.
The bone marrow from guinea pigs which had received
12 ip. injections of sheep's blood contained 77.2 ± 1.6 x
g
10 (mean ± 1 S.E.) basophils which accounted for 7.9 ± 0.2%
of the total nucleated cells. After treatment with ex-
carboxyl iron the basophil yield was 97.4 ± 2.6% whereas
only 73.5 ± 1.3% of the total nucleated cells were recovered.
The removal of phagocytic cells resulted in a cell suspension
containing 5-24% (mean 10.2) basophils.
A typical distribution following centrifugation on a
Ficoll gradient is shown in the upper part of Fig. 6. The
total nucleated cell peak, at 6.0-7.0% Ficoll (1.025-1.027
g.ml-^), included numerous lymphocytes and a variety of
mature and immature nucleated forms. The basophil peak,
at 8.0-8.7% Ficoll (1.030-1.032 g.ml-*) included basophils
at various stages of development and a heterogeneous mixture
of immature myeloid and erythroid cells. In general 60-100
g
x 10 basophils, the majority mature, were present in the
pooled Ficoll fractions from two sheep's blood treated
guinea pigs. A few neutrophils (about 1-3%) and eosinophils
(about 2-5%) were also present but erythrocyte contamination
was relatively negligible, the ratio of nucleated cells to
»
erythrocytes being approximately 3:1. Using sheep's blood
as the antigen, an overall basophil purification of 2.5-8.0
(mean 3.8) fold was achieved, whilst with ovalbumin the








































































































The leucocytes obtained from the Ficoll gradients were
greater than 98% viable (as judged by trypan blue dye exclusion)
were capable of in vitro migration to complement activated
guinea pig serum (Jones and Kay, 1974) and released histamine
when challenged by antigen.
A preparation of purified guinea pig bone marrow basophils
is shown in plate I.
Plate I
Preparation of guinea pig bone marrow basophil
leucocytes. (May Grunwald/Giemsa, x 2000 magnification)
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3.0 DETERMINATION OF OPTIMUM CONDITIONS
Varying numbers of basophil-enriched cell suspensions
14
were incubated with 10 pi C-histidine for 90 min and the
14 14
amounts of C-histidine taken up and C-histamine formed
determined (Fig. 1). There was direct proportionality
14
between the number of cells and the amount of C-histidine
14
incorporated and C-histamine synthesized. Therefore, the
0
number of cells used in all other experiments, 3-5 x 10
nucleated cells, did not appear to be a limiting factor of
any significance.
The efficiency of the washing procedure employed is
demonstrated in Table II. There was no significant decrease
in the amount of radioisotope present in the supernatant after
14
the second wash. The amount of C-labelled histidine and
histamine present in the third and subsequent washes was
negligible compared to that associated with the cells. In
all further experiments presented the cells were, therefore,
14 14
washed twice and the amounts of C-histidine or C-histamine
present in the final cell suspensions were assumed to
represent that associated with the cells.
3.1 Time course
14 14
The variation in the uptake of C-histidine and C-
14
histamine and the amount of C-histamine formed with time
is shown in Fig. 2. There was a rapid initial uptake of
44C-histidine which slowed down after about 60 min and
reached a constant level at approximately 180 min. By
240 min 10% of the added 14C-histidine had been incorporated.
The time course of 44C-histamine formation did not exhibit
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The uptake of C-histidine and the formation of C-
histamine by various concentrations of cells rich in basophils








1st Spin 171511 169653 173679 198179 204616
1st Wash 6008 6417 6850 4950 4500
2nd Wash 1919 1383 1410 320 325
3rd Wash 1506 1337 940 140 65
4th Wash 1491 1327 1010 145 59
5th Wash 995 1200 960 - -
Cells 43068 49500 37510 710 740
Total Recovered 226498 230817 222359 204444 210305
% Recovered 102.0 104.0 100. 2 92.1 94.7
TABLE II
The distribution of radioisotope, expressed as disintegra¬
tions per minute (d.p.m.), in the washing supernatants and
cell pellet of basophil-enriched cell suspensions after
14
incubation with 0.1 pCi (222,000 d.p.m.) C-histidine or
14
C-histamine for 90 min.
Fig. 2
Time course of uptake of 44C-histidine (G—0) and 44C-
. 14
histamine <4 — 4> and the amounts of C-histamine formed
(E2 — E) by basophil-enriched cell suspensions. Each point
14
represents the mean ± 1 S.E. of 8 experiments for C-histidine
uptake and 14C-histamine formation and 3 experiments for 14C-
histamine uptake.
14
build-up of newly synthesized C-histamine. This gradual
increase persisted for the duration of the experiment at which
14
time C-histamine accounted for 24% of the incorporated radio¬
isotope.
14 14
In contrast to C-histidine, the amount of C-histamine
incorporated was comparatively small. Thus even after the
termination of the experiment at 240 min only 0.7% of the added
14
C-histamine had been taken up.
In further experiments a time of 90 min was chosen since
this gave an appreciable uptake compared to "background" values.
Also, in experiments with metabolic inhibitors and histamine
receptor antagonists (see below) there was a slight loss of
cell viability when incubations were performed for longer
periods of time.
3.2 Influence of extracellular histidine and histamine
concentration
The results of histidine and histamine uptake and
histamine formation measured as a function of extracellular
histidine and histamine concentration are shown in Figs. 3
and 3A. There was a rapid increase in the amount of
histidine incorporated as the concentration of histidine
was raised and over the concentration range used (0.18-
1000 |_i.moles. I-"*") saturation was not reached. At the
lowest concentration used, 0.45 p.moles. 1 11% of the
added 14C-histidine was incorporated while only 0.8% was
taken up when the extracellular concentration was 1 m.mole.l
14
The percentage of the C-histidine taken up which was con¬
verted to "^C-histamine decreased with increasing extra¬
cellular histidine concentration. The absolute amounts of
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Fig. 3
The effect of increasing the extracellular concentrations
14 14 14
of C-histidine on C-histidine uptake (© — Q) and C-
histamine formation (E —■ E) and of increasing the extra-
14 14
cellular concentration of C-histamine on C-histamine




CONCENTRATION (m moles. 1 x 10 )
Fig. 3A
The effect of increasing the extracellular concentrations
14 14 14of C-histidine on C-histidine uptake (• — ©) and C-
histamine formation (E — B) and of increasing the extra-
14 14cellular concentration of C-histamine on C-histamine
uptake — D- The results are the mean ± 1 S.E. of 4
experiments.
C-histamine formed reached a plateau at an extracellular
histidine concentration of 70 p.moles.I-1. It should be
noted that histidine concentrations above 7.2 p.moles.I-4
were obtained by the addition of increasing amounts of
unlabelled histidine. This reduced the specific activity
to such an extent that due to the limitations of the
techniques used, determination of histamine formation was
not possible at histidine concentrations above 130 p.moles. I-4.
There was a progressive increase in the amount of
histamine taken up as its extracellular concentration was
raised. The percentage of added histamine incorporated did
not vary substantially (0.26-0.11%) over the concentration
range used (0.18-1000 p.moles.I-4).
Concentrations of 1.8 p.moles. I-4 histidine and
histamine were used in further studies since these resulted
in incorporation significantly above "background" but kept
the quantity of radioisotope used to a minimum.
3.3 Effect of varying the incubation temperature
The uptake of 44C-histidine showed marked temperature
o 14
dependence, being maximal at 37 , whereas C-histamine uptake
and formation, although dependent on temperature, continued to
increase up to 43° (Fig. 4). There was low but significant
uptake of 44C-histidine at 0° which increased steadily to
peak at 37°. 44C-histamine formation increased less rapidly
14
but did not show the same decrease that was found with C-
ft
histidine uptake above 37°. There was very little uptake of




The effect of varying the incubation temperature on the
14 14
uptake of C-histidine (© — 0) and C-histamine — ^,)
and the amount of histamine formed (E — E). Each point
represents the mean ± 1 S.E. of 4 experiments where cells were
14
incubated with C-histidine and 3 experiments where cells
14
were incubated with C-histamine.
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Membranes undergo phases change at various temperatures
associated with an increase in fluidity. The rapid increase
14 o
in C-histamine uptake above 30 may have been due to these
14
changes whereas C-histidine uptake did not seem to be
affected to the same extent.
3.4 Effect of pH
14 14 14
The uptake of C-histidine and C-histamine and C-
histamine formation over the pH range 6.5-8.0 is shown in
14
Fig. 5. There was no significant variation in C-histidine
14
uptake or C-histamine formation under these conditions.
14
However, the amount of C-histamine incorporated varied at
either end of the pH range when compared to physiological
values (pH 7.2-7.4). There was a significant difference
(p <0.05) between the uptake at pH 6.5 and 8.0.
All further experiments were carried out in buffer at
pH 7.25-7.4 and all solutions were adjusted to the same pH
as the cell suspensions to which they were added.
Fig- 5
The effect of varying the incubation pH on the uptake of
44C-histidine (G — 0) and 44C-histamine (4 — h) anc* the
amount of histamine formed (0 — US). Each point represents
the mean of ± 1S.E. of 5 experiments where cells were
incubated with 14C-histidine and 4 experiments where cells
14
were incubated with C-histamine.
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4.0 SPECIFICITY OF HISTIDINE AND HISTAMINE UPTAKE AND
HISTAMINE FORMATION
The specificity of the uptake of histidine and histamine
and histamine synthesis was investigated using several
approaches including (i) populations of varying basophil
content, (ii) different cell types and (iii) inhibition
studies with other amino acids.
4.1 Correlation with basophil content
Those fractions, from a Ficoll gradient, which contained
the greatest number of basophils corresponded to (i) the peaks
14
of maximal incorporation of C-histidine, (ii) the maximal
14
amount of C-histamine synthesis de novo and (iii) the highest
concentration of "extractable" histamine (Fig. 6). In
14
contrast, C-histamine uptake was minimal in all the fractions
and showed no relation to their basophil content.
The percentage of basophils in cell suspensions from 80
different guinea pigs (each batch of cells being the pool
from two animals) was compared with their capacity to incor-
14 14
porate either C-histidine or C-histamine or synthesize
14
new histamine (Fig. 7). The uptake of C-histidine and
14C-histamine formation was directly proportional to the
percentage of basophils in these populations (p <0.001).
14
In contrast, there was no correlation with. C-histamine
uptake.
4.2 Different cell types •
14 14 14
Differences in C-histidine, C-histamine and C-
leucine uptake between basophils and other leucocytes are




Separation of guinea pig bone marrow cells by a continuous
Ficoll gradient. The uptake of 14C-histidine and 14C-histamine
14
and the amount of C-histamine formed are expressed as p.moles
6
per 3 x 10 nucleated cells. The histamine content is
expressed as the number of pg histamine present per fraction.

























































Comparison of the uptake of C-histidine and C-
14
histamine and the amounts of C-histamine formed with cell
suspensions containing varying percentages of basophils.
The uptake of 14C-histidine and 14C-histamine and the amount




The uptake of C-histidine by cell suspensions
enriched with eosinophils (88%), neutrophils (95%) and
macrophages (92%) and normal bone marrow cells was 18.2%,
22.0%, 40.9% and 34.3% (respectively) of that observed in
basophil-enriched suspensions. Since on average the
basophil-enriched cell suspensions contained only 30%
basophils the data suggests that histidine uptake by this
cell type was highly preferential. The uptake of ^C-
histamine by all cell types studied was extremely low
14
compared to C-histidine uptake. Basophil-enriched cell
suspensions incorporated 35.9%, 231.5%, 76.7% and 307.7%
14
more C-histamine than eosinophil-rich, neutrophil-rich,
macrophage-rich and normal bone marrow cell suspensions,
respectively.
14
C-leucine was most avidly taken up by the cell
suspensions enriched with basophils. Under similar
conditions all the cell types tested, apart from the
14
eosinophil, incorporated a greater amount of C-leucine
14
than C-histidine. However, eosinophil-rich, neutrophil-
rich, macrophage-rich and normal bone marrow cell suspensions
incorporated only 12.9%, 30.8%, 74.5% and 37.6% (respectively)
14
of the C-leucine taken up by basophil-rich preparations.
14 .
C-histamine formation was only detected in the
basophil-rich preparations.
14 14 14
The uptake of C-histidine and C-histamine and C-
histamine formation was also compared in basophil-enriched
cell suspensions derived from the peripheral blood and bone
marrow of the same animals (Table III). Although the per¬



















































Basophil Enriched Mononuclear Normal Bone Neutrophils Eosinophils
Bone Marrow Cells Cells Marrow Cells
Fig. 8
14 14 14
The uptake of C-leucine, C-histidine and C-histamine
by basophil-enriched, mononuclear, normal bone marrow,
neutrophil-enriched and eosinophil-enriched cell suspensions.
14
Each column represents the mean ± 1 S.E. C-leucine uptake:
basophils - 12 experiments; mononuclear cells, neutrophils
and eosinophils - 11 experiments; normal bone marrow cells -
14
15 experiments. C-histidine uptake: basophils - 23
experiments; eosinophils and normal bone marrow cells - 16
experiments; neutrophils and mononuclear cells - 14 experiments
14C-histamine uptake: basophils - 14 experiments; normal bone
marrow cells - 7 experiments; neutrophils - 5 experiments;





































































































the same there was wide variation between different
experiments. Peripheral blood cells incorporated less
14
C-histidine and formed a smaller amount of new histamine
than bone marrow counterparts although they converted a
14
slightly larger percentage of the C-histidine taken up
14
to C-histamine. There was no significant difference in
14
the amount of C-histamine taken up by basophil preparations
from the two sources.
14
4.3 Kinetic studies on C-histidine uptake by different
cell types
In part 4.2 it was demonstrated that different cell
types varied considerably in their capacity to incorporate
14
C-histidine. Experiments were, therefore, designed to
determine whether these observations were a reflection of
differences in the kinetics of the transport process in these
cells. Eosinophil-, neutrophil-, macrophage- and basophil-
rich preparations, in addition to normal bone marrow cell
suspensions were incubated for 45 min with various concentra¬
tions of "^C-histidine (Fig. 9 and 9A). The incubation time
was chosen because it appeared from preliminary observations
and the data shown in Fig. 2 that the initial velocity was
linear during the first 45 min.
Over the concentration range employed some of the cell
types appeared to reach a saturated level of uptake. The
uptake by eosinophil- and neutrophil-enirched cell suspensions
paralleled each other at low concentrations, up to 500 p.moles
but tended to drift apart at higher concentrations. At
extremely low concentrations, below 0.5 p.moles.1 , the
normal bone marrow cells followed the same curve as the
104
1 234 56 789 10 11 12
CONCENTRATION (n moles. I"1)
Fig- 9
The effect of increased substrate concentration on the
14
uptake of C-histidine by basophil-enriched (© — ©),
macrophage-enriched (j| — A), neutrophil-enriched (1 — E),
eosinophil-enriched <□ — o) and normal bone marrow (O — O)
cell suspensions. The points represent the mean ± 1 S.E.
Basophil-enriched cell suspensions - 6 experiments; macrophage-
enriched, neutrophil-enriched, eosinophil-enriched and normal
bone marrow cell suspensions - 5 experiments.
1
' 1 2 3 4 5 6 7 8 9
CONCENTRATION (/n moles, l"1 x 10"2)
Fig. 9A
The effect of increased substrate concentration on the
14
uptake of C-histidine by basophil-enriched (G — ©),
macrophage-enriched neutrophil-enriched (E — 1),
eosinophil-enriched <o — □> and normal bone marrow (0 — O)
cell suspensions. The points represent the mean ± 1 S.E.
Basophil-enriched cell suspensions - 6 experiments; macrophage-
enriched, neutrophil-enriched, eosinophil-enriched and normal
bone marrow cell suspensions - 5 experiments.
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basophil-rich preparations but tailed off more and more as
the extracellular histidine concentration was increased.
Cell suspensions rich in macrophages had a low uptake rate,
at substrate concentrations below 2 p.moles. l-"^, which
increased steadily as the concentration of histidine was
raised, becoming progressively more similar to that of the
basophils before levelling off.
The starting point for analysis of the kinetics of all
enzymatic reactions is the Michaelis-Menten relationship.
Accordingly the data for the basophil and eosinophil-
enriched cell suspensions was fitted to the Michaelis-
Menten equation using a computer programme written by Dr. Ian
Nimmo. The substrate concentration, experimentally observed
velocity, computer derived velocity and residuals (a measure
of how well an experimentally derived value agrees with the
calculated value) for the basophil and eosinophil-enriched
cell suspensions are shown in Table IV. If the uptake of
14
C-histidine followed a simple Michaelis-Menten relationship,
i.e. a graph of velocity against substrate concentration was
a rectangular hyperbole, then an equal number of positive and
negative residuals would be anticipated. When the present
14C-histidine uptake data was tested the majority of the
residuals were positive, 9 out of 10 and 8 out of 10 for the
basophil- and eosinophil-rich preparations respectively.
The data was similarly analysed by another computer
k
programme to determine the Hill coefficients (see Appendix
1.2) for all the cell populations used. The calculated
velocities and residuals obtained using this programme are
given in Tables V and VI. The Hill coefficients (h) were
TABLE IV
14
The rate of C-histidine uptake and the calculated
velocities and residuals, obtained by fitting the data to
the Michaelis-Menten relationship, for basophil- and
eosinophil-enriched cell suspensions incubated with various
14
concentrations of C-histidine for 45 min. The experi¬
mentally observed and computer derived velocities are
14
expressed as p.moles C-histidine incorporated per 45 min
0
for 3 x 10 nucleated cells. The experimental results
are the mean of 6 experiments for basophil-enriched cell


































































































The rate of C-histidine uptake and the calculated
velocities and residuals, obtained by fitting the data to
the Hill equation, for basophil- and eosinophil-enriched




























































































The rate of C-histidine uptake and the calculated
velocities and residuals, obtained by fitting the data
to the Hill equation, for normal bone marrow, mononuclear







































































































































all less than one (Table VII) suggesting that negative co-
operativity was occurring. The calculated maximum velocity
(VfiAX^ anc* the substrate concentrations which gave half
(s^q) are also given for each cell population in Table VII.
14
The present results suggest that C-histidine uptake
does not follow simple Michaelis-Menten kinetics. At low
substrate concentrations the uptake was greater than would
be predicted by the Michaelis-Menten relationship and at high
concentrations it was lower than predicted, i.e. negative co-
operativity (see Appendix 1.1 for possible explanation).
The calculated velocities and residuals for a simula¬
tion, containing two values, obtained by fitting the data
calculated in Appendix 1.3 to the Hill equation, are given in
Table VIII. The Hill coefficient (Table VII) was negative,
therefore a system containing more than one transport system
with different KM's would probably exhibit negative co-
operativity.
14
4.4 Influence of various amino acids on C-histidine
uptake and histamine formation
The addition of unlabelled L-histidine had a dramatic
14 14
effect on the uptake of C-histidine and C-histamine
14
formation, whereas D-histidine had no effect on C-histidine
14
uptake, although it appeared to decrease slightly C-histamine
formation (Fig. 10).
At all concentrations of L-histidine used there was
14
a significant decrease (p <0.001) in the amount of C-
histidine incorporated and "^C-histamine synthesized. C-
histidine uptake was unaffected by D-histidine but at the





Basophils 14361. 2 472. 1 0.90 935.6
Normal Bone Marrow 11015. 5 595. 1 0.83 2203.0
Mononuclear 5113. 0 226. 0 0.96 283.1
Neutrophils 4758. 0 284. 3 0.78 1869.0
Eosinophils 2489. 3 179. 5 0.82 561.0
Simulation 1. 99 1. 36 0.95 1.38
TABLE VII
The maximum veolcity (Vj^x), Michaelis-Menten
constant (K), Hill constant (h) and substrate concentra¬
tion which gives half (^50^ ^or basophil-enriched,
normal bone marrow, mononuclear, neutrophil-enriched
and eosinophil-enriched cell suspensions and a simulation.
For the various cell types Vj^AX is expressed as p.moles
14 • 6
C-histidine incorporated per 45 min for 3 x 10
nucleated cells and s^q has units of |_l.moles.1











0.5 0.5333 0.5509 -0.018
0.75 0.7504 0.7162 0.034
1.0 0.8333 0.8453 -0.012
1.5 1.0286 1.0354 -0.007
2.0 1.1667 1.1693 -0.003
2.5 1.2698 1.2691 0.001
3.0 1.35 1.3466 0.003
TABLE VIII
The computer derived velocities and residuals,
obtained by fitting the data to the Hill equation, for
a simulated experiment where the substrate concentration
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-lvCONCENTRATION (moles. 1 A)
Fig. 10
14
The effect of L- and D-histidine on the uptake of C-
histidine and 14C-histamine formation. Each point represents
the mean ± 1 S.E. of 6 experiments.
1 17
but statistically significant (p <0.05) inhibition of 44C-
histamine formation.
The effect of most naturally occurring amino acids on
14
C-histidine uptake and histamine formation is shown in
Figs. 11 to 15.
14
Tryptophan gave significant inhibition of C-histidine
-3 -1
uptake at all concentrations used, 10 moles.1 (p <0.01)
-4 -5 -1
and 10 and 10 moles.1 (p <0.05). Its inhibition of
14 -3 -1
C-histamine 'synthesis was significant at 10 moles.1
(p <0.001) and 10 4 moles.1 4 (p <0.05). Tyrosine produced
14 -3 -1
significant inhibition of C-histidine uptake at 10 moles.1
-4 -1
(p <0.01) and 10 moles.1 (p <0.05). At all concentrations
14
it significantly decreased C-histamine synthesis.
The sulphur containing amino acids, methionine and
14
cysteine, produced dose-dependent inhibition of C-histidine
14
uptake and C-histamine synthesis. Methionine significantly
14 14
decreased C-histidine uptake and C-histamine synthesis at
10~3 moles.I-4 (p <0.01 and p <0.001 respectively), the latter
also being significantly inhibited at 10 4 moles.1 4 (p <0.05).
At 10"3 (p <0.01) and 10~4 moles.1~4 (p <0.05) cysteine
14
decreased the amount of C-histidine incorporated, at the
14
same concentrations it also inhibited C-histamine formation
(p <0.01).
The three hydrophobic amino acids, phenylalanine,
14
leucine and isoleucine, inhibited C-histidine uptake and
44C-histamine formation in a dose-dependent fashion (Fig. 12).
14
Phenylalanine and isoleucine significantly decreased C-
histidine uptake and 44C-histamine formation at 10~3 moles.1 4
(p <0.001), 10 moles.1 (p <0.01) and 10 moles.1
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and ~'C-histamine formation. Each column represents the
mean ± 1 S.E. Tryptophan, tyrosine and cysteine - 3
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The effect of amino acids on the uptake of 14C-histidine
14
and C-histamine formation. Each column represents the
mean ± 1 S.E. Phenylalanine, and leucine - 3 experiments;
isoleucine - 4 experiments.
120
3 1 4
was significant at 10~ moles.1~ (p <0.01) and 10~
moles.1 4 (p <0.001). Its inhibitory effect on 44C-
histamine formation was significant at all concentrations
used, 10 3 moles.1 4 (p <0.01) and 10-4 and 10~3 moles. 1~4
(p <0.05).
Alanine, serine and threonine had no statistically
14
significant effect on C-histidine uptake but at high
14
concentrations decreased the amount of C-histamine
— 3 -1
synthesized (Fig. 13). Alanine and serine at 10 moles.1
-3 -4 -1
and threonine at 10 and 10 moles.1 significantly
14
inhibited C-histamine formation (p <0.05).
14
The effect of valine, lysine and glutamine on C-
14
histidine uptake and C-histamine formation is shown in
-3 -1
Fig. 14. Valine and lysine at 10 moles.1 significantly
14
inhibited (p <0.01) C-histidine uptake whereas at all
14
concentrations used glutamine was without effect. C-
histamine synthesis was significantly decreased by valine
at 10"3 moles.1 4 (p <0.001) and 10 4 moles.1 4 (p <0.01),
-3 —1
and by lysine and glutamine at 10 moles.1 (p <0.05).
Proline, glycine, cystine, arginine, aspartic acid,
asparagine and glutamic acid had no significant effect on
either 14C-histidine uptake or 14C-histamine formation over


























































and """xC-histamine formation. Each column represents the
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CONCENTRATION (moles. I"1)
Fig. 14
The effect of amino acids on the uptake of C-histidine
14
and C-histamine formation. Each column represents the











20 Proline Glycine Cystine
0 r*p '-Li qp i T j lXJ—T?
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Arginine Aspartic acid Asparagine Glutamic acid



































The effect of amino acids on the uptake of C-histidine
14
and C-histamine formation. Each column represents the
mean ± 1 S.E. Proline, glycine, arginine, aspartic acid
and glutamic acid - 4 experiments; cysteine and asparagine -
3 experiments.
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5.0 COMPARISON WITH RAT MAST CELLS
14 14 14
The uptake of C-histidine and C-histamine and C-
histamine formation was studied in purified preparations of
14
rat peritoneal mast cells. The amounts of C-histidine
14 14
and C-histamine incorporated, C-histamine formed de novo
and endogenous histamine are shown in Table IX along with similar
data for the guinea pig bone marrow basophil.
The values reported are for pure mast cell and basophil
populations. Since mast cells and basophils were never
14
obtained as pure preparations the uptake of C-histidine
14
and C-histamine was calculated by subtracting the amounts
incorporated by the contaminating cells. This was possible
since the contaminating cells could be obtained free of mast
cells or basophils.
The guinea pig basophil incorporated about four times
14
as much C-histidine as the rat mast cell on a cell to cell
basis under the same conditions. However, the rat mast cell
14
converted approximately 83% of the incorporated C-histidine
to "^C-histamine whereas the basophil converted only 31%.
14
There was no significant difference in C-histamine uptake
14
between the two cell types. The amount of C-histamine
taken up was extremely low compared to the amount formed from
14
the C-histidine incorporated. Rat peritoneal mast cells









(p moles per 10 cells)
33.3 ± 4.7 121.9 ± 12.3
Histamine formation
0
(p moles per 10 cells)




(p moles per 10 cells)
5.2 ± 1.1 5.9 ± 0.7
Histamine content
g
(pg per 10 cells)
12.5 ± 1.8 1.13 ± 0.08
TABLE IX
14 14
The uptake of C-histidine and C-histamine,
14
amount of C-histamine formed and endogenous histamine
content of rat peritoneal mast cells and guinea pig bone
marrow basophils. The figures represent the mean ± 1 S.E
14
Rat mast cells: C-histidine uptake - 14 experiments;
14 ■ 14
C-histamine formation - 8 experiments; C-histamine
uptake - 4 experiments; histamine content - 6 experiments
14 14
Guinea pig basophils: C-histidine and C-histamine
uptake and "^C-histamine formation - 17 experiments;




The uptake of C-histidine and C-histamine and the
14 14
conversion of the incorporated C-histidine to C-histamine
was measured in suspensions of guinea pig bone marrow cells
rich in basophils.
14
When the same amounts of C-labelled histidine and
histamine were added to equal numbers of basophils the uptake
of histidine was approximately 35 times greater than that of
histamine.
Highly purified preparations of eosinophils, neutrophils
and mononuclear cells and normal bone marrow cells incorporated
14
less than half as much C-histidine when compared to basophil-
14
enriched cell suspensions; C-histamine uptake by all cell
types was virtually negligible.
14 14 14
C-histidine and C-histamine uptake and C-histamine
formation was dependent on the time of incubation, substrate
14
concentration and temperature but only C-histamine uptake
varied significantly with pH.
Kinetic studies showed that the uptake of histidine,
under the conditions used, did not fit a simple Michaelis-
Menten relationship. However, s^q and values for the
various cell preparations were determined.
Thirteen out of the twenty amino acids tested gave
14
some degree of inhibition of C-histidine uptake and/or
14C-histamine formation. The pattern of inhibition obtained
»
fitted that which would be expected from transport studies
on other mammalian cell types.
APPENDIX TO SECTION I
APPENDIX 1.1. POSSIBLE REASONS FOR THE OBSERVATION OF
NEGATIVE CO-OPERATIVITY IN THE UPTAKE OF 14C-HISTIDINE
Negative co-operativity would occur if the measured
velocity was not linear, i.e. an initial velocity was not
being measured. It may be that at high substrate con¬
centrations the rate of uptake was not linear for the
entire 45 min incubation and a shorter time should have
been used.
Another possibility is that more than one Michaelis-
Menten constant (K^) was present in each set of data since
none of the cell preparations was completely homogeneous,
either in terms of cell type or maturity. To investigate
this theory data containing two K^'s was composed
(Appendix 1.3) and the Hill equation fitted by computer.
Thirdly, there is no reason why the results obtained
could not be due to real effects. It is possible that the
transport systems studied do not behave like enzymes and
the uptake of histidine follows different relationships.
1 23
APPENDIX 1.2. DEFINITION OF HILL EQUATION
The Hill equation was first proposed to explain the
reaction of oxygen with haemoglobin (Barcroft and Hill, 1909).
However, it can also be applied to enzyme catalysed reactions
in which case it simplifies to:
h
V. s
v = „ h where V = maximum velocityJi T S
s = substrate concentration
K = Michaelis-Menten constant
v = velocity
h = Hill coefficient
If v = -§-V then,
T, hV. s
*V " K + sh
„ h „ h
K + s = 2s
K = sh
Taking logarithms of each side,
log K = h log s
log s = 1/h log K = log K 1/h
. . substrate concentration to give y V = ^
A Hill coefficient of 1 infers that a plot of velocity
against substrate concentration is hyperbolic - simple
Michaelis-Menten relationship. If the value is greater
than 1 then a positive co-operative effect is occurring and
if it is less than 1 then negative co-operativity is present.
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APPENDIX 1.3. CALCULATION OF SIMULATION DATA
The Michaelis-Menten equation:
V. s
v = K + s where v = velocity
V = maximum velocity
s = substrate concentration
K = Michaelis-Menten constant
defines the quantitative relationship between enzyme reaction
rate and substrate concentration if both K and V are known.
To compile the simulation data V was taken to be 1 and
the K values 1 and 2.
•
• • v-jL = s and Vg = s
1 + s 2 + s
s s
hence the observed velocity (vobs) = ^ + s + 2 + s
A set of observed velocities was calculated for seven
substrate concentrations between 0.5 and 3.0. These values
along with the computer derived velocities and residuals are
given in Table VIII.
SECTION II - HISTIDINE AND HISTAMINE UPTAKE AND
NEV HISTAMINE FORMATION BY BASOPHILS
EFFECT OF METABOLIC INHIBITORS
1.0 INTRODUCTION
From the results in Section I the basophil appears to
have the capacity to preferentially take up exogenous
histidine, as compared to other cell types, and (as also
shown by Galli e_t aJL (1976)) to convert this incorporated
histidine to histamine. The uptake of histidine, which
appears to be the main source of histamine, fulfils the
three characteristics of mediated transport, i.e. substrate
specificity, saturatability and specific inhibition.
Therefore, further experiments were carried out to determine
if the uptake occurred by an active or passive mediated
process.
The most fundamental criterion of an active mediated
process is transport against a chemical or electrochemical
gradient. This requires precise knowledge of the concentra¬
tion of the transported substance in the two compartments
concerned. However, it is not always possible to establish
from analytical measurements, if these can be made, whether
or not a true thermodynamic gradient exists.
A second criterion of active mediated transport, but
not necessarily an infallible test, is to determine if the
process is dependent upon a source of metabolic energy.
Therefore, the influence of a number of metabolic inhibitors
on histidine uptake was investigated. Their effects on
histamine uptake were examined since it was unclear from
Section I if this process was mediated or not. Histamine
formation de novo was also studied in the presence of the
various metabolic inhibitors to determine if inhibition of
histidine uptake led to a decrease in the amount of histamine
formed.
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2.0 EFFECT OF METABOLIC INHIBITORS ON 14C-HISTIDINE UPTAKE
The effect of various metabolic inhibitors on the uptake
14
of C-histidine is shown in Figs. 16-18. The doses chosen
were those which gave the same degree of cell viability as
diluent controls.
2.1 General metabolic inhibitors
14
Iodoacetamide decreased the amount of C-histidine
incorporated in a dose-dependent fashion producing a
significant inhibition at 10~4 moles.1 4 (p <0.01).
NSD 1055, an inhibitor of L-aromatic amino acid decarboxylase
and specific histidine decarboxylase, gave significant
-4 -6
inhibition at all the concentrations used, at 10 and 10
moles.l-"^ (p <0.001) and 10~3 moles.1~4 (p <0.05).
2.2 Inhibitors of microtubule and microfilament function
14
Colchicine had no effect on C-histidine uptake over
-4 -6 -1
the concentration range 10 to 10 moles.1 . Cyto-
6 1
chalasin B gave significant inhibition at 10" moles.1"
(p <0.001).
2.3 Inhibitors of glycolysis and agents which influence
aerobic respiration
The inhibitors of glycolysis, 2-deoxy-D-glucose and
14
sodium fluoride, decreased the amount of C-histidine taken
up by the basophil-rich cell suspensions (Fig. 17).
_3
2-deoxy-D-glucose produced significant inhibition at 10
1 4" I. 2
moles.1 (p <0.01) and 10" moles.1~ (p <0.05). At 10
and 10~3 moles.I"1 sodium fluoride significantly (p <0.01)
14 ...
decreased the uptake of C-histidine.
2,4-dinitrophenol, an uncoupler of oxidative phospho¬
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The effect of metabolic inhibitors on the uptake of
C-histidine. Each column represents the mean ± 1 S.E.
6 1
Colchicine and cytochalasin B (10 mol.1 ) - 6 experiments;
-7 -1
cytochalasin B (10 mol.1 ) - 5 experiments; NSD 1055 and
— 8 —1
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-1,CONCENTRATION (moles. 1 l)
Fig- 17
14
The effect of metabolic inhibitors on the uptake of C-
histidine. Each column represents the mean ± 1 S.E.
6 —1
Antimycin A (10 mol.1 ) - 6 experiments; sodium fluoride
(10~3 and 10"4 mol.l-4), 2,4-dinitrophenol (10-3 and 10 8
-1 -7 -1
mol.l ) and antimycin A (10 mol.1 ) - 5 experiments;
2,4-dinitrophenol (10 4 mol.l-4) and antimycin A (10 8 mol.l 4)
-2 -5
4 experiments; 2-deoxyglucose, sodium fluoride (10 and 10
mol.l 4) and 2,4-dinitrophenol (10 ' mol.l "L) - 3 experiments.-7 -1
14
produced a dose-dependent decrease in C-histidine uptake.
At all the concentrations used, 10~^, 10~^ and 10~® moles, l-^",
2,4-dinitrophenol gave significant inhibition (p <0.01) while
—6 — 1
antimycin A produced a significant decrease at 10 moles.1
(p <0.001) and 10-^ moles.l-"'" (p <0.05).
2.4 Inhibitors of protein, RNA and DNA synthesis
The inhibitor of protein synthesis, cycloheximide, and
RNA synthesis, actinomycin D, gave a significant inhibition
of "^C-histidine uptake at 10 ^ and 10 ^ moles.1 * (p <0.01).
Mitomycin C, an inhibitor of DNA synthesis, over the dose
-5 -7 -1


















































The effect of metabolic inhibitors on C-histidine
uptake. Each column represents the mean ± 1 S.E.
6 7 1
Actinomycin D (10" and 10 mol.l" ) - 5 experiments;
cycloheximide and mitomycin C - 4 experiments; actinomycin
6 7 — 1
(10" and 10" mol.l" ) - 5 experiments; cycloheximide and
— 5 —8
mitomycin C - 4 experiments; actinomycin D (10 and 10
mol.l"^) - 3 experiments.
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3.0 EFFECT OF METABOLIC INHIBITORS ON HISTAMINE SYNTHESIS
14
The amount of C-histamine formed de novo from the
14
C-histidine which was incorporated in the presence of the
various metabolic inhibitors, expressed as the percentage
difference from controls, is shown in Table X.
Only NSD 1055 had any significant effect on the amount
of ^C-histamine synthesized. It gave significant inhibition
(p <0.001), a greater than 90% reduction in the amount formed,
at all concentrations used.
TABLE X
The effect of metabolic inhibitors on the amount
14
of C-histamine formed. The figures represent the
mean difference from controls (± 1 S.E.) expressed as
a percentage. * = 2 experiments; ° = 3 experiments;
* = 4 experiments; + = 6 experiments; ** = experiment
performed in glucose-free Tyrode's buffer;


























































































































































4.0 EFFECT OF METABOLIC INHIBITORS ON 14C-HISTIDINE UPTAKE
14
The effect of the various metabolic inhibitors on C-
histamine uptake is shown in Table XI.
-2 -1
Sodium fluoride at 10 moles.1 and antimycin A at
— 6 — 1
10 moles.1 gave slight but significant inhibition (p <0.05)
14
of C-histamine uptake. All other agents tested failed to
produce a significant effect.
TABLE XI
The effect of metabolic inhibitors on the uptake of
14
C-histamine. The figures represent the mean
difference from controls (± 1 S.E.) expressed as a
percentage. ° = 3 experiments; * = 4 experiments;
** = experiment performed in glucose-free Tyrode's











































































































































5-° REQUIREMENT FOR SODIUM IONS
The effect of ouabain, a specific inhibitor of Na+-K+-
14 14 14
dependent ATPase, on C-histidine and C-histamine and C-
histamine formation is shown in Fig. 19.
Ouabain produced a dose-dependent decrease in the amount
14
of C-histidine incorporated. There was a significant
difference from control at all concentrations used (p <0.01).
14
C-histamine formation was also significantly decreased by
ouabain at 5 x 10-^ moles. I-"*" (p <0.01), 10"^ and 5 x 10""^
moles.I-"*" (p <0.05) and 5 x 10~® moles.I-"*" (p <0.001).
14
The percentage difference between the amount of C-
histamine taken up by the cell suspensions in the presence
and absence of ouabain was relatively small although it is
5 0 ^
statistically significant at 5 x 10 and 5 x 10 moles.1
(p <0.05).
Replacing the sodium ions in the buffer by choline
14
resulted in a significant reduction in the amount of C-
histidine (p <0.05) and ^C-histamine (p <0.01) incorporated

































































The effect of ouabain and Na+-free medium on the uptake
14 14 14
of C-histidine and C-histamine and C-histamine formation
14
Each column represents the mean ± 1S.E. Ouabain on C-
14 -5
histidine uptake and C-histamine formation (5 x 10 and
5 x 10~6 mol.l-"'") - 4 experiments; 10 ^ and 10 ® mol. 1 ^ - 5
14
experiments. Ouabain on C-histamine uptake - 3 experiments
Histidine uptake and histamine formation in Na+-free medium -
5 experiments. Histamine uptake in Na+-free medium - 4
experiments.
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6.0 TIME COURSE OF THE EFFECT OF METABOLIC INHIBITORS
Ouabain and antimycin A were used to study the variation
in inhibitory effects with time (Fig. 20).
14
Ouabain produced no significant decrease in C-
histidine uptake over the first 30 min of incubation but
there was a steady increase in the percentage inhibition as
the incubation time was increased. At 120 min the ouabain
14
treated cells incorporated only 49% as much C-histidine as
the control cells. At this time the cell viabilities were
the same in both control and treated suspensions but there
was a gradual decrease in the viability of the treated cells
14
after this time. Ouabain did not affect C-histamine
synthesis up to 120 min. After 120 min there was a decrease
in histamine synthesis in treated cells presumably due to
loss in viability.
14
There was a constant degree of inhibition of C-
histidine uptake by antimycin A throughout the period
studied. The percentage decrease in uptake ranged from 34%
at 120 min to 38% at 30 min. In this experiment at an
incubation time of 30 and 60 min there was a significant
increase in histamine formation (p <0.05). Above 60 min























Time course of the effect of ouabain (10 mol.1 ) and
antimycin A (10 ^ mol.l-^) on the uptake of "^C-histidine and
14
C-histamine formation. The results represent the values
from one experiment and the bars represent the mean of the
triplicates ± 1 S.E.
14
7.0 EFFECT OF METABOLIC INHIBITORS ON 14C-HISTIDINE UPTAKE
BY MACROPHAGE-RICH, NEUTROPHIL-RICH AND NORMAL BONE
MARROW CELL SUSPENSIONS
14
C-histidine uptake by macrophage-enriched, neutrophil-
enriched and normal bone marrow cell suspensions was inhibited
by iodoacetamide, ouabain and cycloheximide (Fig. 21).
14
Iodoacetamide produced a dose-dependent decrease in C-
histidine uptake by normal bone marrow cells which was
-4 -1
significantly different from the controls at 10 moles.1
(p <0.001) and 10-^ moles. I-"*" (p <0.01). The uptake by the
same cell type was significantly decreased by ouabain (p <0.01)
-5 -1
and cycloheximide (p <0.05) at 10 moles.1
-4
The highest concentration of iodoacetamide, 10 moles.1
— 5 -1
and ouabain at 10 moles.1 inhibited (p <0.01) the uptake
14
of C-histidine by mononuclear cells. Cycloheximide, at
-5 -1
10 moles.1 , also produced a significant (p <0.05) decrease
14
in the amount of C-histidine incorporated.
A single experiment using a neutrophil-rich cell
suspension produced the same pattern of inhibition as was
found with normal bone marrow cells although the degree of
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CONCENTRATION (mole.f1)
Fig. 21
The effect of metabolic inhibitors on the uptake of "^C-
histidine by normal bone marrow, macrophage-enriched and
neutrophil-enriched cell suspensions. Each column represents
the mean ±1 S.E. of 3 experiments for normal bone marrow and
macrophage-enriched cell suspensions and the results of 1
experiment for the neutrophil-enriched cell suspension.





C-histidine uptake by basophil-enriched cell suspensions
was decreased by agents which inhibit glycolysis, oxidative
phosphorylation, histidine decarboxylase, protein synthesis
and RNA synthesis. Inhibition was demonstrable in a dose-
and time-dependent fashion and at concentrations which had no
apparent effect on cell viability. Inhibitors of DNA synthesis
14
and microtubule function had no effect on C-histidine uptake.
Cytochalasin B, an inhibitor of microfilament function, also
14
decreased the amount of C-histidine incorporated but only at
concentrations previously shown to affect hexose transport.
NSD 1055, an histidine decarboxylase inhibitor, gave a
14
significant decrease in the amount of C-histamine formed.
In the presence of all the other metabolic inhibitors tested,
except ouabain, the basophils produced the same total amount of
histamine even although less of the substrate, histidine, had
been taken up.
14
C-histamine uptake was significantly decreased by high
concentrations of sodium fluoride and antimycin A.
14 14
C-histidine and C-histamine uptake were dependent on
the presence of Na+ ions and an active Na+-K+-dependent ATPase.
These results suggest that histidine was taken up by an
active-mediated process but that once the histidine had entered
the basophil the amount of histamine formed was independent of
energy from the main metabolic pathways. Since histamine
h
uptake was relatively small the energy required may be
negligible and the uptake continued even in the presence of
metabolic inhibitors. There was a requirement for Na+ ions
for maximal histamine incorporation.
SECTION III - STUDIES ON THE BIOREGULATION OF HISTIDINE
AND HISTAMINE UPTAKE AND NEW HISTAMINE FORMATION BY BASOPHILS
151
1.0 INTRODUCTION
Basophil degranulation, whether by humoral or cellular
mechanisms, leads to the release of several pharmacologically-
active mediators including histamine (Lichtenstein, 1968).
Histamine has been shown to interact with the cell type from
which it originates. For instance, the antigen-induced release
of histamine from basophils of sensitized individuals was
inhibited by the addition of histamine prior to antigen
challenge (Bourne et aJ, 1971). Low concentrations of
histamine inhibit the chemotactic response of normal basophils
to a fragment cleaved from the fifth component of complement,
C5a (Lett-Brown and Leonard, 1977).
In addition to the "classical" pharmacological actions of
histamine, such as increased vascular permeability, contraction
of smooth muscle, bronchoconstriction and the secretion of
gastric hydrochloric acid (Beaven, 1976), it is now recognized
that it has various other effects such as those on leucocytes.
For example, histamine promotes the migration of human eosino¬
phils in vivo (Clark et aT, 1975) and of guinea pig eosinophils
in vitro (Jones and Kay, 1977). Histamine also inhibits
-5
eosinophil "chemotaxis" to endotoxin-activated serum at 10
1 g -|moles.1~ but enhances it at 10~ moles.1~ (Clark e_t al, 1977).
Furthermore, human eosinophil complement receptors were enhanced,
or unfolded, by histamine (Anwar and Kay, 1978) and the amine
inhibits lysosomal enzyme release from neutrophils (Busse and
Sosman, 1976).
The pharmacological actions of histamine are mediated
by at least two distinct classes of receptor designated HI and
H2, which can be differentiated by the use of receptor specific
antagonists. The effects on both the vasculature and smooth
muscle are blocked by classical, HI, histamine receptor
antagonists (Ash and Schild, 1966), whereas gastric acid
secretion is abrogated by the more recently developed H2-
receptor antagonists (Black ejt al, 1972). The differentia¬
tions of these two receptor types has also been confirmed
by the relative agonist activities of certain histamine
analogues (Durant et al, 1975; Parsons £t aJL, 1977).
Since histamine has been shown to influence many
cellular processes its effect on its own biosynthesis was
14
investigated by studying its effect on C-histidine and
14 14
C-histamine uptake and C-histamine de novo. In addition
the effects of the major in vivo histamine catabolites and
various histamine receptor antagonists and agonists were
studied.
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2.0 THE EFFECT OF HISTAMINE
The effect of histamine and its major catabolites,
imidazoleacetic acid (ImAA), l-methyl-4-imidazoleacetic acid
(1,4-MeImAA), N-acetylhistamine (N-AcHm) and 1,4-methylhistamine
(1,4-MeHm), on "^C-histidine and "^C-histamine uptake and ^C-
histamine formation is shown in Figs. 22-24. Histamine
receptor agonists and antagonists were then used to identify
the possible mechanism of histamine's effect.
14
2.1 Effect of histamine and its major metabolites on C-
14 14
histidine and C-histamine uptake and C-histamine
formation
Histamine and two of its catabolites, ImAA and 1,4-
14
MeImAA, increased the uptake of C-histidine (Fig. 22).
14
Histamine significantly increased the amount of C-histidine
taken up at 10~^ moles. 1 ^ (p <0.001) and 10~^ moles. I-"*"
_ 3
(p <0.01). 1,4-MeImAA gave a significant effect at 10
moles. I-"*" (p <0.01) while at 10-^ and 10"^ moles. I-* ImAA
produced a significant enhancement (p <0.01). N-AcHm and
1,4-MeHm had no appreciable effect over the concentration
-3 -5 -1
range 10 to 10 moles.1
-3 -4 -1
Histamine, at 10 and 10 moles.1 , produced a
significant enhancement of histamine formation (p <0.001)
— 3 — 1
while ImAA at 10 moles.1 also produced an increase (p <0.05).
1,4-MeImAA, N-AcHm and 1,4-MeHm had no apparent effect on
histamine formation under the conditions used.
In other systems histamine had been shown to produce
pposite effects at different concentrations. However,
between 10~5 and 10~10 moles.l"1 histamine failed to influence
significantly histidine uptake or C—histamine formation.
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CONCENTRATION (moles.1)
Fig. 22
The effect of histamine and its major catabolites on 14
histidine uptake. Each column represents the mean ± 1 S.E.
Histamine - 13 experiments; ImAA and N-AcHm - 5 experiments



























The effect of histamine and its major catabolites on C-
histamine formation. Each column represents the mean ± 1 S.E.
Histamine - 13 experiments; 1,4-MeHm and 1,4-MeImAA - 6





























































The effect of histamine and its major metabolites on the
14
uptake of C-histamine. Each column represents the mean ±
-4 -5
1 S.E. L-histidine - 6 experiments; Hm (10 and 10
mol.1 ^), ImAA, 1,4-MeImAA and 1,4-MeHm - 4 experiments;
-3 -1
N-AcHm - 3 experiments; Hm (10 mol.1 ) - 2 experiments.
15
As expected histamine significantly inhibited the
14 -3 -4 -1
uptake of C-histamine at 10 and 10 moles.1 (p <0.001).
14
The decrease in the uptake of C-histamine was dose-dependent
as was the inhibition caused by ImAA, 1,4-MeImAA and 1,4-MeHm
which was statistically significantly different from control
-3 -1
values at 10 moles.1 (p <0.05). L-histidine and N-AcHm
14
had no effect on C-histamine uptake.
2. 2 Time course
14
The effect of varying the time of incubation with C-
histidine, after pre-incubation for various times with
14
histamine, on C-histidine uptake is shown in Fig. 25.
With all pre-incubation regimes there was an increase in
14
C-histidine uptake, compared to controls, which become more
marked with time. There was a statistically significant
increase (p <0.05) at 30, 60, 90 and 120 min with a 40 min
pre-incubation with histamine. However, the increase did
not become significant until 60 min when a shorter, 20 min,
pre-incubation was used and until 90 min when the pre-
14
incubation with histamine was only 10 min or -the C-
histidine and histamine were added together.
The time course for the increase of histamine formation
14
followed the same pattern as that for C-histidine uptake.
Pre-incubation with histamine for 40 min produced an increase
(P <0.05) in the amount of histamine formed at times above
14
60 min. However, when the histamine and C-histidine were
»
added simultaneously there was no significant effect until
90 min.
The length of the pre-incubation with histamine prior
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Time course of C-histidine uptake following pre¬
incubation for 40 min (0 —0), 20 min (B — B), 10 min — £)
-3 -1
or no pre-incubation (O — O) with histamine (10 moles.1 ).
The results represent the mean ± 1 S.E. 40 min pre-incubation
at 30, 60 and 90 min - 4 experiments; at 10 and 120 min - 3
experiments; 20 and 10 min pre-incubation - 3 experiments;
no pre-incubation - 4 experiments.
Fig. 26
14
Time course of C-histamine formation following pre¬
incubation for 40 min (© — ©) or no pre-incubation (0 — O)
-3 -1
with histamine (10 moles.1 ). The results represent the
mean ± 1 S.E. 40 min pre-incubation at 30 and 90 min - 4
experiments; at 10, 60 and 120 min - 3 experiments; no
pre-incubation - 3 experiments.
14
alter the enhancement of C-histidine uptake (Fig. 26 and
Table XII) nor histamine formation (Table XII). The
14
histamine must be present during the incubation with C-
histidine since there was no significant difference from
controls in experiments where the histamine was removed by
14












































































































































3.0 THE EFFECT OF HISTAMINE RECEPTOR AGONISTS
2-(2-aminoethyl) thiazole, an Hl-receptor agonist,
14 -3 -1
significantly inhibited C-histidine uptake at 10 moles.1
(p <0.01) and 10~^ moles.I-1 (p <0.05), and "^C-histamine
formation at 10~^ moles, l-^" (p <0.01) and 10-^ and 10~^
moles.I-1 (p <0.05) (Fig. 27).
"Dimaprit", an H2-receptor agonist, significantly
14
decreased the amount of C-histidine incorporated at the
-4 -1
highest concentration used, 10 moles.1 (p <0.01) and the
14
amount of C-histamine formed at all concentrations used
14
(p <0.05). The uptake of C-histidine was not significantly
affected by 4-methylhistamine, another H2-receptor agonist,
but the two lowest doses gave a significant (p <0.05)
14
reduction in the amount of C-histamine formed.
2-(2-aminoethyl) thiazole produced a dose-dependent
14
decrease in the amount of C-histamine incorporated. The
_ 3
decrease was significantly different from controls at 10
-4 -1
and 10 moles.1 (p <0.05). The H2-receptor agonists were



















































-1,CONCENTRATION (moles. 1 )
Fig. 27
14
The effect of histamine agonists on the uptake of C-
14
histidine and C-histamine formation. Each column represents
the mean ± 1 S.E. 2-(2-aminoethyl) thiazole and 4-methyl-
-4 -5 -1
histamine and "Dimaprit" (10 and 10 moles.1 ) - 4
— 0 — 1



















































The effect of histamine agonists on the uptake of
14
C-histamine. Each column represents the mean ± 1 S.E.
of 4 experiments.
4.0 EFFECT OF HISTAMINE RECEPTOR ANTAGONISTS
Neither the Hl-receptor antagonists, mepyramine and
chlorpheniramine, nor the H2-receptor antagonists, metiamide
and burimamide, had a significant effect on the uptake of
^C-histidine (Fig. 29) and ^C-histamine (Fig. 31) and the
14
formation of C-histamine de novo (Fig. 30).
-5 -4
Mepyramine and chlorpheniramine at 10 and 10 moles.1
respectively, gave a significant inhibition (p <0.05) of the
14
enhancement of C-histidine uptake due to histamine (Fig. 29)
14
The increase in C-histamine formation caused by histamine
-5 -1
was significantly inhibited by mepyramine, at 10 moles.1
(p <0.01) and at 10~^ and 10-^ moles.l-"'" (p <0.05), and
-4 -1
chlorpheniramine, at 10 moles.1 (p <0.05). In contrast,
the H2-receptor antagonists had no significant effect on the
14 14
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10"4 10 5 10"6
Fig. 29
The effect of histamine antagonists on the uptake of 14C-
14
histidine and the enhancement of C-histidine uptake by
histamine. The results represent the mean ± 1 S.E.
14
Enhancement of C-histidine: mepyramine and burimamide -
4 experiments; chlorpheniramine and metiamide - 5 experiments.
14
Uptake of C-histidine uptake: chlorpheniramine and
_ 5
metiamide - 7 experiments; burimamide and mepyramine (10 and
10 ^ moles.1 1) - 6 experiments; mepyramine (10~7 moles.1_1) -
4 experiments.







































The effect of histamine antagonists on C-histamine
14
formation and the enhancement of C-histamine formation by
histamine. The results represent the mean ± 1 S.E.
14
Enhancement of C-histamine formation - 4 experiments.
14
Uptake of C-histamine: chlorpheniramine and metiamide
-5 -6 -1
6 experiments; mepyramine (10 and 10 moles.1 ) - 5
-7 -1

























































The effect of histamine antagonists on "C-histamine




Histamine increased, in a dose- and time-dependent
14 14
fashion, the uptake of C-histidine and the amount of C-
14
histamine formed from the C-histidine which had been
incorporated. At high concentrations ImAA and 1,4-MeImAA
14 14
also produced an increased uptake of C-histidine and C-
histamine formation. N-AcHm and 1,4-MeHm had no effect on
either of these variables.
14
C-histamine uptake was inhibited by histamine, ImAA,
1,4-MeImAA and 1,4-MeHm in a dose-dependent fashion but was
unaffected by L-histidine and N-AcHm.
14
The effect of histamine on C-histidine uptake and
14
C-histamine formation was abolished by washing the cells
free of the added amine prior to the addition of radiolabelled
histidine.
14 14
C-histidine uptake and C-histamine formation were
decreased by the Hl-receptor agonist, 2-(2-aminoethyl)
thiazole; "Dimaprit" and 4-methylhistamine, H2-receptor
14
agonists, inhibited C-histamine formation while only the
14
former affected C-histidine uptake.
HI- and H2-receptor antagonists had no significant
effect on the variables measured per se. However, the Hl-
receptor antagonists inhibited the histamine-induced increase
14 14
of C-histidine uptake and C-histamine formation suggesting
that the observed enhancement may be Hl-receptor-dependent.
section iv - the effect of various pharmacological
mediators and anti-allergy and anti-inflammatory drugs




The challenge of sensitized mast cells and basophils
by specific antigen is accompanied by the release of a number
of mediators with varied pharmacological effects. Besides
histamine and slow reacting substance of anaphylaxis (SRS-A)
these agents also include eosinophil chemotactic factor of
anaphylaxis (ECF-A) (Kay and Austen, 1971) whose activity has
been attributed, at least in part, to two related acidic
tetrapeptides, alanine-glycine-serine-glutamic acid and
valine-glycine-serine-glutamic acid (Goetzl and Austen, 1975).
Lung tissue and blood leucocytes from various species are also
capable of synthesizing and releasing prostaglandins (Dawson
et al, 1976; Piper and Walker, 1973), bradykinin (Austen and
Orange, 1975) and 5-hydroxytryptamine (Sjoerdsma et aT, 1975).
Prostaglandins (Bourne et al, 1974) and 5-hydroxytryptamine
(Holroyde and Eyre, 1976) have been shown to modulate the
release of histamine through modulations of cyclic nucleotide
levels. Bradykinin increases cyclic nucleotide levels in
guinea pig lung (Stoner et al, 1973) although a direct action
on histamine release has not yet been shown.
Anti-inflammatory and anti-allergy drugs are known to
influence mast cells and the release of mediators in addition
to a number of other cellular processes.
Non-steroidal anti-inflammatory drugs, including aspirin,
indomethacin and paracetamol, inhibit prostaglandin synthetase,
a collection of microsomal enzymes which convert arachidonic
acid to certain prostaglandins by an oxygenation process
(Vane, 1971). They are also known to suppress antigen and
compound 48/80-induced histamine release from rat mast cells
(Norn, 1971).
1 7
Adrenocortical steroids with glucocorticoid effects
reduce the number of identifiable tissue mast cells (Asboe-
Hansen, 1952). They have also been shown to reduce the
number of circulating eosinophils, a response which was once
used as a test for adrenocortical insufficiency (Thorn et al,
1948). Corticosteroids have little or no effect on prosta¬
glandin synthetase but are thought to inhibit prostaglandin
release (Lewis and Piper, 1975). Since they also stabilize
lysosomal membranes they may prevent the production of the
substrates for prostaglandin synthesis.
The anti-allergy drug, disodium cromoglycate ("Intal"),
inhibits the liberation, but not the effect, of mediators of
immediate-type hypersensitivity reactions initiated by antibody-
antigen interactions in man (Cox, 1967).
Since these drugs affect the function of mast cells and/or
basophils and a number of mediators have been shown to influence
14 14
the release process, their effect on C-histidine and C-
14
histamine uptake and C-histamine formation was investigated.
. 1 73
2.0 EFFECT OF MEDIATORS
The effects of the human ECF-A tetrapeptides and a
synthetic analogue, prostaglandins E1, E„ and F0 , 5-JL Z <-t (1
hydroxytryptamine and bradykinin on 44C-histidine and 44C-
14
histamine uptake and C-histamine synthesis are shown in
Fig. 32-34.
2.1 ECF-A tetrapeptides
The alanyl- (Ala-Gly-Ser-Glu), valyl- (Val-Gly-Ser-Glu)
and the analogue (valine-glycine-aspartic acid-glutamic acid)
tetrapeptides had no statistically significant effect on the
measured parameters (Fig. 32).
2.2 Prostaglandins
14 14
The amount of C-histidine incorporated and C-histamine
formed de novo was increased, in a dose-dependent fashion, by
the three prostaglandins tested (Fig. 33). There was a
14
significant enhancement (p <0.05) of C-histidine uptake by
-4 -1
prostaglandins Eg and a4 4® moles. 1 . Prostaglandin E^
14
gave a significant increase in the amount of C-histamine
—4 —5 —1 * —6
synthesized at 10 and 10 moles.1 (p <0.05) and at 10
moles.1 4 (p <0.01). At all the concentrations used, 10-4
and 10"6 moles.I-4 (p <0.05) and 10~^ moles.I-4 (p <0.01),
14
prostaglandin Eg increased the amount of C-histamine formed.
14
With prostaglandin F9 the amount of C-histamine formed was£ cx
-4 -5
significantly different from control values at 10 and 10
moles.1 4 (p <0.05).
14
There was no marked effect on C-histamine uptake by
any of the prostaglandins used. Only prostaglandin Eg, at
-4 -1
the highest concentration used, 10 moles.1 , gave an
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Fig. 32
The effect of the ECF-A tetrapeptides (Ala-Gly-Ser-Glu
and Val-Gly-Ser-Glu) and a synthetic analogue (Val-Gly-Asp-Glu)
14 14 14
on C-histidine and C-histamine uptake and C-histamine
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Fig. 33
The effect of prostaglandins (PGE1, PGE and PGF„ ) on
14 2 cc
C-histidine and C-histamine uptake and 14C-histamine
formation. Each column represents the mean ± 1 S.E. of
3 experiments for 14C-histidine uptake and 14C-histamine
formation and 5 experiments for 14C-histamine uptake.
1
2.3 5-hydroxytryptamine and bradykinin
14
5-hydroxytryptamine had no significant effect on C-
14 14
histidine and C-histamine uptake and C-histamine formation
at any of the concentrations used. Bradykinin did not
14 14
significantly alter the amounts of C-histidine and C-


































































The effect of 5-hydroxytryptamine on the uptake of C-
14 14
histidine and C-histamine and C-histamine formation and
14 14
of bradykinin on C-histidine and C-histamine uptake.
The results represent the mean ± 1 S.E. 5-hydroxytryptamine
14C-histidine uptake and 14C-histamine formation - 4 experi¬
ments; 14C-histamine uptake - 3 experiments. Bradykinin
n
__ o _ ^
(8.6 x 10" and 8.6 x 10" moles.1 ) - 2 experiments.
0 1
The result for bradykinin at 8.6 x 10 moles.1 is for 1
experiment.
3.0 ANT I-INFLAMMATORY AND ANTI-ALLERGY AGENTS
The glucocorticoid, hydrocortisone, the non-steroidal
anti-inflammatory drugs, indomethacin and aspirin, and the
anti-allergy drug, Intal, had no significant effect on any
of the parameters measured (Table XIII).
TABLE XIII
14
The effect of various drugs on the uptake of C-
14 14
histidine and C-histamine and C-histamine formation.
The results represent the mean ± 1 S.E. or the mean of
#
































































































The ECF-A tetrapeptides, 5-hydroxytryptamine and
14
bradykinin, did not significantly alter the uptake of C-
14 14
histidine and C-histamine and C-histamine formation.
The prostaglandins studied (PGE^, PGE2 and PGF2a)
14
significantly increased the amount of C-histamine formed.
In addition, PGE„ and PGF0 , also significantly increased the^ (X
14 14
uptake of C-histidine. The uptake of C-histamine was
unaffected by prostaglandins with the exception of the
highest concentration of PGEg.
None of the anti-inflammatory (hydrocortisone, aspirin,
indomethacin) nor the anti-allergy (disodium cromoglycate)
14
drugs used significantly altered the uptake of C-histidine
14 14
and C-histamine and C-histamine formation de novo.
SECTION V - THE EFFECT OF ANAPHYLACTIC HISTAMINE
RELEASE AND THE PRESENCE OF VARIOUS CELL TYPES ON
14C-HISTIDINE UPTAKE AND 14C-HISTAMINE FORMATION
1 o 7I U J
1.0 INTRODUCTION
The anaphylactic release of pharmacological mediators
is a non-cytotoxic secretory process. Cells which have dis¬
charged their granule contents after an antigen-antibody
interaction remain viable as judged by exclusion of vital
dyes, electron microscopic morphology and by continued motility
under the phase contrast microscope (see General Introduction).
It seems reasonable to anticipate, therefore, that degranulated
basophils are capable of repair and regranulation.
Eosinophils or their products have been frequently
implicated as regulators of immediate type hypersensitivity
(see Aims) and their possible role in tissue mast cell repair
have been suggested. For this reason the interactions between
eosinophils and basophils were investigated.
2.0 THE EFFECT OF HISTAMINE RELEASE
Incubation of sensitized basophils with the appropriate
antigen caused the release of histamine. Histamine release,
expressed as a percentage of the total histamine present in
the cell suspensions prior to antigen challenge, after
incubation with various dilutions of antigen is shown in
Fig. 35.
The cells from guinea pigs injected with sheep's blood
gave a dose-dependent release of histamine, when incubated
with a blood cell lysate, which was significantly different
from controls at a "^10, "^lOO dilution (p <0.05). The
histamine release from the cells of an ovalbumin-stimulated
animal challenged with purified ovalbumin showed a dose
response below 4 mg.ml-"'". However, inhibition of release
was observed at 5 mg.ml ^. When sheep's blood and ovalbumin
primed animals were challenged with purified ovalbumin and
sheep's red cell lysate, respectively, the histamine release
was the same as the control levels.
Guinea pigs treated with sheep's blood were used as the
source of the sensitized basophils in experiments designed to
investigate the effect of histamine release on the amounts of
14C-histidine incorporated and 14C-histamine formed de novo.
Except for some preliminary experiments, the dilutions of red
cell lysate used were ly/20, "^lOO and ly/500 since with longer
treatments and incubation times, cells challenged with
undiluted lysate, i.e. final dilution 1/^10, tended to be less
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Fig. 35
The amount of histamine released by basophil-enriched
cell suspensions from guinea pigs injected with sheep's
blood or ovalbumin when incubated with the antigen used in
their stimulation. Various dilutions of sheep's red cell
lysate, or concentrations of ovalbumin were used. C =
control (no antigen added).
Each column represents the mean ± 1 S.E. Sheep's
blood primed animals - 4 experiments. Ovalbumin primed
animals - 3 experiments.
186
14 14
2.1 C-histidine uptake and C-histamine formation
immediately after antigen challenge
14
The percentage difference in C-histidine uptake and
14
C-histamine formation, from unchallenged cells, after a
14
90 min incubation with C-histidine immediately following
challenge is shown in Fig. 36. There was a dose-dependent
14 14
increase in the amount of C-histidine incorporated and C-
14
histamine formed. The increase in the amount of C-histamine
14
synthesized was more marked than the increase in C-histidine
14
uptake. The amount of C-histamine formed by basophils
which had released a portion of their stored histamine was
significantly greater than the amount of histamine formed by
unchallenged controls at 4^10 (p <0.05) and "^lOOO (p <0.001)
dilutions. Histamine release had no statistically significant
14
effect on the amount of C-histidine incorporated.
14
2.2 C-histidine uptake and histamine formation 24 hr
after antigen challenge
In another series of experiments challenged and control
cells were cultured in Eagle's Minimal Essential Medium without
14
histidine for 24 hr prior to incubation for 90 min with C-
histidine in Tyrode's buffer (Fig. 36). Under these conditions
14
there was no significant difference in C-histidine uptake
between challenged and control cells. Ip contrast, the amount
of 14C-histamine synthesized from the 14C-histidine incorporated
was significantly increased following challenge with ^20
(p <0.05) and ly/500 (p <0.01) dilutions of red cell lysate.
In one experiment the cells from the same guinea pigs
were used both immediately after challenge and 24 hr later.





















































The effect of anaphylactic histamine release induced by
sheep's blood cell lysate on 14C-histidine uptake and 14C-
histamine formation. A - immediately after challenge.
B - after culture for 24 hr.
The release of histamine was dose-dependent in all
experiments. Each column represents the mean ± 1 S.E.
A - 1/10, 1/100 - 4 experiments; 1/1000 - 3 experiments.
B - 6 experiments.
188
14
synthesized in the 90 min incubation with C-histidine, by
the same number of cells, was similar for both treatments.
2.3 Time course
In the two sets of experiments detailed above (parts
2.1 and 2.2) the cells were incubated with ^C-histidine for
90 min. The results given in Fig. 37 show the amounts of
14 14
C-histidine incorporated and C-histamine formed following
prolonged incubations of up to 6 hr.
At incubation times above 30 min the antigen challenged
14
cells incorporated more C-histidine than unchallenged
controls, the difference becoming more marked with time.
The extent of the anaphylactic reaction did not influence
the degree of enhancement of uptake since, while the various
dilutions of antigen gave a dose-dependent release of histamine,
14
they produced virtually identical C-histidine incorporation.
14
A greater amount of C-histamine was synthesized from
14
the C-histidine incorporated in the antigen-challenged
cells at all time points. By 6 hr the cell suspension which
was challenged with "^100 dilution of antigen formed over 80%
14
more C-histamine than the control, while the two other
challenged preparations produced over 40% more.
189
Fig. 37
14 14Time course of C-histidine uptake and C-histamine
formation after incubation with 1/20 (C — E), 1/100
and 1/500 (O — 0) dilution of sheep's blood cell lysate or
control solution ( © — © ). The results are from 1 experiment
and the lysate caused a dose-dependent release of histamine.
1
3.0 EFFECT OF VARIOUS CELL TYPES
In Section I it was shown that basophil-enriched cell
1 4
suspensions incorporated substantially more C-histidine
than the other cell types tested, viz. eosinophils, neutrophil
mononuclear cells and normal bone marrow cells. Further,
14C-histamine formation de novo from the incorporated "^C-
histidine was measurable only in the basophil suspension.
14 14The effect on C-histidine uptake and C-histamine
formation of mixing large numbers of purified eosinophils,
neutrophils and macrophages with basophil-enriched cell
suspensions is shown in Figs. 38-43. Each figure shows the
results from several experiments. It was impossible to pool
the results from each experiment on the same cell type because
of the variation in the number of cells used and the large
variations in uptake encountered.
3.1 Eosinophils
Fig. 38 shows the results of three experiments where
eosinophil-enriched cell suspensions (>90%) were mixed with
basophil-enriched cell suspensions for 40 min prior to the
14
addition of C-histidine for 90 min. The ratios of
eosinophils to basophils was 3:1 in the first experiment and
14
2:1 in the other two. The uptake of C-histidine and the
amount of "^C-histamine formed by the mixture of cells was
not significantly different from the amounts assimilated by
the cells when incubated separately.
In other experiments suspensions rich in basophils and
eosinophils and a mixture of the two cell types were cultured
for 18 hr at 37° in Eagle's Minimal Essential Medium
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Fig. 38
The amount of 14C-histidine taken up and 14C-histamine
formed by basophil-enriched cell suspensions (B), eosinophil-
enriched cell suspensions (E) and a mixture of the two
✓ % 14
populations (B+E) during a 90 min incubation with C-
histidine, 40 min after mixing the cells. Each group of
columns represent the results of 1 experiment (carried out
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Fig. 39
The amount of 14C-histidine taken up and 14C-histamine
formed by basophil-enriched cell suspensions (B), eosinophil-
enriched cell suspensions (E) and a mixture of the two
populations (B+E) during a 90 min incubation with 44C-
histidine 18 hr after mixing the cells. Each group of
columns represent the results of 1 experiment (carried out
in triplicate) and the bars ± 1 S.E.
incubated for 90 min in Tyrode's buffer in the presence of
14 14
C-histidine. The amounts of C-histidine incorporated
14
and C-histamine formed in three different experiments are
shown in Fig. 39. The ratios of eosinophils to basophils
were 4:1, 5:1 and 4:1, respectively. Again there was no
appreciable difference in 14C-histidine uptake and "^4C-
histamine synthesis between the mixture and the sum of the
two cell types alone.
The eosinophil-enriched cell suspensions were obtained
from the peritoneal cavity of guinea pigs stimulated by
injections of horse serum. In the two experiments shown in
Fig. 40 the eosinophils were incubated for 15 min with horse
serum prior to mixing with the basophil-enriched cell
14
suspensions and incubation with C-histidine. Once more
14 14
the total amount of C-histidine incorporated and C-
histamine formed by the basophil and eosinophil suspensions
alone was not significantly different from the amount
accumulated by a mixture of the two cell types.
3.2 Neutrophils, macrophages and eosinophils
Neutrophil-rich (>95%), macrophage-rich (>90%) and
eosinophil-rich (>86%) cell suspensions were added to cell
suspensions rich in basophils in the ratio 4:1 for 40 min
14
prior to the addition of C-histidine. The concentration
of histidine used in the three experiments shown in Fig. 41
was 21.8 \i.moles, l"1 (0.1 [iCi:21.8 nmoles). None of the
cell types tested produced any difference in the amount of
14C-histidine incorporated or 14C-histamine formed between
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Fig. 40
14 14
The amount of C-histidine taken up and C-histamine
formed by basophil-enriched cell suspensions (B), eosinophil-
enriched cell suspensions incubated with horse serum (E) and
a mixture of the two populations (B+E) during a 90 min
14
incubation with C-histidine, 40 min after mixing the cells.
Each group of columns represent the results of 1 experiment
(carried out in triplicate) and the bars ± 1 S.E.
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4.0 THE EFFECT OF EOSINOPHILS ON 14C-HISTIDINE UPTAKE AND
HISTAMINE FORMATION BY BASOPHILS AFTER ANTIGEN
CHALLENGE
Sensitized basophils, which had been challenged with
antigen to release a portion of their stored histamine, were
14
capable of incorporating a greater amount of C-histidine
and forming significantly more histamine than unchallenged
14
basophils (part 2.1 - 2.3). If the slight uptake of C-
histidine by eosinophils is taken into account the presence
of eosinophils at a ratio of 3:1 (Fig. 42) and 2:1 (Figs. 43
14
and 44) did not influence the enhanced uptake of C-
14
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Fig. 41
14 14
The amount of C-histidine taken up and C-histamine
formed by basophil (B), macrophage (M), neutrophil (N) and
eosinophil (E) enriched cell suspensions, mixtures of
basophils and macrophages (B+M), basophils and neutrophils
(B+N) and basophils and eosinophils (B+E). Each group of
columns represent the results of 1 experiment (carried out
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Unchallenged */20 */100 V^OO
Blood cell lysate Blood cell lysate Blood cell lysate
Fig. 42
The amount of C—histidine taken up and "^C—histamine
formed by basophil-enriched cell suspensions (B), eosinophil-
enriched cell suspensions (E) and a mixture of the two cell
populations (B+E), all of which had been incubated with
various dilutions of sheep's blood lysate or control. Each
column represents the mean of 1 experiment (carried out in
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Fig. 43
14 14
The amount of C-histidine taken up and C-histamine
formed by basophil-enriched cell suspensions (B), eosinophil-
enriched cell suspensions (E) and a mixture of the two cell
populations (B+E), all of which had been incubated with
various dilutions of sheep's blood lysate or control. Each
column represents the mean of 1 experiment (carried out in
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Unchallenged
B E B+E B E B+E B E B + E
1/20 1/100 V500
Blood cell lysate Blood cell lysate Blood cell lysate
Fig. 44
The amount of 14C-histidine taken up and 14C-histamine
formed by basophil-enriched cell suspensions (B), eosinophil
enriched cell suspensions (E) and a mixture of the two cell
populations (B+E), all of which had been incubated with
various dilutions of sheep's blood lysate or control. Each
column represents the mean of 1 experiment (carried out in
triplicate) ± 1 S.E.
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5.0 EFFECT OF EOSINOPHIL-DERIVED PRODUCTS
Purified human eosinophil cationic protein and lysozyme
14
had no significant effect on the amount of C-histidine
14
incorporated or C-histamine formed (Fig. 45). A crude
preparation from the granules of guinea pig eosinophils was
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The effect of eosinophil derived products (human
eosinophil cationic protein, lysozyme and a guinea pig
eosinophil granule preparation) on 14C-histidine uptake and
14
C-histamine formation. Each column represents the mean ±
1 S.E. of 3 experiments.
6.0 RELEASE OF 14C-HISTAMINE AND 14C-HISTIDINE
Basophil-enriched cell suspensions, from guinea pigs
primed with sheep's blood, gave a dose-dependent release of
14
C-histamine when challenged with a sheep red cell lysate
after incubation with 14C-histidine (Fig. 46). The 14C-
histamine released was calculated as a percentage of the
14
total C-histamine present after spontaneous release had
been subtracted. All the antigen dilutions used gave a
release which was significantly different from control
(p <0.001).
14
C-histidine was also released, in a dose-dependent
fashion, by antigen from cell suspensions which had been
14
incubated with C-histidine in the presence or absence of
NSD 1055 (Fig. 47). The release is expressed as a percentage
difference from unchallenged controls since the basophil
suspensions were not 100% pure and a portion of the total
14
C-histidine present before challenge would be associated
with the contaminating cells and, therefore, not available
for antigen-induced release.
14
There was a significant release of C-histidine from
14
the cells incubated with C-histidine by all dilutions of
antigen used, 4/^10 (p <0.05) and 4^100 and 1000 (p <0.01).
14
When the cells were incubated with C-histidine in the
presence of the histidine decarboxylase inhibitor, NSD 1055,
14 14
to prevent the conversion of C-histidine to C-histamine,
there was also a dose-dependent release of radioisotope.
14
In the presence of NSD 1055 the release of C-histidine was
significantly different from controls at antigen dilutions
























The amount of C-histamine released by various
dilutions of antigen (sheep's blood cell lysate) from
14
basophil-enriched cell suspensions incubated with C-




































The amount of C-histidine released by various
dilutions of antigen (sheep's blood cell lysate) from
basophil-enriched cell suspensions incubated in the
— 5 — 1
absence (A) or presence (B) of NSD 1055 (10 moles.1 ).
Each column represents the mean ±1 S.E. of 6 experiments.
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7.0 SUMMARY
Basophils from guinea pigs sensitized with sheep's blood
or ovalbumin released histamine following challenge with
specific antigen. The amounts of histamine released were
related to the concentrate of antigen used.
Basophils which had undergone an "anaphylactic" reaction
14
were still capable of incorporating C-histidine and forming
14
C-histamine de novo. Indeed, there was a time-dependent
14 14
increase in C-histidine uptake and C-histamine formation
by cells depleted of histamine by antigen challenge when
compared to unchallenged controls.
Eosinophils, neutrophils and macrophages under a variety
14
of conditions had no effect on C-histidine incorporation or
14
C-histamine synthesis by "unchallenged" basophils and in the
case of eosinophils, on "challenged" cells.
14
The uptake of C-histidine and histamine formation de
novo was unaffected by purified eosinophil cationic protein.
14
Basophils which had been incubated with C-histidine
14
gave a dose-dependent release of C-histamine when challenged
with antigen. Under the same conditions a proportion of the
14
incorporated C-histidine was also released.
CHAPTER V - DISCUSSION
SECTION I - CHARACTERIZATION OF THE UPTAKE OF
HISTIDINE AND HISTAMINE AND HISTAMINE FORMATION
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The method developed by Dvorak et al (1974) for the
preparation of basophil-rich suspensions has been found to be
reliable and reproducible. In the present study the most
important single factor which determined the final purity was
the initial basophil content of the bone marrow preparations.
The bone marrow from sheep's blood treated guinea pigs contained
from 1.6 to 19.4% (mean 7.9) basophils, and that of ovalbumin
treated animals 1.2 to 10.4% (mean 5.0). The overall purifica¬
tion achieved was four- to five-fold and, therefore, since at
least 20% basophils were required in the final suspension, bone
marrow containing less than 5% basophils was unsuitable for
routine experiments and rejected.
Sheep's blood proved to be the most reliable antigen(s)
and was used for virtually all the experiments. The degree of
purification achieved was in agreement with the values originally
reported by Dvorak ejt al (1974). However, the same number of
nucleated cells could be obtained from two animals, whereas five,
of similar weight, were required by the original workers.
The translocation of solutes across a cell membrane may
proceed by three different routes: non-mediated diffusion,
active mediated transport and passive mediated transport.
In non-mediated flux, or passive diffusion, the solute
molecules remain in their initial molecular species throughout
the transport process. Non-mediated transport is at all times
dependent on the concentration of the solute and is entirely
the result of simple physical diffusion down a concentration
or electrochemical gradient.
Mediated transport exhibits saturation kinetics, suggestive
of specific sites to which the substance undergoes reversible
209
binding. A second characteristic of mediated transport is
specificity for the material transported. Such transport
systems may also be inhibited quite specifically by structurally
related substances or non-competitively by reagents capable of
blocking or altering functional groups of proteins. There are
two types of mediated transport processes, active and passive.
An active mediated process, which carries a substance
against a chemical or electrochemical gradient, is dependent
upon a source of metabolic energy and is unidirectional (Ussing,
1949; Danielli, 1954). Passive mediated transport, sometimes
called facilitated diffusion, requires no input of free energy
other than that needed to maintain the structure of the cell
membrane and may be in either direction depending on the relative
concentrations in the two compartments (Stein, 1967).
14
The uptake of C-histidine by guinea pig bone marrow
basophils fulfilled most of the characteristics of active
mediated transport. Thus it exhibited saturation kinetics
(Figs. 3A and 9A and Table VII) was inhibited by several other
amino acids (Figs. 11-14) but was not affected by the D-
stereoisomer (Fig. 10) and was dependent on the integrity of
a number of metabolic pathways (Figs. 16-18).
14
The uptake of C-histamine was non-saturable under the
conditions used (Fig. 3A) but it was inhibited by several of
14
its major catabolites (Fig. 24). C-histamine uptake was
virtually independent of metabolic energy (Table XI) but
»
required the presence of sodium and an active sodium pump
(Fig. 19). These facts suggest that histamine enters the
cells studied by passive mediated transport which requires
the movement of sodium to compensate for its net positive
charge at a neutral pH.
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Between 20 and 30% of the "^C-histidine taken up by
the basophil-enriched cell suspensions was converted to
14
C-histamine whereas in eosinophil-rich, neutrophil-rich,
macrophage-rich and normal bone marrow cell suspensions
14
there was no detectable C-histamine formation. The enzyme
responsible for the formation of histamine, L-histidine
decarboxylase, is controlled by a complex interaction of
various mechanisms (see Introduction, Section I, part 5.1).
The activity varies with substrate concentrate which affects
the pH optimum of the enzyme. Histidine and histamine may,
in certain circumstances, form cyclic compounds with the co¬
enzyme, pyridoxal 5'-phosphate. In this feedback mechanism
newly formed histamine could inhibit its own synthesis; excess
histidine could also have the same effect on amine formation.
At a comparatively low extracellular histidine concentra¬
tion, 70 p moles. I-"*", the amount of histamine formed apparently
reached a constant maximal level. This was probably due to
the saturation of the intracellular histidine decarboxylase
under the conditions used. However, at concentrations above
100 p. moles, l-"^ a substantial amount of unlabelled histidine
was present and this lowered its specific activity to such an
extent that accurate determination of histamine formation was
impossible by the chromatographic method used. Therefore,
the amount of histamine formed at high concentrations could
not be determined.
The uptake of histidine by bone marrow cell suspensions
rich in basophils, as measured in this study, was the summation
of several processes. The value obtained was a measure of
the amount of histidine extracted from the medium by the cell
suspension and included: histidine which was in the process
of passing through the membrane or may have been bound to the
membrane itself; some which had passed through the membrane
and was still essentially free histidine; a portion which
had been decarboxylated to histamine and bound in the
granules; and that which had been incorporated into proteins.
14
The uptake of C-histidine could also have involved the
14 14
leakage of C-histidine and newly formed C-histamine from
the cells during the incubation and washings. However,
insignificant amounts of labelled histidine and histamine were
detected in the supernatant of cell suspensions which were the
controls for the experiments on anaphylactic histidine and
histamine release (Results, Section V, part 6.0). These
14
cells had been incubated with C-histidine, washed and then
incubated at 37° for 15 min. The amount of spontaneously
released radioisotope was less than 3% of that present within
the cells.
14
The C-histamine uptake was a measure of the histamine
which was associated with the cells. Its precise location
was not defined but it may have been bound to the cell membrane,
have passed through into the cell or have been bound in the
granules. There was no evidence that the histamine was
metabolized within the cells since the chromatographic profile
of the incorporated histamine extracted by multiple freeze-
thawing was similar to that of the histamine used in the
ft
incubation.
The cell suspensions used for the study of histidine and
histamine uptake contained, on average, 30% basophils.
Therefore, a certain proportion of the incorporated radio¬
isotope was associated with other cell types. However, the
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amount of histamine formed was a direct measure of the
synthesis of histamine by the basophils since no other cell
type tested was able to decarboxylate histidine. Histamine
formation was, therefore, a gauge of variations of histamine
metabolism in basophils.
The evidence for the basophil being more efficient in
incorporating histidine and forming new histamine than other
leucocytes depended on these activities (i) being superimposed
with the basophil peak following cell separation (Fig. 6);
(ii) correlating with the percentage of basophils in various
cell suspensions (Fig. 7); and (iii) being significantly
higher in purified basophil preparations when compared to
preparations of other cell types (Fig. 8). All these
conditions were fulfilled by the data presented.
Although bone marrow basophils were used in all the
experiments, cells isolated from the peripheral blood gave
14 14
similar results in terms of C-histidine and C-histamine
14
uptake and C-histamine formation (Table III). Blood
cells incorporated about half the amount of histidine taken
up by bone marrow derived cells. Although less histamine
in toto was formed by the blood cells, the percentage of the
incorporated histidine which was converted to histamine was
about the same in the cells from the two sources (blood cells
converted 26.1% and bone marrow cells 23.9%).
This may have been a reflection on the maturity of the
cells involved. The less'mature bone marrow cells take up
more histidine requiring a large proportion for cellular
processes other than histamine formation, e.g. protein
synthesis. On the other hand, the fully differentiated
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blood cells may have partially lost the ability to incorporate
histidine, and possibly other amino acids, since they do not
require these as precursors for protein synthesis to the same
extent as bone marrow cells. However, the basophils from
the two sources are capable of decarboxylating histidine,
albeit to different extents.
When blood and bone marrow derived cells were incubated
14
with C-histamine under similar conditions there was no
significant difference in the amounts of histamine incorporated.
Using similar chromatographic assays but different incuba¬
tion procedures Galli et aT (1976) showed that guinea pig blood
3 3
basophils could synthesize H-histamine from H-histidine and
3that the uptake of exogenous H-histamine was relatively
trivial. These workers also demonstrated that histamine
synthesis by lymphocyte cultures was essentially undetectable.
Ten times as much new histamine was formed in the first hour
14
of incubation with C-histidine in the bone marrow cell
suspensions than reported by Galli for cells from peripheral
blood. However, after 6 hr the results were essentially in
agreement. The initial variations are probably explained by
the differences in the incubation conditions. Galli et al
(1976) used a tissue culture medium while in the present study,
which was designed primarily to investigate histidine uptake
over short periods, a simple balanced salt solution was used
since the uptake of histidine was partially inhibited by the
ft
presence of certain amino acids.
The uptake of histidine and histamine and histamine
synthesis has been studied in cells from tissues of various
species (Furano and Green, 1964; Lindell et al, 1961;
Schayer, 1956; Day and Green, 1962a and b). Cabut and
Haegermark (1966), using rat peritoneal mast cells, and Day
and Stockbridge (1964), studying mouse neoplastic mast cells,
suggested that preformed histamine was accumulated by passive
diffusion and binding to the granules. Later, work by Heisler
and Uvnas (1972) showed that passive diffusion of histamine was
probably of minor significance and that transport was due to
facilitated diffusion. Cabut and Haegermark (1968) produced
evidence that histidine transport into rat peritoneal mast cell
was an active mediated process, in agreement with the data here
Rat mast cells incorporated substantially less histidine
than the same number of basophils whereas histamine uptake
and formation was not significantly different in the two cell
types (Table IX). The greater histidine incorporation by
basophils may have been due to the presence of immature,
rapidly developing cells within the populations studied.
This is emphasized when the amount of histamine formed is
considered. The rat mast cells converted 83% of the incorpora
ted histidine to histamine compared to only 31% for the
basophils. It is, therefore, probable that a large portion
of the histidine taken up by the basophils is used for other
processes, e.g. protein synthesis. Alternatively, the rat
mast cells may have lost part of their transport system for
histidine and other amino acids as they matured and less amino
acids were required for cell development. Mast cells at the
same stage of development as the basophils may possess the same
»
capacity for histidine incorporation.
Therefore, over the 90 min incubation period rat mast cell
histidine decarboxylase was capable of converting virtually all
the incorporated histidine to histamine. Although working at
the same rate, and therefore forming approximately the same
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amount of histamine, the basophil enzyme decarboxylated a
smaller percentage of the incorporated histidine since the
substrate concentration was higher. If a longer incubation
time, without additional substrate being incorporated, was
employed the basophils may be capable of converting more of
the histidine to histamine.
One million basophils contained 1.13 pg of histamine
(Table IX). Over a 90 min incubation when the extracellular
histidine and histamine concentration was 1.8 p.moles. 1~^ the
same number of basophils synthesized 4.2 ng histamine and
incorporated 0.65 ng preformed histamine, 0.4 and 0.06% of
the extractable endogenous histamine, respectively.
Since the mast cells contained about ten times more
histamine than the basophils, the uptake and synthesis of
histamine, under the conditions used, would have little effect
on the intracellular histamine concentration. Similar values
were obtained by Cabut and Haegermark (1966 and 1968) for rat
mast cells. Using essentially the same conditions, in 60 min,
the uptake of histamine accounted for 0.02% of the histamine
content whereas the formation of histamine from histidine
increased the histamine concentration by only 0.015%. They
calculated, using the data for mature cells, that a mast cell
surrounded by 2 p moles.1 ^ histidine would take 30 weeks to
0
build up a histamine store of 15 pg per 10 cells.
For the basophil-enriched cell suspensions, if the extra-
*
-1
cellular histamine concentration were raised to 1 m.mole.l ,
the amount of histamine taken up in 90 min would account for
about 10% of the intracellular histamine. It was only possible
to measure histamine synthesis up to an external histidine
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concentration of 100 |i.moles, I-1. At this concentration,
over 90 min, the internal histamine concentration was raised
2.2%.
Therefore, using data obtained from a normal resting
basophil, it would take about 3 days to produce the amount
of histamine present within the granules if the extracellular
histidine concentration was 100 [i.moles. l-^". The iri vivo
extracellular histidine concentration is not known but the
maturing basophil may be much more efficient at taking up
histidine and forming new histamine than the cells used in
these experiments. They may take up histidine at a greater
rate and if there was very little histamine present within
their granules they could decarboxylate the histidine more
rapidly.
After an anaphylactic reaction the concentration of
histamine in the microenvironment around a basophil or mast
cell may be extremely high. In the rat mast cell the
histamine concentration has been calculated to be approxi¬
mately 0.3 moles, l-"'" (Uvnas, 1969). Consequently, after
degranulation the uptake of histamine could be significant
in the regranulation process.
Therefore, under normal circumstances, histidine may be
the principal source of granular histamine but in certain
conditions, e.g. following degranulation, exogenous histamine
could replenish part of the stored amine. However, ijn vitro
experiments on enzyme activity inform only about the potential
rates of histamine formation and histidine and histamine uptake,
not about the rate of formation in the living organism. This
is because neither the enzyme nor the substrate quantities,
not to mention the interrelationships which may exist among
various substrates, coenzymes and enzymes, are known.
The transport of most neutral amino acids in animal
cells appears to be predominantly mediated, presumably
involving a mobile carrier that binds its substrate before
translocating it across the "osmotic barrier". This is
inferred from the criteria considered characteristic of such
transport processes as saturation kinetics, specificity and
typical interactions between different amino acids during
transport.
The transport of amino acids shows saturation kinetics
that often fit the Michaelis-Menten relationship, double
reciprocal plots of initial transport rate against extra¬
cellular concentration being linear, at least at low con¬
centrations (Heinz, 1954). At high concentrations there
is very often deviation from linearity, the line diverging
towards the origin. This can be attributed to a non¬
saturable transport component, often taken as free diffusion
which may not always be justified, because a mediated system
with sufficiently low affinity, i.e. high K^, would behave
similarly (Christensen and Liang, 1966a).
The kinetics of histidine uptake were studied to
determine if there were differences in the transport process
of various cell types. The initial uptake of histidine was
measured over a wide concentration range, 0.18-1000 |i.moles. 1
(Figs. 9 and 9A). At all concentrations the greatest uptake
occurred in the basophil-enriched cell suspensions.
Reciprocal plots of initial rate against substrate concentra¬
tion were not linear and, therefore, more detailed analysis
was carried out using a computer programme to compare the
experimentally derived data with that predicted by the
Michaelis-Menten relationship and the Hill equation. The
experimentally derived values for the uptake of histidine
by basophil- and eosinophil-enriched cell suspensions did
not fit a rectangular hyperbole as predicted by the
Michaelis-Menten equation (Table IV). The observed values
were greater than would be expected at low concentrations
and lower than expected at high concentrations. This is
suggestive of negative co-operativity (Conway and Koshland,
1968; Newsholm and Start, 1973). To test this hypothesis
the results for all the cell types were fitted to the Hill
equation (Tables V and VI). Negative co-operativity was
occurring in the uptake of histidine by all cell types since
the Hill coefficients, h, were less than one (Table VII).
Negative co-operativity would arise if the measurements
were not initial velocities and/or if there were more than
one uptake process each with a different K^. The values for
the maximum velocities, VMAX, and substrate concentrations
which give half maximum velocity, s^q, are empirical figures
but some conclusions can be drawn from them. By comparing
the two bone marrow derived cell suspensions the basophils
seem to have an effect on the derived values. The V^x of
the basophil containing cell suspension was higher and the
s5Q lower, suggesting that the basophils are more efficient
in taking up histidine at low substrate concentrations and,
if the substrate concentration were high, they would incorporate
histidine to a greater extent.
The transport of a given metabolite by mammalian cells
is a complex process and a given transport system can exhibit
wide scope, transporting a number of similar substances.
Also, a metabolite may simultaneously be transported by two
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or more apparently independent systems. The decoding of the
several systems involved in the transport of a single metabolite
may be quite complicated. A given metabolite may share a
transport route with several other metabolites. This may
involve two or more transport systems and the degree of sharing
may be different for each system and for each pair of
metabolites. Therefore, a complex, quantitative inhibition
analysis, requiring experimental modification of the environ¬
mental conditions is necessary (Christ ensen, 1966 and 1969).
By application of these discriminating techniques, a number of
systems for the transport of amino acids have been described
(Christensen, 1977). Support for the transport systems
which have been described so far come from differences in
developmental history of the systems and also from differences
in their genetic determination, inducability, repressibility
and sensitivity to hormonal stimulation (Christensen, 1973).
The transport systems for neutral amino acids have been
defined by using Ehrlich ascites tumour cells, but they are
taken to be representative of those in the cells of higher
animals in general (Oxender et al, 1977).
The most conspicuous transport systems are the Na+-
dependent A systems and the Na+-independent L system
!
(Oxender and Christ ensen, 1963). Essentially all the
neutral amino acids are transported to some degree by both
these systems. Amino acids with short, polar or linear side
chains tend to be preferred by the A systems, e.g. alanine,
glycine and serine, while the L system shows preference for
branched chain and aromatic amino acids, e.g. leucine,
valine and phenylalanine.
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Another Na+-dependent system almost completely specific
to glycine is not seen in the Ehrlich cells. It has been
defined from its description in the pigeon red blood cells
by Vidaver (1964) and is present in nucleated and reticulated
red blood cells. A variant form with broader specificity
may occur in the intestine and kidney (Christ ensen, 1975).
A third Na+-dependent system called ASC has an inter¬
mediate range of specificity. The amino acids transported
by the ASC system have a 3 to 5 carbon straight chain, their
hydroxyl and sulphydryl derivatives and also asparagine,
glutamine and the prolines can be incorporated by this route.
The ASC system is found in almost every cell type including
immature and eunucleated red cells (Wise, 1976a), leukaemic
cells (Thomas and Christensen, 1971) and lymphocytes (Wise,
1976b) and it also participates in placental transport
(Enders £t al, 1976).
Cationic amino acids are transported by a single system,
Ly+. This system requires a positively charged group in the
side chain with a P&2a Srea~ker than 8.7 (Christ e nsen and
Liang, 1966b). Diamino acids may be transported by the
neutral systems to a variable degree.
A complete inhibition and kinetic analysis of histidine
transport by basophil-rich cell suspensions was outwith the
scope and aims of this thesis. However, a few preliminary
experiments were carried out to determine if the observed
ft
patterns of inhibition obtained were compatible with the
already established transport systems for amino acids.
By observations in Ehrlich ascites tumour cells and
various red blood cells, histidine is thought to react
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equally with the A and L systems (Oxender and Christensen,
1963). It does not seem to be incorporated to any extent
by the ASC system (Christensen et al, 1967). An extensive
study by Christensen (1968) into histidine uptake by Ehrlich
cells, at a concentration of 1 m.mole.l-1 at pH 7.4, suggested
that 30% of the histidine was taken up by system A, 66% by
system L, 1% by system Ly+ and 3% by a non-saturable route.
This author also postulated that at lower concentrations the
dominance of the L system would be greater.
Phenylalanine, leucine and isoleucine are thought to be
predominantly incorporated by the L system. Therefore, they
should readily inhibit the uptake of amino acids transported
by that system but only minimally suppress the uptake by A
and ASC systems. Figure 12 shows that the uptake of histidine
was depressed by about 60% in the presence of these amino acids
at 1 m.mole.l-"''.
Tryptophan, tyrosine and methionine divide their uptake
almost equally between the A and L systems. The first two
mentioned are grouped together with histidine as having
approximately the same reactivities towards the two systems
(Christensen, 1977). Cysteine can probably be incorporated
by all neutral amino acid transporting systems although it is
preferentially incorporated by the ASC system which has not
been shown to facilitate histidine incorporation to any
extent (Christensen et al, 1967). The uptake of histidine
by the basophil-enriched cell suspensions was markedly
decreased by tryptophan, tyrosine and cysteine and to a
lesser extent by methionine (Fig. 11). Cysteine reacts with
pyridoxal 5'-phosphate to form thiazolidine derivatives
(Buell and Hansen, 1960). It is, therefore, possible that
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its primary effect was on histamine formation and that the
decrease of histidine uptake could have been due to a
negative feedback by histidine. However, the effects of
tryptophan, tyrosine and methionine were probably due to
direct competition for uptake.
Valine shows a greater reactivity to the L system
whereas alanine, serine and threonine are incorporated more
readily by the A system. The uptake of histidine was
significantly inhibited by valine (Fig. 14) but alanine,
serine and threonine were without effect (Fig. 13).
Proline which has very little or no reactivity with the L
system, and glutamine which reacts equally with the A, L
and ASC systems caused no alteration in the amount of
histidine incorporated.
Lysine is a substrate for the cationic transport
system, Ly+, but can also be transported to a lesser extent
and depending on the pH by the neutral system. The slight
inhibition of histidine transport by lysine (Fig. 14) may
have been due to the interaction of this amino acid with a
neutral system. It is also possible that histidine is a
substrate for the Ly+ system and the observed effect was a
measure of histidine uptake by the cationic transport system
since at pH 7.4 about 5% of the histidine is present in a
cationic form.
A partial requirement for sodium ions was observed
since the uptake of histidine was reduced by about 18% in
Na+-free medium (Fig. 19) suggesting that an Na+-dependent
system is involved, at least to a small extent. The role
of sodium will be discussed in detail later.
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An effect, by the various amino acids used, on the
amount of histamine formed de novo could be merely a
reflection on the decreased uptake and/or a direct effect
on histidine decarboxylase. Histidine is decarboxylated
to histamine by two enzymes. A general aromatic-L-amino
acid decarboxylase which will decarboxylate histidine,
tryptophan, tyrosine, phenylaline, 3,4-dihydroxyphenylalanine
(DOPA) and 51-hydroxytryptophan (5-HTP) has a low activity
towards histidine (Lovenberg et al, 1962). There is also
a specific histidine decarboxylase which has a high affinity
for histidine and does not decarboxylate DOPA or 5-HTP.
This enzyme has been shown to occur in a variety of tissues
including rat peritoneal mast cells (Rothschild and Schayer,
1958) and bone marrow (Hakanson, 1963a). The non-specific
enzyme has been described in many animal tissues (Watson,
1956; Mitchell, 1963) and is probably present in almost all
tissues, even in those in which a specific histidine de¬
carboxylase occurs (Hagen £t al, 1960).
These two enzymes can be differentiated by the use of
various inhibitors. Benzene has been shown to increase
the activity of aromatic amino acid decarboxylase but to
have no effect on or slightly decrease the activity of the
specific enzyme (Mackay et al, 1961). Alpha-methyl DOPA is
a specific inhibitor of aromatic amino acid decarboxylase
(Robinson and Shepherd, 1962; Levine et al, 1965), whereas
an a-methylhistidine (Mackay and Shepherd, 1960) and
brocresine (Reid and Shepherd, 1963) affect the specific
enzyme.
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Galli et al (1976) showed that various inhibitors of
histidine decarboxylase reduced histamine synthesis in
suspensions of guinea pig blood cells rich in basophils,
whereas a-methyl DOPA was without effect. In the present
study it is probable that the histidine decarboxylase activity
in the basophil-enriched cell suspensions can be attributed to
the specific enzyme. Tyrosine, tryptophan and phenylalanine
which are substrates for the general aromatic amino acid
decarboxylase and would, therefore, be expected to compete with
histidine, did not produce any greater inhibition of histamine
formation than methionine and cysteine which are not de-
carboxylated. However, complete characterization of the
enzyme(s) present within guinea pig basophils would require
the study of the effect of the various known inhibitors in a
cell-free system.
Pyridoxal 5'-phosphate under certain conditions may react
in an irreversible fashion with amines and amino acids. In
such reactions Schiff's bases are transformed into cyclic
compounds (see Introduction, Section I, part 5.1). Various
complex combinations may occur, depending on the reacting
amino acid, possibly leading to the inhibition of decarboxyla¬
tion processes. Schott and Clark (1952) showed that DOPA
decarboxylase was inhibited by histamine and histidine and
Mackay and Shepherd (1962) studied the inhibition of histidine
decarboxylase by imidazole derivatives.
» *
All the amino acids which produced an inhibition of
histidine uptake caused an even greater percentage reduction
in the amount of histamine formed. This was most marked
with methionine (Fig. 11). The percentage decrease in
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histamine formation, by methionine, was approximately the
same as was found for tryptophan and tyrosine although it
was only half as effective at decreasing histidine uptake.
Alanine, serine and threonine was almost without effect
on histidine uptake but gave significant inhibition of
histamine formation. Glutamine which had no influence on
histidine uptake, decreased the amount of histamine formed
by 60% at 1 m.mole.l ^ (Fig. 14). Since these amino acids
were without effect on histidine uptake it is probable that
they inhibited histidine decarboxylase by complexing with
pyridoxal 5'-phosphate.
Histidine uptake was decreased when the incubation medium
was free of Na+-ions but the amount of histamine formed was
not significantly different from the controls. Therefore,
it is probable that the L system, if required, is capable of
providing the basophil with virtually all its histidine and
at other times with a substantial part of it, the rest being
made up by the A and Ly+ systems and possibly by non-mediated
transport.
However, it is worth re-emphasizing that the in vitro
techniques used were performed under defined experimental
conditions and that in vivo the relative importance of the
transport systems may be different.
Stereospecificity, which may be absolute with certain
enzyme systems, is less pronounced in amino acid transport.
In most cases the affinity of a given system for the L-
configuration is several times higher than for the D-
configuration, but D-amino acids may be accepted and
incorporated by the same system (Christ e nsen et el, 1952).
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The uptake of histidine by basophil-rich cell suspensions
appears to be confined to the L-stereoisomer. Conclusive
evidence could be provided by showing that (i) D-histidine
was not taken up by the cells and (ii) the stereoisomers were
not mutually inhibitory. In the present study it has been
shown that high concentrations of D-histidine had no effect on
the uptake of its L-stereoisomer (Fig. 10) and it, therefore,
seems likely that the transport system(s) being studied act
virtually exclusively on the L-stereoisomer; although the
possibility still exists that the D-histidine can enter the
cells by a different process.
There was a statistically significant decrease in the
amount of histamine formed by the basophil-enriched cell
-3 -1
suspensions in the presence of 10 moles.1 D-histidine
(Fig. 10). Mackay and Shepherd (1962) have shown that D-
histidine is capable of forming cyclic compounds with
pyridoxal 5'-phosphate. Therefore, the observed inhibitory
effect is probably due to inactivation of the coenzyme.
Alternatively, the decreased histamine formation could be
the result of a small amount of the L-configuration being
present in the D-histidine. This, however, seems unlikely
since the presence of contaminating L-histidine would have
produced an inhibition of histidine uptake.
The energy requirements for histidine and histamine
uptake and histamine formation were investigated using various
metabolic inhibitors. Whereas the principal mode of action
for all the agents used has been established, the possibility
that they may have other, as yet undetermined, effects must
be considered. Therefore, as with all studies using
metabolic inhibitors, the results must be interpreted with
caution.
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Iodoacetamide, an agent which affects all enzymes with
essential sulphydryl groups (and could, therefore, influence
a number of metabolic pathways including glycolysis (Webb,
1966; Park £t ad, 1961)), had a pronounced, although not
complete, inhibitory effect on histidine uptake.
2-deoxyglucose and sodium fluoride caused a marked
reduction in the amount of histidine incorporated. These
agents are well established inhibitors of glycolysis.
2-deoxyglucose is converted to 2-deoxyglucose-6-phosphate
which is a competitive inhibitor of phosphoglucoisomerase
(Wick et al, 1957). Fluoride ions are known to inhibit
2+ 2+
enzymes which require Mg , Ca or similar ions (Peters et al,
1964). Sodium fluoride abolishes the enolase reaction which
results in the accumulation of phosphoglyceric acid, presumably
because of the formation of magnesium fluorophosphate which
binds tightly to the enzyme.
The uncoupler of oxidative phosphorylation, 2,4-dinitro-
phenol (Loomis and Lipmann, 1948), and the respiratory chain
inhibitor, antimycin A (Rieske and Zaugg, 1962), inhibited the
incorporation of histidine, indicating that aerobic respiration
is required for maximal histidine uptake.
Since contractile proteins, such as microtubules and
microfilaments are known to participate in certain secretory
processes (Wright and Malanista, 1973; Wessels et aT, 1971)
it is possible that they may also be involved in the uptake
process. They could theoretically transport histidine,
preformed histamine or newly synthesized histamine to the
basophil granule or they may stabilize the membrane transport
systems or enzymes such as Na^-K dependent adenosinetriphospha—
tase (Na+-K+ dependent ATPase) which are known to facilitate
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membrane transport. Cytochalasin B inhibited histidine
uptake at the highest concentration used. Although this
agent binds to microfilaments, stabilizing them as the
protomer (Miranda ejt al, 1974), and alters membrane-associated
functions such as directional migration, pinocytosis and
phagocytosis (Allison et al, 1971), it also inhibits hexose
transport at doses similar to those used (Cohn et al, 1972).
Therefore, its effect on histidine transport may have been
due to a decrease in the energy available from glycolysis.
No effect was observed with colchicine and, therefore,
functional microtubules (Wilson et, al, 1974) do not appear
to be involved in histidine uptake.
Whether or not the amount of histidine incorporated was
affected by the above agents, the amount of histamine formed
in the presence of the inhibitors was not significantly
different from controls.
The histidine incorporated by the basophils could be
used for protein synthesis, in addition to the formation of
histamine. Cycloheximide, a recognized inhibitor of protein
synthesis (Vazquez, 1974), had a pronounced effect on histidine
incorporation but had no effect on the amount of new histamine
formed. A similar but less extensive inhibition of histidine
uptake, without influencing histamine formation, was found with
actinomycin D, an inhibitor of RNA synthesis (Craig, 1973).
Mitomycin C which inhibits DNA synthesis (Iyer and Szybalski,
1963) had no significant effect on histidine uptake or
histamine formation.
The inhibition observed with actinomycin D was probably
a reflection of an effect on protein synthesis similar to
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that observed with cycloheximide. This inhibition should,
in theory, make more histidine available for histamine
formation. There was no increase in the amount of histamine
formed in the presence of these inhibitors and, in fact,
there was a decrease in the amount of histidine taken into
the cells. This suggests that, if blocking protein synthesis
did lead to an increase in the intracellular histidine con¬
centration and if under these conditions histidine decarboxy¬
lase was saturated, there is a negative feedback by histidine
influencing its own uptake.
The cell suspensions, as discussed previously, contained
only about 30% basophils. Therefore, the proportion of
histidine taken up by the other cell types may vary in the
presence of metabolic inhibitors. If these agents affected
the different cell types present to a greater or lesser degree,
and since histamine formation was not affected by these agents,
it was possible that the uptake of histidine by basophils was
not influenced by metabolic inhibitors and the decrease in
uptake observed could have been due to the almost complete
inhibition of uptake in the contaminating cells. However,
the pattern of inhibition of histidine uptake in neutrophil-
rich, macrophage-rich and normal bone marrow cells (Fig. 21)
was very similar to or less than that observed in the
basophil-rich cell suspensions. Therefore, the uptake of
histidine by the basophils must have been decreased to some
extent. This again suggests that under the conditions used
histidine decarboxylase was saturated and synthesizing the
maximum amount of histamine possible, and that this pathway
of histidine catabolism has the greatest affinity for
histidine.
230
Histamine synthesis was virtually completely inhibited
by the presence of NSD 1055, an inhibitor of histidine
decarboxylase (Mackay and Shepherd, 1960). As in the case
of cycloheximide the intracellular concentration of histidine
would be expected to increase. The amount of histidine
incorporated was significantly reduced in the presence of
NSD 1055 again suggesting a negative feedback by histidine
controlling its uptake.
There was a slight, although significant, decrease of
histamine uptake in the presence of high concentrations of
sodium fluoride and antimycin A. The other metabolic
inhibitors tested were without effect (Table XI). Since
only very small amounts of histamine were incorporated,
under the conditions used, there may have been enough
endogenous energy present or since none of the agents would
inhibit all energy producing processes, enough energy could
have been formed by the unaffected pathways to allow histamine
transport to proceed unaffected. Alternatively, the uptake
of histamine may not require energy directly and the effects
of sodium fluoride and antimycin A were due to indirect
effects on the membrane or electrochemical gradients.
The transport of solutes may be linked to the simultaneous
transport of sodium ions (Mitchell, 1970). This sytem has
been used to explain the uptake of sugars (Crane, 1965),
amino acids (Kipnis and Parrish, 1965) and noradrenaline
(Bogdanski and Brodie, 1969) by various tissues. The energy
required for the active transport of sodium ions is provided
by the hydrolysis of ATP through Na+-K+ dependent ATPase
(Skou, 1965). The active transport of sodium ions is
specifically inhibited by the cardiac glycoside, ouabain
(Allen and Schwartz, 1974). Ouabain inhibited the uptake of
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histidine and histamine and histamine formation (Fig. 19).
Incubation of basophil-enriched cell suspensions in Na+-free
medium (choline substituted) also significantly inhibited
the uptake processes but not histamine synthesis.
As discussed previously part of the histidine uptake
may proceed via the Na+-dependent A system. If there was
no extracellular Na+ ions or if Na+-K+-dependent ATPase was
inhibited a proportion of the uptake of histidine would be
inhibited. The effect of ouabain on histamine synthesis
was probably a reflection on decreased cellular activity
since the electrochemical gradients would have been affected.
Histamine uptake was severely depressed by incubating
the cells in Na+-free medium but the effect of ouabain was
much less pronounced. At pH 7.4 histamine will carry a net
positive charge (Kier, 1968) and to keep the electrochemical
gradient at the correct potential the movement of Na+ ions
to compensate for this charge would be necessary.
Therefore, the basophil has the capacity to incorporate
histidine by an active mediated process and its metabolic
requirements are distinct from those required for the
synthesis of histamine. In contrast, the uptake of histamine
is comparatively small and appears to occur by a passive
mediated process.
SECTION II - MODULATION OF HISTIDINE AND HISTAMINE
UPTAKE AND HISTAMINE SYNTHESIS BY HISTAMINE, OTHER
PHARMACOLOGICAL MEDIATORS AND ANTI-INFLAMMATORY
AND ANTI-ALLERGY DRUGS
2*7 "7J J
Histamine was shown to increase significantly the amount
of histidine taken up (Fig. 22) and the amount of histamine
formed de novo (Fig. 23) in a dose- and time-dependent fashion.
At the highest concentrations used ImAA and 1,4-MeImAA also
gave a significant enhancement of these two variables. The
two other catabolites of histamine tested, N-AcHm and 1,4-MeHm,
were without effect.
Recently ImAA has been shown to produce a similar effect
to histamine in studies on human and guinea pig eosinophil
chemotaxis (Turnbull and Kay, 1976; Jones and Kay, 1977)
and human eosinophil complement receptor enhancement (Anwar
and Kay, 1978). In all these cases N-AcHm, 1,4-MeHm and
1,4-MeImAA were without effect.
The enhancement of histamine formation followed the same
pattern as the increased histidine uptake and may have been
due to increased substrate availability for the enzyme
histidine decarboxylase. This, however, seems unlikely
since, as previously discussed, the enzyme appeared to be
saturated at the concentration of histidine present in the
control cells and an increase in substrate concentration
would have no effect on the amount of histamine formed.
In addition, histidine is incorporated by transport systems
which also take up other amino acids. A direct primary
effect on the transport mechanism for histidine uptake would
also influence the potential transport of other amino acids
•
which were not required in greater quantities.
With the concentration of histamine used a substantial
amount of histamine may have entered the cells. A direct
intracellular effect of histamine, the product of the reaction,
is, however, unlikely to stimulate its production. In fact
histamine may, in certain conditions, form a cyclic compound
with pyridoxal 5'-phosphate, the histidine decarboxylase
coenzyme, resulting in the inhibition of enzyme activity
(Rotilio and Mondovi, 1966). Therefore, an increased
intracellular histamine concentration would be expected to
inhibit histamine formation. Histidine decarboxylase
activity can also be controlled by variations in its pH
optimum. This mechanism of autoregulation depends on the
fact that the available substrate concentration and K»„M
change with pH (see Introduction). It is possible that a
high intracellular histamine concentration may influence
histidine decarboxylase activity by affecting the pH in the
vicinity of the enzyme.
However, it is unlikely that the observed enhancement
of histidine uptake and histamine formation was due to a
direct intracellular effect of histamine. The removal of
histamine from the external medium, which would probably
have no effect on the intracellular concentration of histamine,
resulted in the abrogation of the effect (Table XII).
There may be no requirement for histamine to enter the
cells since histamine receptors on the plasma membrane when
activated by histamine could liberate a secondary messenger
into the cytoplasm which in turn could stimulate the uptake
of histidine and/or histidine decarboxylase activity. At
present, there is no direct evidence that basophils possess
such receptors although they have been detected on most
other leucocytes (Saxon et al, 1977; Diaz et al, 1979).
However, there is indirect evidence for their existence
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since the effects of histamine on histamine release
(Lichtenstein and Gillespie, 1973) and chemotaxis to C5a
(Lett-Brown and Leonard, 1977) were reported to be blocked
by H2-receptor antagonists.
None of the histamine receptor antagonists studied
produced a significant effect on histidine uptake or histamine
formation per se (Figs. 29 and 30). Mepyramine and chlor¬
pheniramine, principally Hl-receptor antagonists, caused a
significant inhibition of the enhancement of histidine uptake
and histamine formation by histamine whereas H2-receptor
antagonists, burimamide and metiamide, were without effect.
It is, therefore, possible that histamine may act through an
Hl-receptor to produce increased histidine incorporation and
histamine formation.
An increase in cellular cyclic AMP has been suggested
as the mechanism for the self-induced inhibition of histamine
release (Bourne jet ad, 1971a). However, only chemotaxis of
human basophils to C5a and not to lymphokines or formylated
peptides was inhibited by histamine (Lett-Brown and Leonard,
1977). Therefore, a role for cAMP in this case is unlikely
since it would be required to depress chemotaxis to C5a but
have no effect on the response to the other chemotactic factors.
The interaction of histamine with a receptor would by
analogy with receptors for peptide hormones (Sutherland et al,
1965) produce a secondary messenger within the cell which
would by itself or by stimulating other systems produce the
observed effects. The enhancement of histamine formation
could occur by increasing the activity of histidine decarboxy¬
lase. This, in turn, would lead to an increase of histidine
incorporation since its intracellular concentration would have
fallen.
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Under certain conditions various stimuli induce histidine
decarboxylase activation (Schayer, 1962; Schayer et al, 1959;
Assem el; al, 1972). The inducible enzyme has a high affinity
for histidine and is strongly inhibited by alpha-methyl-
histidine but only slightly by alpha-methyl-DOPA, suggesting
that it is a specific histidine decarboxylase. Control of
the levels of enzyme activity depends on the rate of its
synthesis and degradation (Schmike et al, 1965). Certain
environmental conditions may stimulate the activation of pre¬
formed proenzymes and/or an induction of new enzyme formation.
However, no covalent activation step is known for histidine
decarboxylase. The increase in histidine decarboxylase
activity described in many tissues by a variety of stimuli
was blocked by inhibitors of protein synthesis (Schayer and
Reilly, 1968). Therefore, the synthesis of new protein seems
to be required for this activation of histidine decarboxylase.
The formation of a new enzyme would probably take longer
than the incubation period employed and significant enhance¬
ment of histidine uptake and histamine synthesis was observed
within 60 min of the addition of the histamine. Depending on
the turnover time of the enzyme stimulation of production and
inhibition of breakdown could lead to greater histidine
decarboxylase activity. The histamine forming capacity of
certain tissues has been shown to increase within 3 hr of
stimulation by antigen (Kahlson et aT, 1966).
The activity of histicline decarboxylase is also regulated
by variations in the optimum pH and the availability of active
coenzyme (see General Introduction). If these factors were
affected by the product(s) of the interaction of histamine
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with a membrane receptor then activation of histidine
decarboxylase could result.
As previously discussed, under the conditions used,
histamine was incorporated in relatively small amounts
compared to histidine. However, the amount taken up can
be decreased in a dose-dependent fashion by ImAA, 1,4-MeImAA
and 1,4-MeHm probably by simple competitive inhibition
(Fig. 23). N-AcHm and L-histidine did not influence histamine
uptake. Therefore, there is some degree of specificity in
histamine uptake by basophil-enriched cell suspensions.
2-(2-aminoethyl) thiazole, principally an Hl-receptor
agonist, inhibited histamine uptake in a dose-dependent
fashion while the two H2-receptor agonists, "Dimaprit" and
4-methyl-histamine, were without significant effect (Fig. 27).
It is, therefore, possible that 2-(2-aminoethyl) thiazole as
well as interacting with Hl-receptors was also taken up by the
same process as histamine into the cells.
It could be argued that a portion of the histamine,
associated with the cells, was bound to receptors in the
plasma membrane and that the inhibition by 2-(2-aminoethyl)
thiazole was a reflection of the amount bound to Hl-receptors.
However, the Hl-receptor antagonists and the H2-receptor
agonists and antagonists had no effect on histamine uptake.
Although the H2-receptor agonists did not inhibit
histamine uptake the possibility that they are taken into the
cells cannot be ruled out.' They may enter to a small extent
by passive diffusion or by some other mediated pathway distinct
from histamine uptake. The same applies to the histamine
receptor antagonists.
2-(2-aminoethyl) thiazole significantly inhibited
histidine uptake and histamine formation in a dose-dependent
fashion. The H2-receptor agonists were much less effective,
4-methylhistamine having no significant effect on histidine
uptake. Since it is possible that 2-(2-aminoethyl) thiazole
may enter the cells it is also possible that it inhibits
histidine decarboxylase. The inhibition could arise through
cyclic formation with pyridoxal 5 *-phosphate, a mechanism
which has been described for amines and amino acids (Mackay
and Shepherd, 1962). In this way pyridoxal 5*-phosphate
would become inactivated and histidine decarboxylase activity
inhibited. It is also possible that it inhibited histidine
decarboxylase directly since it is structurally similar to
histamine, the product of the reaction. The inhibition of
histidine decarboxylase would lead to a decrease in the amount
of histamine formed and a build up of histidine which could
inhibit its uptake by negative feedback.
The effect of the H2-receptor agonists can also be
explained by inactivation of pyridoxal phosphate but not by
cyclic compound formation. They could act by a mechanism
similar to cysteine (Buell and Hansen, 1960). The inter¬
action with the enzyme at the site where histamine is bound
is also possible. The fact that they are not as effective
as 2-(2-aminoethyl) thiazole suggests that they are not taken
up to the same extent or that they are not as effective at
blocking histidine decarboxylase activity.
Since the effect of the histamine agonists on histamine
formation was greater than that on histidine uptake, and
2-(2-aminoethyl) thiazole inhibited histamine uptake, it is
unlikely that the primary action of these agents was a direct
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effect on histidine uptake. By itself a decrease in
histidine uptake of about 20% should not cause an even
greater effect on histamine formation. As previously
shown using metabolic inhibitors, a decrease in uptake
of 60% had no effect on the amount of histamine formed.
Therefore, the slight effect of 2-(2-aminoethyl) thiazole
on histidine uptake must have been accompanied by a primary
effect on histidine decarboxylase activity which in turn
affects histidine uptake by negative feedback.
Histamine can, therefore, influence its own storage
within the basophil. It is possible that basophils possess
both types of histamine receptor which, when stimulated, may
produce various intracellular effects either concomitantly
or separately.
Basophils could be recruited to the site of IgE-
mediated histamine release or areas of inflammation and
injury by C5a. The high histamine concentration, via H2-
receptors, would deactivate the cells from further chemotaxis,
holding them at a position where they may be required. The
stimulation of the H2-receptor would at the same time inhibit
further histamine release until a time when the extracellular
concentration had decreased and more was required. Inter¬
action with Hl-receptors would be stimulating the waiting
basophils to form more histamine and hence be fully armed,
or stimulating degranulated basophils to produce new histamine
so that they could release again if required.
The pattern of effect of prostaglandins E1, E2 and F2q;
on histidine uptake and histamine formation were similar to
those of histamine. The effect on histamine formation was
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greater than that on histidine uptake suggesting that the
primary effect was an increase in histidine decarboxylase
activity which led to increased histamine formation with a
concomitant decrease in the intracellular histidine concentra¬
tion which stimulated histidine uptake.
There was no significant effect on histamine uptake by
prostaglandins E^ and F2q;. T^e histamine uptake in the
presence of the highest concentration of prostaglandin Eg
was statistically greater than the control but an increase
of only 10% was an insignificant effect compared to the
histamine content of the cells.
Prostaglandins of the E and F series have been reported
to act in opposition to each other. In the rat E prosta¬
glandins cause vasodilation and the F prostaglandins, vaso¬
constriction (Crunkhorn and Willis, 1971). Prostaglandins
E^ and E2 have been shown to stimulate adenyl cyclase in
human leucocytes (Bourne et aT, 1971b; Scott, 1970).
E prostaglandins cause inhibition of histamine release from
mast cells via a negative feedback mechanism which is
probably dependent upon activation of adenyl cyclase via
prostaglandin-specific adenyl cyclase receptors (Lichtenstein
-4
et al, 1972). In human lung, high concentrations (10
moles.I-1) of prostaglandins E^, E2 and F2q, inhibited antigen
stimulated histamine release by increasing cAMP levels.
—8 —1
However, at low concentrations (5 x 10 moles.1 ) there was
an enhancement of histamine release with a concomitant fall
in cAMP levels (Tauber et al^, 1973). Similarly, using human
leucocytes Bourne et al^ (1972) demonstrated that prostaglandins
E1 and Eg inhibited antigenic histamine release while F1q. was
ineffective.
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Therefore, the fact that prostaglandins E-^, E2 and F2q,
stimulated histidine uptake and histamine synthesis suggests
that the levels of cAMP may possibly modulate histamine
synthesis as well as release.
The human ECF-A tetrapeptides and a synthetic analogue
had no effect on histidine and histamine uptake and histamine
formation. It is probable that guinea pig ECF-A is chemically
distinct from its human counterpart since Jones and Kay (1977)
reported that the valyl- and the analogue peptides did not
attract guinea pig eosinophils iui vitro whereas the alanyl-
peptide had only slight activity.
5-hydroxytryptamine and bradykinin have not been identified
in guinea pig basophils. However, the latter has been shown
to increase cyclic nucleotide levels, both cyclic AMP and
cyclic GMP, in guinea pig lung (Stoner et al, 1973). The
effect on cyclic AMP was thought to be secondary to an effect
on prostaglandin synthesis; therefore, an in vivo effect may
be possible where prostaglandins could be formed. 5-
hydroxytryptamine has been shown to inhibit histamine release
from bovine granulocytes (Holroyde and Eyre, 1976). Neither
of these mediators, under the conditions used, influenced the
parameters measured.
Therefore, histamine and prostaglandins, which are known
to be released from guinea pig cells, were capable of
modulating histamine storage by increasing the uptake of
histidine and the synthesis of histamine de novo. The mode
of action of these mediators can only be inferred to occur
via changes in cyclic nucleotide levels from their known
stimulation of adenyl cyclase (Bourne ejt aJL, 1974). The
OA*)L. 'T u.
other mediators tested, which were without effect in this
system, may influence histamine formation in the species in
which they occur naturally or i^n vivo where other biological
relationships may be present.
None of the anti-inflammatory drugs nor the anti-allergy
agent tested significantly influenced histidine and histamine
uptake and histamine formation.
Steroid effects are usually thought to occur through
interactions with the genetic material of the cell (Buller
and O'Malley, 1976). They affect the appearance of mast
cells, especially the granules (Asboe-Hansen, 1952). Whether
they cause active degranulation to take place or the reduced
granularity is due to inhibited synthesis and regranulation,
has not been established. Steroids have also been shown to
inhibit prostaglandin release (Lewis and Piper, 1975) but
have no direct effect on histamine release, antibody production
or antibody-antigen interactions. Therefore, a lack of effect
on histidine uptake and histamine formation by resting baso¬
phils with a short incubation time is not unexpected.
Non-steroidal anti-inflammatory drugs inhibit antigen
and compound 48/80 induced histamine release (Norn, 1971) and
prostaglandin synthesis (Vane, 1971). It is thought that
non-steroidal anti-inflammatory drugs reduce the ATP content
of the cells by uncoupling oxidative phosphorylation, possibly
by binding to essential amino groups in the mitochondrial
respiratory chain (Whitehouse, 1968). Although the
inhibitors of aerobic respiration, 2,4-dinitrophenol and
antimycin A (Fig. 17), inhibited histidine uptake the non¬
steroidal anti-inflammatory drugs tested had no significant
effect. The lack of an effect suggests that the reported
influence on ATP levels is not the major factor in the action
of these drugs or the guinea pig basophil was not affected to
a significant extent. The energy required for histidine
uptake is not solely dependent on oxidative phosphorylation
and if these drugs did inhibit aerobic respiration to some
extent, the energy required for histidine uptake could be
supplied by anaerobic pathways or other endogenous sources.
Disodium cromoglycate ("Intal") has been shown by Assem
and Mongar (1970) to markedly inhibit antigen stimulated
histamine release from the passively sensitized lungs of man
and monkey. It also produced a slight inhibition of
histamine release from actively sensitized monkey and human
leucocytes. However, it had no effect on anaphylactic
histamine release from actively or passively sensitized
guinea pig lung. This anti-allergy drug has been reported
to have no effect on guinea pig PCA reactions (Cox et al,
1970), although it has been shown to inhibit the release of
SRS-A from antigen challenged guinea pig lungs. However, the
release of prostaglandins was unaffected (Dawson and Tomlinson,
1974).
Intal had no effect on the uptake of histidine or
histamine formation which could be due to its inactivity
towards guinea pig tissues in general and is probably a true
reflection of its lack of effect on the parameters measured.
SECTION III - THE EFFECT OF EOSINOPHILS ON HISTAMINE
REPLENISHMENT AFTER AN ANAPHYLACTIC REACTION
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Antigen- and polymer-induced histamine release is a
non-cytotoxic process. Thus, rat mast cells and human
basophils when exposed to sub-optimal doses of compound 48/80
and antigen, respectively, are capable of repeated histamine
release (Uvnas and Thon, 1959; Drobis and Siraganian, 1976).
The histamine stores in guinea pig skin are replenished
approximately 48 hr after a passive cutaneous anaphylactic
(PCA) reaction which depleted the histamine by 50% (Jones and
Kay, 1976). This repair process could involve regranulation
and/or recruitment of new cells into the reaction area.
In the two previous sections the development of a model
to study basophil functions, in terms of histamine metabolism,
has been described. Having established the basic technique,
and shown that the basophil has the capacity to regranulate,
histidine uptake and histamine synthesis were studied following
antibody-antigen interactions. Several In vitro biochemical
modulations of histamine metabolism have been described which
may have iji vivo implications on histamine formation. In
this section the theme of repair after degranulation has been
developed by studying the possible interaction of eosinophils,
which are present in reaction sites and have been implicated
in various aspects of type I hypersensitivity including repair,
with basophils.
After actively sensitized basophil-enriched cell
suspensions were challenged with antigen there was a
significant increase in histamine formation (Figs. 35 and 36).
Therefore, the release of histamine and other pharmacological
mediators stimulated the synthesis of histamine. This
increased synthesis could not be due to the presence of
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histamine in the extracellular medium since the cells were
14washed prior to the incubation with C-histidine. The
increased histamine formation may have been due to the
activation of histidine decarboxylase. This could be a
direct effect of removing the end product, activation of
pyridoxal phosphate, increasing substrate availability or
due to an allosteric effect.
Similar results in terms of increased histamine synthesis
have been reported for rat mast cells studied in vivo and in
vitro (Schayer et aJL, 1959; Slorach and Uvnas, 1968), human
leucocytes where the antigen was administered in vivo and in
vitro (Assem ejt al, 1972) and in various tissues of sensitized
rats and guinea pigs after injection of antigen (Kahlson et al,
1966). However, by measuring the total histamine content of
cultured human basophils Drobis and Siraganian (1976) were
unable to demonstrate any net synthesis of histamine. This
was probably due to the lack of sensitivity of their assay.
In the cases where increased histamine formation was reported
the possibility that a portion of the increase was due to the
presence of extracellular histamine cannot be ruled out.
Eosinophils have been postulated to dampen and control
type I hypersensitivity reactions by producing substances
which inhibit mediator release, by inactivating the released
mediators and by inhibiting mediator replenishment (see Aims).
Their role in mediator replenishment was further investigated
by studying their effect on histidine uptake and histamine
formation by basophils. As discussed above, there was an
increase in histidine incorporation and histamine formation
following antigen-mediated histamine release. When
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eosinophils were incubated with the basophils they did not
influence this effect.
An effect of eosinophils on histamine replenishment
was postulated after it was found that the removal of
eosinophils in vivo with anti-eosinophil serum reduced the
time required to restore histamine levels after PCA reaction
from 48 hr to 9 hr (Jones and Kay, 1976). However, the
experiments carried out in vitro showed that the eosinophil
had no effect on the challenged basophils repair processes.
Although not conclusively shown, since no iui vitro system can
simulate the complex interactions which occur within an
organism, the results suggest that other factors are involved.
These may include the interaction of eosinophils with other
cells, mediators or other reaction products. It is also
possible that basophils have distinct differences from mast
cells in terms of histamine replenishment.
Eosinophils are capable of removing histamine from the
site of an allergic or inflammatory reaction. They contain
histaminase and have been shown to have other antihistamine
properties (see Aims). It was demonstrated in Section II
of this chapter that histamine was capable of stimulating
histamine formation by the basophil. If the released
histamine was removed by the eosinophils the repair process
could be curtailed. The basophil was also shown (Section I)
to incorporate small amounts of preformed histamine.
However, if the concentration of histamine in the extra¬
cellular fluid was increased, as after an anaphylactic
reaction, a substantial amount of histamine could be
incorporated. Again the eosinophil could be responsible
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for the removal of this potential source of the amine.
However, Jones and Kay (1976) measured total skin
histamine which should include extracellular as well as
intracellular histamine. This value was decreased by 55%
1 hr after challenge and the presence or absence of
eosinophils had no effect. The amount they measured was
presumably mostly within mast cells; therefore, replenish¬
ment by the uptake of preformed histamine must have been
minimal.
The repair process must, therefore, involve histamine
synthesis from incorporated histidine which has been shown
to be stimulated after mediator release. Some factor
associated with the eosinophil is responsible for slowing
down this process. This factor may be present within the
eosinophil or the eosinophil may remove a messenger which
would otherwise stimulate repair.
Over 50% of the guinea pig eosinophil granule's protein
is composed of basic protein (Gleich et al_, 1974). Similar
arginine-rich cationic proteins have been isolated from the
granules of human leukaemic myeloid cells (Olsson jet al^, 1977).
The purified human protein and a crude preparation of guinea
pig eosinophil granules had no significant effect on the uptake
of histidine and histamine formation by basophil-enriched cell
suspensions.
Therefore, the interaction between eosinophils and
k • *
basophils or mast cells which slows down the repair process
appears to be complex and possibly only occurs in vivo or
involves only mast cells.
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Anaphylactic C-histidine and C-histamine release
14
The C-histamine which had been formed from the
14
incorporated C-histidine was stored in a form which could
be released by an antigen-induced antibody-mediated
reaction (Fig. 45). Similar histamine release was
demonstrated by Galli £t aJ (1976) using concanavalin A
and in studies of histidine uptake by rat mast cells (Cabut
and Haegermark, 1968) using compound 48/80 as the releasing
agent.
Incubation of sensitized basophils with antigen also
14
resulted in a dose-dependent release of C-histidine (Fig. 46).
The release of histidine could be measured in normal cells and
cells incubated in the presence of NSD 1055 which inhibited
the conversion to histamine completely. The physiological
significance of this release is not clear but it is possible
that the released histidine could be converted to histamine
outwith the basophils or mast cells and thus spread the
effect of an anaphylactic reaction. Cabut and Haegermark
(1968) showed that in the presence of NSD 1055 none of the
histidine taken up by rat mast cells was associated with the
granules. Therefore, the possibility that the release of
histidine was due to enhanced spontaneous release or increased
leakiness in the presence of antigen cannot be ruled out.
However, this seems unlikely since K+ ions and enzyme markers
are not released during a type I hypersensitivity reaction
ft
(Johnson and Moran, 1969). The histidine may be loosely
associated with the granules and, therefore, easily detached
during the differential centrifugation procedure. Until
the precise location and amounts of histidine present within
the basophils are known the physiological significance of
histidine release must remain uncertain.
SECTION IV - GENERAL CONCLUSIONS AND SUGGESTIONS
FOR FURTHER STUDY
Guinea pig bone marrow cell suspensions rich in basophils
have proved to be very useful for the study of histamine
14
storage and anabolism. The uptake of C-histidine was a
reliable monitor of basophil functions associated with
histamine storage. However, all the cell types studied
were capable of incorporating histidine to some extent and
the histidine taken up by basophils is available for protein
synthesis in addition to histamine formation. Therefore,
determination of the amount of histamine synthesized by the
action of histidine decarboxylase may be a more accurate
gauge of basophil activity since it is the only cell present
in normal bone marrow capable of decarboxylating histidine.
The general model required the purification of basophil
leucocytes from the bone marrow of antigen-stimulated guinea
pigs. The method of Dvorak et al^ (1974) provided large
numbers of basophils although the purity rarely exceeded 40%.
Whole sheep's blood was far superior to ovalbumin in
consistently stimulating basophil production.
Although histamine is not the only pharmacologically
active mediator present within the basophil, it has by far
the simplest structure and is the easiest to measure.
Therefore, as set out in Chapter II, it was the logical
choice for this study.
Basophils appear to incorporate histidine by active
mediated transport whereas, although histamine uptake appears
to be mediated, it is passive in nature. The uptake of
these two compounds and leucine was studied in a number of
cell types and in all cases the uptake was greatest in the
cell populations containing basophils. This, along with
the results of the kinetic study which was carried out,
suggests that the basophil has a greater capacity for
incorporating histidine, and possibly other amino acids,
than other cell types. Whether this is due to the kinetics
of the transport systems or the proportion of the histidine
which is incorporated by the different systems proposed for
amino acid uptake, is uncertain. Until completely pure
basophil suspensions can be obtained, conclusions concerning
the efficiency of the basophil in incorporating histidine
must remain speculative. Even then, since the histidine is
involved in a number of metabolic processes within the cell,
conclusive verdicts will probably not be possible until the
structure(s) responsible for histidine transport can be studied
in cell-free systems.
The majority of the studies carried out were over short
incubation periods; therefore, the cells were maintained in
a simple balanced salt solution. Tissue culture medium has
been used to maintain basophils for up to 72 hr (Galli et. al,
1976; Drobis and Siraganian, 1976). However, this adds the
complication that histidine uptake and histamine formation are
greatly reduced in such a system due to the presence of other
amino acids. Most culture systems also employ homologous
serum which also has an inhibitory effect (personal observa¬
tion). This type of problem might be alleviated if
histidine with a greater specific activity became available.
ft >
It would then be possible to measure histidine uptake and
histamine synthesis in cultured basophils which would then
be in a more physiological medium.
Basophils are end-cells, they are not capable of
division, but the present observations and the work of
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Galli et_ aJ^ (1976) has established that they retain the enzymes
required for the replenishment of their histamine stores and
are even capable of increasing their histamine forming capacity
after anaphylaxis. However, although they are a good model
for studying initial repair after a type I hypersensitivity
reaction, they are not the only one.
Mast cells are capable of incorporating histidine and
histamine and synthesizing histamine. Mast cell suspensions
have been obtained by enzymatic digestion of the surrounding
tissue (Pearce et al, 1977). Results of metabolic studies
with such cells would have to be interpreted with caution
since this harsh treatment may affect the integrity of the
cell membrane and produce alterations in their transport
systems. The peritoneal cavity of the rat contains free
mast cells which have been used in this present study and by
others (Cabut and Haegermark, 1968) to investigate histamine
formation.
The rat mast cell responds differently in various aspects
of type I hypersensitivity to man and guinea pigs. This,
along with the fact that although very pure populations of
mast cells can be obtained they are not present in very large
numbers, makes large scale experiments of the kind used in
this thesis impossible. However, they can be induced to
release their stored mediators by a variety of stimulants.
Degranulation can be initiated by antigen, by antibody in
reverse-type reactions, by various macromolecules including
compound 48/80 and dextran and by calcium ionophores. The
effect of histamine release induced by various stimuli on
histamine metabolism could, therefore, be studied using rat
peritoneal mast cells.
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Mast cells are present in almost every tissue of the
body. Those of the skin, respiratory and alimentary tracts
and eyes are most commonly involved in type I hypersensitivity
reactions. Differences in histidine uptake and histamine
synthesis by different tissues under various conditions could
be studied in tissue slices. The effect of histamine release
could possibly be studied over long periods since the cells would
probably remain viable longer. Guinea pig lung can be actively
and passively sensitized and this model may prove as useful as
the basophil.
The exact location of the incorporated histidine and
histamine and the newly synthesized histamine has not been
investigated although in the mast cell the incorporated
histidine was not associated with the granules (Cabut and
14
Haegermark, 1968). The C-histamine synthesized from the
14
incorporated C-histidine was released by antigen challenge
along with endogenous histamine. Therefore, it seems likely
that the newly formed histamine is stored in the granules.
14
The amounts of C-histamine taken up were insufficient to
measure release of radioactively labelled histamine. However,
if larger substrate concentrations were employed this may be
possible. A certain amount of labelled histidine was
released along with the histamine by antigen challenge.
Further investigations are required to ascertain whether this
is of physiological importance. The intracellular concentra¬
tion and location of histidine and the amounts released by
normal basophils during an anaphylactic reaction will have
to be determined.
By differential centrifugation the exact location of
the radioisotope could possibly be identified. Autoradio-
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graphy may provide another clue to the location and would
confirm that the major cell type involved in histidine and
histamine uptake in the cell suspension used was the
basophil.
Over 20 years ago Sutherland and Rail (1958) identified
adenosine-3*,5'-monophosphate (cAMP) as the intracellular
"second messenger" mediating adrenalin stimulation of hepartic
glycogenolysis. Since that time cAMP has been implicated in
the control of processes in fields as varied as endocrinology,
immunology, neurophysiology, microbiology, plant biochemistry
and cell growth and differentiation (Jost and Rickenberg, 1971;
Pastan et al, 1975).
Vasoactive hormones and mediators of inflammation have
been shown to modulate immune processes through cAMP and
possibly cGMP levels (see General Introduction).
Histamine and prostaglandins which have been shown to
increase cAMP caused an increase in histamine formation and
a concomitant increased histidine uptake. However, the
precise role of cAMP in the enhancement of histamine formation
is uncertain at present. An extensive study, using agents
such as [3- and a-adrenergic agonists and metabolic inhibitors
which affect the intracellular levels of cAMP as well as
measuring variations in cAMP concentrations, would be
necessary before firm conclusions could be drawn.
The effect of histamine was abrogated by Hl-receptor
antagonists suggesting that the basophil membrane possesses
receptors for this amine. Other effects of histamine on
the basophil have been assigned to stimulation of H2-receptors
(Lett-Brown and Leonard, 1977; Lichtenstein and Gillespie,
1973). Histamine receptors can be visualized by the rosette
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technique which has been used to identify their presence on
a number of different cell types (Diaz et al, 1979; Saxon
et al, 1977). It would, therefore, be of interest to
determine if the postulated histamine receptors can be
demonstrated unequivocally on the basophil plasma membrane.
This would give more weight to the theory that the enhance¬
ment of histamine formation occurring via changes in cAMP
levels.
The histamine and prostaglandins used to demonstrate the
enhancement of histidine uptake and histamine formation were
synthetic in origin. Authentic mediators can be obtained
from actively and passively sensitized guinea pig lungs by
challenge with the appropriate antigen (Kay ejt al, 1971).
These so-called anaphylactic diffusates could then be used
to determine if they influenced histamine metabolism by the
basophil. They would contain several other pharmacologically
active mediators including SRS-A, PAF and ECF-A which would
all be from the same species as the basophils on which they
were being tested. Such a system might mimic in vivo
conditions more closely.
The initial aim of the work described in this thesis was
to investigate the effects of eosinophils on histamine
replenishment following an anaphylactic reaction, using
the guinea pig basophil as a single cell model.
Following an anaphylactic reaction, basophils were still
ft
capable of forming new histamine and indeed there was a
stimulation of histamine synthesis. However, the eosinophil
was without effect. This may have been due to a variety of
reasons.
The basophil may not be a good model for investigating
repair after anaphylaxis since it is turned over fairly
rapidly and is an end cell.
Secondly, for technical reasons, the ratio of eosinophils
to basophils used was low, ranging from as little as 2:1 to
5:1. The eosinophil comprises about 1-4% of the blood
leucocytes in the guinea pig. However, cell suspensions
containing a greater proportion of eosinophils can be obtained
from the peritoneal cavity of animals stimulated by multiple
injections of horse serum (Kay, 1970b). Cell suspensions
containing up to 40% eosinophils can be obtained by these
methods and they are easily purified further by density
gradient centrifugation. However, the total number of cells
obtained from each guinea pig is very small compared to the
number of basophils required for the experiments. Recently
a method has been developed which has been reported to give
much larger numbers of cells (Pincus, 1978). This method
could be used in the future to produce sufficient cells for
the investigation of the role of the eosinophil or eosinophil-
derived products on histamine replenishment following
anaphylaxis.
Thirdly, the mediators which were released had to be
removed by washing the cells after the challenge with antigen.
The antigen used was a sheep's blood cell lysate produced by
exposing the pelletted cells to distilled water. The
viability of the basophil-enriched cell suspensions was
affected if the cells were left in contact with the antigen
for long periods after challenge. The antigen was removed
by washing the cells after 15 min and, therefore, the released
mediators were also removed. It would be possible to purify
25
the antigen(s) by removing the haemoglobin and other cellular
contents. This purified antigen could also be concentrated
and a constant known amount could be used to induce mediator
release. Using the purified antigen, at low concentrations,
it may be possible to adjust the level so that the cells
release a maximum amount of mediators without their viability
being affected by contaminants of the antigen preparation.
It would then be possible to study the effect of anaphylaxis
per se and the effect of eosinophils on the repair process
in the presence of the released pharmacologically active
mediators.
The eosinophil by itself may not be the only controlling
factor in the replenishment of mediators after a type I hyper¬
sensitivity reaction. It may accomplish its observed effect
of slowing down mast cell repair by interacting with other
cell types, by removing and modifying substances or be
stimulated itself by substances present in vivo which were
not present in the experimental incubation medium.
The various mediators and drugs were studied on resting
basophils. The effect of these agents might have been
different if the cells had been challenged with antigen and,
therefore, already stimulated to produce more histamine.
Either the basophil model using tissue culture medium or
possibly tissue slices could be used for this investigation
since longer incubation periods would be necessary.
As mentioned previously, guinea pig tissues can be
passively sensitized with antibody directed against a
specific antigen. It would, therefore, be possible to vary
the degree of sensitization and the class of antibody involved.
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Preliminary uptake studies using tissue culture conditions
were complicated by the fact that, along with certain amino
acids, serum inhibited the uptake of histidine and histamine
formation. The effect of serum and antibodies of different
classes and at different concentrations requires investigation.
The guinea pig basophil can, therefore, be used to study
histamine formation under various conditions by measuring
histidine and histamine uptake and histamine synthesis; but
that is by no means the only area where this model could be
used.
Basophils and/or mast cells have been reported to be
capable of phagocytosis (Sampson and Archer, 1967), pinocytosis
(Chan and Yoffey, 1960) and the production of superoxide
radical (Henderson and Kaliner, 1978). They could be a
source of many enzymes including histidine decarboxylase,
esterases and proteases for kinetic studies. Since they can
be obtained in large numbers the presence of other enzymes
and mediators and the structure of the known mediators could
be investigated. Basophils from the peripheral blood have
been used by Galli et al (1978) to produce an anti-basophil
serum which may be useful in elucidating basophil function
in vivo.
The release of mediators can be stimulated by a number
of factors apart from antigen. These include antibody directed
against IgE or equivalent, formylated peptides, cytotoxic
release following interaction of antibody against surface
antigen and complement activation, reagents such as con-
canavalin A and calcium ionophore and in patients suffering
from cold urticaria by exposure to low temperatures. The
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exact mechanism by which these factors induce release could
be investigated along with the reasons why certain agents,
such as compound 48/80 and disodium cromoglycate, react with
the cells from one species and not another.
Rat peritoneal mast cells have been shown to adhere to
complement coated parasites, suggesting that the mast cell
possesses complement receptors (Sher, 1976). The rosette
technique could be used to investigate the presence of
complement receptors on guinea pig basophils. Basophils are
also capable of migrating towards certain agents including
C5a, lymphokines and suspensions from bacterial cultures.
The role of chemotaxis in the function of the basophil is
not completely understood. They are known to accumulate
in skin sites in delayed-type hypersensitivity (see General
Introduction). The guinea pig basophil could be used to
study the factors which influence this migration. The effect
of the chemotactic factors on any complement receptors
identified could also be examined since it has been shown
that agents which induce chemotaxis are also capable of
increasing the number of detectable complement receptors in
various cells (Anwar and Kay, 1978; Kay et aT, 1979).
It has been suggested that mast cells or their products
play a part in the local tissue resistance against the develop¬
ment and growth of tumours (Cramer and Simpson, 1944;
Engelbreth-Holm and Asboe-Hansen, 1953). A role for the mast
cell in the host response to parasite infection has also been
suggested (Mulligan ejt aT, 1965; Ogilvie, 1974). In this
case the eosinophil is also implicated (Butterworth et a.1,
1977; Anwar et al, 1979).
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Further investigation of these diseases could involve
the use of single cell experimental systems. Therefore,
the guinea pig basophil model might prove useful in the
unravelling of a number of important medical problems.
BIBLIOGRAPHY
ACKERMAN, G.A. (1963). Cytochemical properties of the
blood basophilic granulocyte.
Ann. N.Y. Acad. Sci., 103, 376-393.
ACKERMAN, G.A. and N.C. BELLIOS (1955). A study of the
morphology of the living cells of blood and bone marrow in
vital films with the phase contrast microscope. I. Normal
blood and bone marrow.
Blood, 10, 3-16.
ACKERMAN, G.A. and M.A. CLARK (1971). Ultrastructural
localization of peroxidase activity in human basophil
leukocytes.
Acta Haematol., 45, 280-284.
ALBANUS, L. and G. WINQVIST (1961). Basophils, eosinophils
and histamine in the bone marrow of the guinea pig.
Acta Haematol., 26, 365-371.
ALLEN, J.C. and A. SCHWARTZ (1974). Na+-K+-ATPase, the
transport enzyme: evidence for its proposed role as
pharmacologic receptor for cardiac glycosides.
Ann. N.Y. Acad. Sci., 242, 646-657.
ALLISON, A.C., P. DAVIES and S. DE PETRIS (1971). Role
of contractile microfilaments in macrophage movement and
endocytosis.
Nature New Biol., 232, 153-155.
AMES, B.N. and H.K. MITCHELL (1952). The paper chromato¬
graphy of imidazoles.
J. Am. Chem. Soc., 74, 252-253.
ANWAR, A.R.E0 and A.B. KAY (1978). Enhancement of human
eosinophil complement receptors by pharmacologic mediators.
J. Immunol., 121, 1245-1250.
264
ANWAR, A.R,E., S.R. SMITHERS and A.B, KAY (1979). Killing
of schistosomula of Schistosoma mansoni coated with antibody
and/or complement by human leukocytes in vitro: requirement
for complement in preferential killing by eosinophils.
J. Immunol., 122, 628-637.
ARCHER, G.T. and M. JACKAS (1965). Disruption of mast cells
by a component of eosinophil granules.
Nature, 205, 599-600.
ARCHER, G.T. and V.J„ McGOVERN (1968). Mast cell changes
in rats with eosinophilia.
J. Path. Bact., 95, 217-224.
ARCHER, R.K. (1960). Eosinophil leucocyte-attracting effect
of histamine in skin.
Nature, 187, 155-156.
ARCHER, R.K., W. FELDBERG and B.A. KOVACS (1962). Anti¬
histamine activity in extracts of horse eosinophils.
Br. J. Pharmacol., 18, 101-108.
ASBOE-HANSEN, G. (1952). The mast cell. Cortisone action
on connective tissue.
Proc. Soc. Exp. Biol. Med., 80, 677-679.
ASBOE-HANSEN, G. (1973). The mast cell in health and
disease.
Acta Dermatovenerol. Suppl., 7J3, 139-147.
ASH, A.S.F. and Ho0o SCHILD (1966). Receptors mediating
some actions of histamine.
Br. J. Pharmacol., 27, 427-439.
ASKENASE, P0W„ (1973). Cutaneous basophil hypersensitivity
in contact sensitized guinea pigs. I. Transfer with immune
serum.
J. Exp. Med., 138, 1144-1155.
265
ASPEGREN, N,, S. FREGERT and H. RORSMAN (1963a). Basophil
leukocytes at sites of allergic eczematous contact
dermatitis.
Int. Arch. Allergy, 23, 150-156.
ASPEGREN, N., S. FREGERT and H. RORSMAN (1963b). Basophil
leukocytes in lesions of various dermatoses.
Acta Dermatovenerol., 43, 544-547.
ASSEM, E.S.K. and J.L. MONGAR (1970). Inhibition of
allergic reactions in man and other species by cromoglycate.
Int. Arch. Allergy Appl. Immunol., 38, 68-77.
ASSEM, E.S.K., H„0. SCHILD and M.R0 VICKERS (1972).
Stimulation of histamine-forming capacity by antigen in
sensitized human leucocytes.
Int. Arch. Allergy Appl. Immunol., 42, 343-352.
AUSTEN, K.F. (1974). Reaction mechanisms in the release
of mediators of immediate hypersensitivity from human lung
tissue.
Fed. Proc., 33, 2256-2262.
AUSTEN, K.F. and R.P. ORANGE (1975). Bronchial asthma:
the possible role of the chemical mediators of immediate
hypersensitivity in the pathogenesis of subacute chronic
disease.
Am. Rev. Resp. Dis., 112, 423-436.
AUSTEN, K.F., R.A. LEWIS, D0J0 STECHSCHULTE, S.I. WASSERMAN,
R.Wo LEID and E.J. GOETZL (1974). Generation and release
of chemical mediators of immediate hypersensitivity.
In Progress in Immunology II; vol. 2, pp 61-71. (L. Brent
and EoJ. Holborow, eds.; North-Holland Publishing Company,
Amsterdam).
266
AUSTEN, K.P., S.I. WASSERMAN and E.J. GOETZL (1976). Mast
cell-derived mediators: structural and functional diversity
and regulation of expression. In Molecular and Biological
Aspects of the Acute Allergic Reactions; pp 293-320.
(S.G.O. Johansson, K. Strandberg and B. Uvnas, eds. ;
Plenum Press, New York).
BACH, M.K. and J.R. BRASHLER (1975). Inhibition of IgE
and compound 48/80-induced histamine release by lectins.
Immunology, 29, 371-386.
BALOGH, K. and R.B. COHEN (1961). Histochemical demonstra¬
tion of diaphorases and dehydrogenases in normal human
leukocytes and platelets.
Blood, 17, 491-496.
BARCROFT, J. and A.V. HILL (1909). The nature of oxyhaemo-
globin, with a note on its molecular weight.
J. Physiol., 39, 411-428.
BEAVEN, M.A. (1976). Histamine.
New Eng. J. Med., 294, 30-36.
BECKER, E.L. and K.F. AUSTEN (1966). Mechanism of immuno¬
logic injury of rat peritoneal mast cells. I. The effect
of phosphonate inhibitors on the homocytotropic antibody-
mediated histamine release and the first component of rat
complement.
J. Exp. Med., 124, 379-395.
BENVENISTE, J. (1974). Platelet-activating factor, a new
mediator of anaphylaxis and immune complex deposition from
rabbit and human basophils.
Nature, 249, 581-582.
BLACK, J.W,, W.A.M. DUNCAN, C„J. DURANT, C„R„ GANELLIN and
EoM„ PARSONS (1972). Definition and antagonism of histamine
H2-receptors.
Nature, 236, 385-390.
BOETCHER, D.A. and E.J. LEONARD (1973). Basophil chemotaxis
augmentation by a factor from stimulated lymphocyte cultures.
Immunol. Commun., 2, 421-429.
BOGDANSKI, D.F. and B.B. BRODIE (1969). The effects of
3
inorganic ions on the storage and uptake of H -norepinephrine
by rat heart slices.
J. Pharmacol. Exp. Ther., 165, 181-189.
BOSEILA, A-W.A. (1959). The normal count of basophil
leucocytes in human blood.
Acta Med. Scand., 163, 525-529.
BOSEILA, A-W.A., E. MOLTKE and H. THORS0E (1959). Influence
of D-thyroxine and L-thyroxine on the basophil count in human
blood.
Acta Endocrinol., 32, 284-288.
BOURNE, H.R., K.L. MELMON and L.M. LICHTENSTEIN (1971a).
Histamine augments leukocyte adenosine 3*,5*-monophosphate
and blocks antigenic histamine release.
Science, 173, 743-745.
BOURNE, H.R., R.I. LEHER, M.J. CLINE and K.L. MELMON (1971b).
Cyclic 3®,5'-adenosine monophosphate in human leukocytes:
Synthesis, degradation and effects on neutrophil candidacidal
activity.
J. Clin. Invest., 50, 920-929.
BOURNE, H.R., L.M. LICHTENSTEIN and K.L„ MELMON (1972).
Pharmacologic control of allergic histamine release in vitro:
268
evidence for an inhibitory role of 3*,5'-adenosine mono¬
phosphate in human leukocytes.
J. Immunol., 108, 695-705.
BOURNE, H„R. , L.M. LICHTENSTEIN, K.L. MELMON, C.S. HENNEY,
V. WEINSTEIN and G.M. SHEARER (1974). Modulation of
inflammation and immunity by cyclic AMP.
Science, 184, 19-28.
BROCKLEHURST, W.E. (1960). The release of histamine and
formation of slow reacting substance (SRS-A) during
anaphylactic shock.
J. Physiol., 151, 416-435.
BROCKLEHURST, W.E. (1962). Slow reacting substance and
related compounds. In Progress in Allergy; vol. 6,
pp 539-558 (Karger, Basel).
BUELL, M.V. and R.E. HANSEN (1960). Reaction of pyridoxal
5'-phosphate with aminothiols.
J. Am. Chem. Soc., 82, 6042-6049.
BULLER, R.E. and B.W. O'MALLEY (1976). The biology and
mechanism of steroid hormone receptor interaction with
the eukaryotic nucleus.
Biochem. Pharmacol., 25, 1-12.
BUSSE, W.W. and J. SOSMAN (1976). Histamine inhibition
of neutrophil lysozomal enzyme release: an H2 histamine
receptor response.
Science, 194, 737-738.
BUTTERWORTH, A.E., J.R. DAVID, D. FRANKS, AaAJ. MAHMOUD,
P.H. DAVID, R.F. STURROCK and V. HOUBA (1977). Antibody-
51
dependent cell-mediated damage to Cr-labelled schistosomula
of Schistosoma mansoni: Damage by purified eosinophils.
J. Exp. Med., 145, 136-150.
269
CABUT, M. and O. HAEGERMARK (1966). Uptake, storage and
release of histamine by rat peritoneal mast cells in vitro.
Acta Physiol. Scand., 68, 206-214.
CABUT, M. and O. HAEGERMARK (1968). Studies on uptake and
decarboxylation of histidine by isolated rat mast cells.
Acta Physiol. Scand., 73, 62-74.
CASWELL, A.H. and B.C. PRESSMAN (1972). Kinetics of transport
of divalent cations across sarcoplasmic reticulum vesicles
induced by ionophores.
Biochem. Biophys. Res. Commun., 49, 292-298.
CHAN, B.S.T. (1972). U1trastructural changes in guinea pig
bone marrow basophils during anaphylaxis.
Immunology, 23, 215-224.
CHAN, B.S.T. and J.M. YOFFEY (1960). The basophil cells of
guinea pig bone marrow and their response to horse serum.
Immunology, 3, 237-243.
CHRISTENSEN, H.N. (1966). Methods for distinguishing amino
acid transport systems of a given cell or tissue.
Fed. Proc., 25, 850-853.
CHRISTENSEN, H.N. (1968). Histidine transport into isolated
animal cells.
Biochem. Biophys. Acta, 165, 251-261.
CHRISTENSEN, H.N. (1969). Some special kinetic problems
of transport.
Adv. Enzymol., £8, 1-20.
ft
CHRISTENSEN, H.N. (1973). On the development of amino acid
transport systems.
Fed. Proc., 32, 19-28.
CHRISTENSEN, H.N. (1975). Recognition sites for material
transport and information transfer.
Curr. Top. Membr. Transp., 6, 227-258.
CHRISTENSEN, H.N. (1977). Implications of the cellular
transport step for amino acid metabolism.
Nutrition Revs., 35, 129-133.
CHRISTENSEN, H.N. and M. LIANG (1966a). On the nature of
the "non-saturable" migration of amino acids into Ehrlich
cells and into rat jejunum.
Biochem. Biophys. Acta, 112, 524-531.
CHRISTENSEN, H.N. and M. LIANG (1966b). Transport of
diamino acids into the Ehrlich cell.
J. Biol. Chem., 241, 5542-5551.
CHRISTENSEN, H.N., T.R. RIGGS, H. FISCHER and I.M. PALATINE
(1952). Amino acid concentration by a free cell neoplasm:
Relations among amino acids.
J. Biol. Chem., 198, 1-15.
CHRISTENSEN, H.N., M. LIANG and E.G. ARCHER (1967). A
distinct Na+-requiring transport system for alanine, serine,
cysteine, and similar amino acids.
J. Biol. Chem., 242, 5237-5246.
CLARK, R.A.F., J.I. GALLIN and A.P. KAPLAN (1975). The
selective eosinophil chemotactic activity of histamine.
J. Exp. Med., 142, 1462-1476.
CLARK, R.A.F., J.I. GALLIN and A.P. KAPLAN (1976).
Mediator release from basophil granulocytes in chronic
myelogenous leukemia.
J. Allergy Clin. Immunol., 58, 623-634.
CLARK, R.A.F., J,A. SANDLER, J.I. GALLIN and A.P. KAPLAN
(1977). Histamine modulation of eosinophil migration.
J. Immunol., 118, 137-145.
COCHRANE, C.G. and H.J. MULLER-EBERHARD (1968). The
derivation of two distinct anaphylatoxin activities from
the third and fifth components of human complement.
J. Exp. Med., 127, 371-386.
CODE, C.F. (1952). Histamine in blood.
Physiol. Rev., 32, 47-65.
COHN, R.H., S.D. BANERJEE, E„R„ SHELTON and M.R. BERNFIELD
(1972). Cytochalasin B. Lack of effect on mucopoly¬
saccharide synthesis and selective alterations in precursor
uptake.
Proc. Nat. Acad. Sci. USA, 69, 2865-2869.
COLVIN, R.B. and H.F. DVORAK (1974). Basophils and mast
cells in renal allograft rejection.
Lancet, _i, 212-214.
COLVIN, R.B., V.W. PINN, B.A. SIMPSON and H.F. DVORAK
(1973). Cutaneous basophil hypersensitivity. IV. The
"late reaction": sequel to Jones-Mote type hypersensitivity.
Comparison with rabbit Arthus reaction. Effect of passive
antibody on induction and expression of Jones-Mote hyper¬
sensitivity.
J. Immunol., 110, 1279-1289.
COLVIN, R.Bo, JaR, BURTON, N.E. HYSLOP, L. SPITZ and N.S.
»
LICHTENSTEIN (1974). Penicillin associated interstitial
nephritis.
Ann. Int. Med. , 8jL, 404-405.
272
CONWAY, A, and D.E. KOSHLAND (1968). Negative cooperativity
in enzyme action. The binding of diphosphopyridine nucleo¬
tide to glyceraldehyde 3-phosphate dehydrogenase.
Biochemistry, 7, 4011-4023.
COOPER, J„R. and C.N.D. CRUICKSHANK (1966). Improved method
for direct counting of basophil leucocytes.
J. Clin. Path. , 3J), 402.
COX, J.S.G. (1967). Disodium cromoglycate (FPL 670)
("Intal"): a specific inhibitor of reagenic antibody-
antigen mechanisms.
Nature, 216, 1328-1329.
COX, J.S.Go, JoE» BEACH, A.M.J.N. BLAIR, A.J. CLARKE,
J. KING, T.B. LEE, D.E.E. LOVEDAY, G.F. MOSS, T.S.C. ORR,
J.T. RITCHIE and P. SHEARD (1970). Disodium cromoglycate
(Intal).
Adv. Drug Res., 5, 115-196.
CRAIG, N. (1973). The effects of inhibitors of RNA and
DNA synthesis on protein synthesis and polysome levels in
mouse L-cells.
J. Cell. Physiol. , 82, 133-150.
CRAMER, W. and W.L. SIMPSON (1944). Mast cells in
experimental skin carcinogenesis.
Cancer Res., 4, 601-616.
CRANE, R.K. (1965). Na+-dependent transport in the
intestine and other animal tissue.
Fed. Proc., 24, 1000-1006.
CRUNKHORN, P. and A.L. WILLIS (1971). Interaction between
prostaglandins E and F given intradermally in the rat.
Br. J. Pharmacol., 41., 507-512.
DALE, H.H. (1913). The anaphylactic reaction to plain
muscle in the guinea pig.
J. Pharmacol. Exp. Ther., 4, 167-223.
DANIELLI, J.F. (1954). Morphological and molecular aspects
of active transport.
Symp. Soc. Exp. Biol., 8, 502-516.
DAWSON, W. and R. TOMLINSON (1974). Effects of cromoglycate
and eicosatraynoic acid on the release of prostaglandins and
SRS-A from immunologically challenged guinea pig lungs.
Br. J. Pharmacol., J52, 107P-108P.
DAWSON, W., J.R. BOOT, A.F, COCKERILL, D.N.B. MALLEN and
D.J. OSBORNE (1976). Release of noval prostaglandins and
thromboxanes after immunological challenge of guinea pig
lung.
Nature, 262, 696-702.
DAY, M. and J.P. GREEN (1962a). The uptake of amino acids
and the synthesis of amines by neoplastic mast cells in
culture.
J. Physiol., 164, 210-226.
DAY, M. and J.P. GREEN (1962b). The uptake of biogenic
amines by neoplastic mast cells in culture.
J. Physiol., 164, 227-237.
DAY, Mo and A. STOCKBRIDGE (1964). The effects of drugs
on the uptake of amines by mast cells.
Br. J. Pharmacol., 23, 405-419.
DAY, RoP., Jo DOLOVICH and J. BIENENSTOCK (1974).
Characteristics of tritiated histamine uptake and release
by human basophils.
Fed. Proc., 33, 752.
274
DIAMANT, B. and P„G. KRUGER (1967). Histamine release from
isolated rat peritoneal mast cells induced by adenosine-5'-
triphosphate.
Acta Physiol. Scand., 71^ 291-302.
DIAZ, P., D.G. JONES and A.B. KAY (1979). Histamine
receptors on guinea pig alveolar macrophages: chemical
specificity and the effect of HI- and H2-receptor agonists
and antagonists.
Clin. Exp. Immunol., 3j5, 462-469.
DRAZEN, J.M. and K.F. AUSTEN (1975). Atropine modification
of the pulmonary effects of chemical mediators in the guinea
Pig.
J. Appl. Physiol., 38, 834-838.
DROBIS, J.D. and R.P. SIRAGANIAN (1976). Histamine release
from culture human basophils: Lack of histamine resynthesis
after antigenic release.
J. Immunol., 117, 1049-1053.
DURANT, G.J., C.R. GANELLIN and M.E. PARSONS (1975).
Chemical differentiation of histamine HI- and H2-receptor
agonists.
J. Med. Chem. , JL8, 905-909.
DVORAK, H.F. (1971). Role of the basophilic leukocyte in
allograft rejection.
J. Immunol., 106, 279-281.
DVORAK, H.F. and M.C. MIHM (1972). Basophilic leukocytes
»
in allergic contact dermatitis.
J. Exp. Med., 135, 235-254.
DVORAK, H.F. and AJo DVORAK (1974). Cutaneous basophil
hypersensitivity. In Progress in Allergy II; vol. 3,
pp 171-181 (L. Brent and E.J. Holborow, eds.; North
Holland, Amsterdam).
DVORAK, H.F. and A.M. DVORAK (1975). Basophilic leukocyte:
structure, function and role in disease.
Clin. Haematol., 4, 651-683.
DVORAK, H.F. and M.E. HAMMOND (1978). Cutaneous basophil
hypersensitivity. In Immediate Hypersensitivity. Modern
Concepts and Developments; chapt. 25, pp 659-692 (M.K.
Bach, ed.; Marcel Dekker, New York).
DVORAK, H.F., B.A. SIMPSON, R.C. BAST and S. LESKOWITZ (1971)
Cutaneous basophil hypersensitivity. III. Participation of
the basophil in hypersensitivity to antigen-antibody
complexes, delayed hypersensitivity and contact allergy.
Passive transfer.
J. Immunol., 107, 138-148.
DVORAK, A.M., H.F. DVORAK and M.J. KARNOVSKY (1972). Uptake
of horseradish peroxidase by guinea pig basophilic leukocytes
Lab. Invest., 26, 27-39.
DVORAK, A.M., H.F. DVORAK and W.H. CHURCHILL (1973).
Immunologic rejection of diethylnitrosamine-induced hepatomas
in Strain 2 guinea pigs. Participation of basophilic
leukocyte and macrophage aggregates.
J. Exp. Med., 137, 751-775.
DVORAK, H.F., S.S. SELVAGGIO, A.M. DVORAK, R.B. COLVIN,
D.B. LEAN and J. RYPYSC (1974). Purification of basophilic
leukocytes from guinea pig blood and bone marrow.
J. Immunol., 113, 1694-1702.
ft
DVORAK, H.F., N.S. ORENSTEIN, A.M. DVORAK, M.E. HAMMOND,
R.O. ROBLIN, J. FEDER, C.F. SCHOTT, J. GOODWIN and
E. MORGAN (1977). Isolation of the cytoplasmic granules
of guinea pig basophilic leukocytes. Identification of
esterase and protease activities.
J. Immunol., 119, 38-46.
276
DVORAK, H.F., N.S. ORENSTEIN, J. RYPYSC, R„B0 COLVIN and
AoM. DVORAK (1978). Plasminogen activator of guinea pig
basophilic leukocytes: probable localization to the plasma
membrane.
J. Immunol., 120, 766-773.
EAGLE, H. (1959). Amino acid metabolism in mammalian cell
cultures.
Science, 130, 432-437.
EHRICH, W.E. (1953). Histamine in mast cells.
Science, 118, 603.
EHRLICH, P. (1891). Fabenanalytische Untersuchunger zur
Histologie und Klinik des Blutes. Hirschwald, Berlin.
ENDERS, R.H., R.M. JUDD, T.M. DONOHUE and C.H. SMITH (1976).
Placental amino acid uptake. III. Transport systems for
neutral amino acids.
Am. J. Physiol., 230, 706-710.
ENGELBRETH-HOLM, J. and G. ASBOE-HANSEN (1953). Effect of
cortisone on skin carcinogenesis in mice.
Acta Path. Micribiol. Scand. , 32, 560-564.
ENGLISH, D. and B.R. ANDERSON (1974). Single-step separation
of red blood cells, granulocytes and mononuclear leukocytes on
discontinuous density gradients of Ficoll-Hypaque.
J. Immunol. Methods, 5, 249-252.
ESTEVES, M.B., O.A. SANTA'ANNA, V.C. dos SANTOS ANNES and
R.A. BINAGHI (1974). Characterization and properties of
an anaphylactic 7S antibody in sheep.
J. Immunol., 112, 722-727.
FELARCA, A.B. and F.C, LOWELL (1971). The accumulation of
eosinophils and basophils at skin sites as related to intensity
of skin reactivity and symptoms in atopic disease.
J. Allergy Clin. Immunol., 48, 125-133.
FOREMAN, J.C., J.L. MONGAR and B.D. GOMPRETS (1973).
Calcium ionophores and movement of calcium ions following
the physiological stimulus to a secretory process.
Nature, 245, 249-251.
FOWLER, J.W. and F.C. LOWELL (1966). The accumulation of
eosinophils as an allergic response to allergen applied to
the denuded skin surface.
J. Allergy, 37, 19-28.
FREDRICKS, R.E. and W.C. MOLONEY (1959). The basophilic
granulocyte.
Blood, 14, 571-583.
FREGERT, S. and H. RORSMAN (1964). Basophil leukocytes in
photocontact dermatitis.
J. Invest. Derm., 42, 405-406.
FURANO, A.V. and J.P. GREEN (1964). The uptake of biogenic
amines by mast cells of the rat.
J. Physiol., 170, 263-271.
GALLI, S.J., A.S. GALLI, A.M. DVORAK and H.F. DVORAK (1976).
Metabolic studies of guinea pig basophilic leukocytes in
short-term tissue culture. I. Measurement of histamine-
synthesizing capacity by using an isotope-thin layer
chromatographic assay.
J. Immunol., 177, 1085-1092.
GALLI, S.J., R.Bo COLVIN, E„ VERDERBER, A.S. GALLI,
R. MONAHAN, A.M. DVORAK and H.F0 DVORAK (1978). Preparation
of a rabbit anti-guinea pig basophil serum: in vitro and
in vivo characterization.
J. Immunol., 121, 1157-1166.
278
GARLAND, L.G. and J.L. MONGAR (1976). Differential histamine
release by dextran and the ionophore A23187: the action of
inhibitors.
Int. Arch. Allergy, 50, 27-42.
GEORGE, W.J., J.D. POLSON, A.G» O'TOOLE and N.D. GOLDBERG
(1970). Elevation of guanosine 3*,5'-cyclic phosphate in
rat heart after perfusion with acetylcholine.
Proc. Natl. Acad. Sci. USA, 66, 398-403.
GIESSEN, M. van der, HOMAN, W0L. , G. van KERNEBEEK, R.C.
AABERSE and P.H. DIEGES (1976). Subclas typing of IgG
antibodies formed by grass pollen-allergic patients during
immunotherapy.
Int. Arch. Allergy Appl. Immunol., 50, 625-640.
GLEICH, G.J. and D. LOEGERING (1973). Selective stimulation
and purification of eosinophils and neutrophils from guinea
pig peritoneal fluids.
J. Lab. Clin. Med., 82, 522-528.
GLEICH, G.J., D.N. LOEGERING and J.E. MALDONADO (1973).
Identification of a major basic protein in guinea pig
eosinophil granules.
J. Exp. Med., 137, 1459-1471.
GLEICH, G.J., D.A. LOEGERING, F. KUEPPERS, S0P. BAJAJ and
KoGo MANN (1974). Physiochemical and biological properties
of the major basic protein from guinea pig eosinophil
granules.
J. Exp. Med., 140, 313-332.
GOETZL, EoJ. and KoF. AUSTEN (1975). Purification and
synthesis of eosinophilotactic tetrapeptides of human lung
tissue: Identification as eosinophil chemotactic factor
of anaphylaxis.
Proc. Natl. Acad. Sci. USA, 72, 4123-4127.
GOETZL, E.J. and AUSTEN, K.F. (1976). Structural deter¬
minants of the eosinophil chemotactic activity of the acidic
tetrapeptides of eosinophil chemotactic factor of anaphylaxis.
J. Exp. Med., 144, 1424-1437.
GOLDBERG, N.D., R.F. O'DEA and M.K. HADDOX (1973). Cyclic
GMP.
Adv. Cyclic Nucl. Res., 3, 155-223.
GRAHAM, H.T., O.H. LOWRY, Fa WHEELWRIGHT, M.A. LENZ and
HoH. PARISH (1955). Distribution of histamine among
leukocytes and platelets.
Blood, 10, 467-481.
GRANT, J.A. and L.M. LICHTENSTEIN (1974). Release of slow
reacting substance of anaphylaxis from human leukocytes.
J. Immunol., 112, 897-904.
GREAVES, M.W. and B.D. BURDIS (1968). Anaphylactic histamine
release from guinea pig basophil leucocytes.
Int. Arch. Allergy Appl. Immunol., 34, 313-323.
GREAVES, M.W. and J.L. MONGAR (1968a). The histamine
content of rabbit leucocytes and its release during In vitro
anaphylaxis.
Immunology, JL5, 733-742.
GREAVES, M.W. and J.L. MONGAR (1968b). The mechanism of
anaphylaxis histamine release from rabbit leucocytes.
Immunology, 1J3, 743-749.
HABERMANN, E. (1972). Bee and wasp venoms.
Science, 177, 314-322.
HAGEN, P., N. WEINER, S. ONO and F. LEE (1960). Amino acid
decarboxylase of mouse mastocytoma tissue.
J. Pharmacol. Exp. Ther., 130, 9-12.
280
H^KANSON, R, (1963a). Histidine decarboxylase in the bone
marrow of the rat.
Experientia, 20, 205-206.
H^KANSON, R. (1963b). Histidine decarboxylase in the foetal
rat.
Biochem. Pharmac. , 12, 1289-1296.
ElSkANSON, R. (1967a). Kinetic properties of mammalian
histidine decarboxylase.
Eur. J. Pharmac., 1_, 42-46.
HAKANSON, R. (1967b). Pyridoxal 5'-phosphate enzymes:
influence of substrate concentration on the pH optimum of
enzyme reactions involving transaldimination.
J. Physiol. Chem., 348, 1730-1733.
HARTMAN, W.J., W.G. CLARK and S.D. CYR (1961). Histidine
decarboxylase activity of basophils from chronic myelogenous
leukemic patients. Origins of blood histamine.
Proc. Soc. Exp. Biol. Med., 107, 123-125.
HASTIE, R. (1971). The antigen-induced degranulation of
basophil leucocytes from atopic subjects, studied by phase
contrast microscopy.
Clin. Exp. Immunol., 8, 45-61.
HASTIE, R. (1974). A study of the ultrastructure of human
basophil leukocytes.
Lab. Invest., 33., 223-231.
HEINZ, E0 (1954). Kinetic studies on the "influx" of
1 /l *
glycine-l-C into the Ehrlich mouse ascites carcinoma cell.
J. Biol. Chem., 23J., 781-790.
HEISLER, S„ and B. UVNAS (1972). In vitro studies on the
uptake of biogenic amines by rat mast cells.
Acta Physiol. Scand. , 863, 145-154.
HENDERSON, W.R. and M. KALINER (1978). Immunologic and
nonimmunologic generation of superoxide from mast cells and
basophils.
J. Clin. Invest., 61, 187-196.
HEYL, Do, E. LUZ, S.A. HARRIS and K. FOLKERS (1952).
Chemistry of vitamin Bg. Additional pyridoxylideneamines
and pyridoxylamines.
J. Am. Chem. Soc., 74, 414-416.
HOLROYDE, M.C. and P. EYRE (1976). Inhibition by 5-
hydroxytryptamine of anaphylactic histamine release from
bovine granulocytes.
Eur. J. Pharmacol., 37_, 397-399.
HUBSCHER, T. (1975a). Role of the eosinophil in the allergic
reactions. I. EDI - an eosinophil-derived inhibitor of
histamine release.
J. Immunol., 114, 1379-1388.
HUBSCHER, T. (1975b). Role of the eosinophil in the allergic
reactions. II. Release of prostaglandins from human eosino¬
philic leukocytes.
J. Immunol., 144, 1389-1393.
HUMPHREY, J.H. and R. JAQUES (1954). The histamine and
serotonin content of the platelets and polymorphonuclear
leukocytes of various species.
J. Physiol., 124, 305-310.
ISHIZAKA, K. and T0 ISHIZAKA (1971). IgE and reaginic
hypersensitivity.
Ann. NoY. Acad. Sci., 190, 443-456.
282
ISHIZAKA, T. and K. ISHIZAKA (1974). Mechanism of passive
sensitization. IV. Dissociation of IgE molecules from
basophil receptors at acid pH.
J. Immunol., 112, 1078-1084.
ISHIZAKA, T. and K. ISHIZAKA (1975). Biology of immuno¬
globulin E.
Prog. Allergy, 19, 60-121.
ISHIZAKA, K., H. TOMIOKA and T0 ISHIZAKA (1970a). Mechanism
of passive sensitization. I. Presence of IgE and IgG
molecules on human leukocytes.
J. Immunol., 105, 1459-1467.
ISHIZAKA, T., K. ISHIZAKA and E.H. LEE (1970b). Biologic
function of the Fc portion of &E molecules.
J. Allergy, 45, 124.
ISHIZAKA, T., H. TOMIOKA and K. ISHIZAKA (1971). Degranula-
tion of human basophil leukocytes by anti-gE antibody.
J. Immunol., 106, 705-710.
ISHIZAKA, T., R. DeBERNARDO, H. TOMIOKA, L0M. LICHTENSTEIN
and K. ISHIZAKA (1972). Identification of basophil
granulocytes as a site of allergic histamine release.
J. Immunol., 108, 1000-1008.
ISHIZAKA, T., C.S. SOTO and K. ISHIZAKA (1973). Mechanism
of passive sensitization. III. Numbers of IgE molecules
and their receptor sites on human basophil granulocytes.
J. Immunol., Ill, 500-511.
IYER, VoN. and W. SZYBALSKI (1963). A molecular mechanism
of mitomycin action: linking of complementary DNA strands.
Proc. Natl. Acad. Sci. USA, 5C>, 355-362.
JAQUES, L.B. and E.T, WATERS (1941). The identity and
origin of the anticoagulant of anaphylactic shock in the
dog.
J. Physiol., 99, 454-466.
JOHANSSON, S.G.O. and H. BENNICH (1967). Immunological
studies of an atypical (myeloma) immunoglobulin.
Immunology, JT3, 381-394.
JOHNSON, A.R. and N.C. MORAN (1969). Selective release of
histamine from rat mast cells by compound 48/80 and antigen.
Am. J. Physiol., 216, 453-459.
JOHNSON, A.R., T.E. HUGLI and H.J. MULLER-EBERHARD (1975).
Release of histamine from rat mast cells by the complement
peptides C3a and C5a.
Immunology, 28, 1067-1080.
JONES, D.G. and A.B. KAY (1974). Passive sensitization of
guinea pig skin in vitro for the antigen-induced release of
anaphylactic mediators.
Clin. Exp. Immunol., 16, 213-222.
JONES, D.G. and A.B. KAY (1976). The effect of anti-
eosinophil serum on skin histamine replenishment following
passive cutaneous anaphylaxis in the guinea pig.
Immunology, 31, 333-336.
JONES, D.G. and A.B. KAY (1977). Chemotactic activity of
guinea pig eosinophils for the ECF-A acidic tetrapeptides,
histamine, histamine metabolites and the effect of HI- and
H2-receptor antagonists.
Int. Arch. Allergy Appl. Immunol., 55, 277-282.
JONES, D0G., D.Lo RICHARDSON and A.B. KAY (1977). Neutrophil
accumulation in vivo following the administration of chemo¬
tactic factors.
Br. J. Haematol., 35, 19-24.
JOST, J-P. and H.V. RICKENBERG (1971). Cyclic AMP,
Ann. Rev. Biochem., 41, 741-774.
JUHLIN, L. (1963a). Basophil leukocyte differential in
blood and bone marrow.
Acta Haematol., 29, 89-95.
JUHLIN, L. (1963b). Basophil and eosinophil leukocytes in
various internal disorders.
Acta Med. Scand., 174, 249-255.
JUHLIN, L. (1963c). Basophil leukocytes in blood and
inflammatory exudate.
Acta Dermatovenereol., 43, 528-543.
KAHLSON, G., E. ROSENGREN and R. THUNBERG (1966). Accelera¬
ted histamine formation in hypersensitivity reactions.
Lancet, i, 782-784.
KALINER, M. and K.F. AUSTEN (1973). A sequence of bio¬
chemical events in the antigen-induced release of chemical
mediators from sensitized human lung tissue.
J. Exp. Med., 138, 1077-1094.
KALINER, M. and K.F. AUSTEN (1974). Hormone control of the
immunologic release of histamine and SRS-A from human lung.
In Cyclic AMP, Cell Growth and the Immune Response; pp 163-
175 (W. Braun, ¥. Lichtenstein and C.W. Parker, eds.;
Springer-Verlag KG, Berlin).
KALINER, M. and K.F. AUSTEN (1974). Cyclic AMP, ATP and
reversed anaphylactic histamine release from rat mast cells.
J. Immunol., 112, 664-674.
KALINER, M., R.P. ORANGE and K.F. AUSTEN (1972). Immunologic
release of histamine and slow reacting substance of anaphylaxis
from human lung. IV. Enhancement by cholinergic and alpha
adrenergic stimulation.
J. Exp. Med., 136, 556-567.
KATER, L.A., E.J. GOETZL and K.F. AUSTEN (1976). Isolation
of human eosinophil phospholipase D.
J. Clin. Invest., 57, 1173-1180.
KAY, A.B. (1970a). Studies on eosinophil leucocyte
migration. I. Eosinophil and neutrophil accumulation
following antigen-antibody reactions in guinea pig skin.
Clin. Exp. Immunol., 6, 75-86.
KAY, AoB. (1970b). Studies on eosinophil leucocyte
migration. II. Factors specifically chemotactic for
eosinophils and neutrophils generated from guinea pig
serum by antigen-antibody complexes.
Clin. Exp. Immunol., 7, 723-737.
KAY, A.B. and K.F. AUSTEN (1971). The IgE-mediated release
of an eosinophil leukocyte chemotactic factor from human
lung.
J. Immunol., 107, 899-902.
KAY, A.B. and K.F. AUSTEN (1972). Chemotaxis of human
basophil leukocytes.
Clin. Exp. Immunol., JL1, 557-563.
KAY, A.B., D.J. STECHSCHULTE and K.F. AUSTEN (1971). An
eosinophil leukocyte chemotactic factor of anaphylaxis.
J. Exp. Med., 133, 602-619.
KAY, A.Bo, E.J. GLASS and DJ. SALTER (1979). Leuco-
attractants enhance complement receptors on human phagocytic
cells.
Clin. Exp. Immunol, (in press).
KELEMAN, E. and Go BIKICH (1956). Insufficiency of acute
response of basophil and eosinophil leukocytes and of blood
histamine after administration of ACTH and cortisone in
untreated myelocytic leukemia.
Acta Haematol., 1_5, 202-206.
286
KELLER, R. (1973). Concanavalin A, a model "antigen" for
the iui vitro detection of cell-bound reaginic antibody in
the rat.
Clin. Exp. Immunol., 13, 139-147.
KELLY, M.T. and A. WHITE (1973). Histamine release
induced by human leucocyte lysates. Implication of a
specific, complement-independent, noncytotoxic reaction.
Infect. Immunity, 8, 8-14.
KIER, L.B. (1968). Molecular orbital calculations of the
preferred conformations of histamine and a theory on its
dual activity.
J. Med. Chem., 11, 441-445.
KIPNIS, D.M. and J.E. PARRISH (1965). Role of Na+ and K+
on sugar (2-deoxyglucose) and amino acid (a-aminobutyric
acid) transport in striated muscle.
Fed. Proc., 24, 1051-1059.
KOVACS, B.A. (1950). Antihistaminic effect of eosinophil
leukocytes.
Experientia, 6, 349-350.
LAGUNOFF, D., M.T. PHILLIPS, O.A. ISERI and E,P. BENDITT
(1964). Isolation and primary characterisation of rat
mast cell granules.
Lab. Invest. , 1J3, 1331-1344.
LEE, ToP., J.F. KUO and P. GREENGARD (1971). Regulation
of myocardial cyclic AMP by isoproterenol, glucagon and
acetylcholine.
Biochem. Biophys. Res. Commun. , 4j5, 991-997.
LETT-BROWN, M.A. and E0J. LEONARD (1977). Histamine-induced
inhibition of normal human basophil chemotaxis to C5a.
J. Immunol., 118, 815-818.
9 Q 7L. u /
LEVINE, R.J., T.L. SATA and A. SJOERDSMA (1965). Inhibition
of histamine synthesis in the rat by cc-hydrazino analog of
histidine and 4-bromo-3-hydroxy benzyloxyamine.
Biochem. Pharmacol., 14, 139-149.
LEWIS, G.P. and P.J. PIPER (1975). Inhibition of release
of prostaglandins as an explanation of some of the actions
of anti-inflammatory corticosteroids.
Nature, 254, 308-311.
LEWIS, RoAo, E,J, GOETZL, S.I. WASSERMAN, F.H. VALONE,
R.H. RUBIN and K.F. AUSTEN (1975). The release of four
mediators of immediate hypersensitivity from human
leukemic basophils.
J. Immunol., 114, 87-92.
LICHTENSTEIN, L.M. (1968). Mechanism of allergic histamine
release from human leukocytes. In Biochemistry of the Acute
Allergic Reaction; pp 153-171 (K.F. Austen and E.L. Becker,
eds.; F.A. Davis Co., Philadelphia).
LICHTENSTEIN, L.M. (1975). The mechanism of basophil
histamine release induced by antigen and by the calcium
ionophore A23187.
J. Immunol., 114, 1692-1699.
LICHTENSTEIN, L.M. and E. GILLESPIE (1973). Inhibition of
histamine release by histamine controlled by H2 receptor.
Nature, 244, 287-288.
LICHTENSTEIN, L.M. and A,Ga OSLER (1964). Studies of the
mechanism of hypersensitivity phenomena. IXQ Histamine
release from human leukocytes by ragweed pollen antigen.
J. Exp. Med., 120, 507-530.
LICHTENSTEIN, L.M. and A.G. OSLER (1966). Comparative studies
of histamine release and potassium efflux from human leukocytes.
Proc. Soc. Exp. Biol. Med., 121, 808-812.
288
LICHTENSTEIN, L.M., E. GILLESPIE, H.R. BOURNE and C0S.
HENNEY (1972). The effects of a series of prostaglandins
on in vitro models of the allergic response and cellular
immunity.
Prostaglandins, 2, 519-528.
LINDELL, S.E., H. RORSMAN and H. WESTLING (1961). Histamine
formation in human blood.
Acta Allerg., 16, 216-227.
LOOMIS, W.F. and F. LIPMANN (1948). Reversible inhibition
of the coupling between phosphorylation and oxidation.
J. Biol. Chem., 173, 807-808.
LOVENBERG, W., H. WEISSBACH and So UDENFRIEND (1962).
Aromatic L-amino acid decarboxylase.
J. Biol. Chem., 237, 89-93.
MACKAY, D. and D«M. SHEPHERD (1960). A study of potential
histidine decarboxylase inhibitors.
Br. J. Pharmac., 15, 552-556.
MACKAY, D. and D.M. SHEPHERD (1962). Inhibition of
histidine decarboxylase and interaction of the inhibitors
with pyridoxal 5'-phosphate.
Biochem. Biophys. Acta, 5j), 553-561.
MACKAY, D., J.Fc RILEY and D.M. SHEPHERD (1961). Amino
acid decarboxylase activity in rat hepatoma.
J. Pharm. Pharmac., 1J3, 257-261.
MAGRO, A.Mo (1974). Involvement of IgE in con A-induced
histamine release from human basophils iri vitro.
Nature, 249, 572-573.
MICHELS, N.A. (1938). The mast cells. In Handbook of
Hematology; vol. 1, pp 232-372 (H. Downey, ed.; Paul B.
Hoeber, New York). Reprinted in Ann. N.Y. Acad. Sci., 103:
Appendix, 1-372, 1963.
MIRANDA, A.F» , G.C. GODMAN, A.D. DEITCH and S.W. TANEBAUM
(1974). Action of cytochalasin D on cells of established
lines. I. Early events.
J. Cell. Biol., 61, 481-500.
MITCHELL, P. (1970). Membranes of cells and organelles:
morphology, transport and metabolism. In Organization and
control in prokaryotic and eukaryotic cells. XXth Symp.
Soc. Gen. Microbiol., pp 121-166.
MITCHELL, R.G. (1958). Basophilic leukocytes in children
in health and disease.
Arch. Dis. Childhood, 33, 193-201.
MITCHELL, R.G. (1963). Histidine decarboxylase in the new¬
born human infant.
J. Physiol., JH36, 136-144.
MONGAR, J.L. and H.O. SCHILD (1957a). Inhibition of the
anaphylactic reaction.
J. Physiol., 135, 310-319.
MONGAR, J.L. and H.O. SCHILD (1957b). Effect of temperature
on the anaphylactic reaction.
J. Physiol., 135, 320-338.
MONGAR, J.L. and H.O. SCHILD (1958). The effect of calcium
and pH on the anaphylactic reaction.
J. Physiol., 140, 272-284.
MONGAR, J.L. and H.O. SCHILD (1962). Cellular mechanisms
in anaphylaxis.
Physiol. Rev., 42, 1226-1270.
290
MOORE, J.E. and G.W. JAMES (1953). A simple direct method
for absolute basophil leucocyte count.
Proc. Soc. Exp. Biol. Med., 82, 601-607.
MORRISON, D.C., J.F. ROSER, P.M. HENSON and C.G. COCHRANE
(1975a). Isolation and characterization of a non-cytotoxic
mast cell activator from cobra venom.
Inflammation, 1_, 103-115.
MORRISON, D.C., J.F. ROSER, C.G. COCHRANE and P.M. HENSON
(1975b). Two distinct mechanisms for the initiation of
mast cell degranulation.
Int. Arch. Allergy, 49, 172-178.
MULLIGAN, W., G.M. URQUHART, F.W. JENNINGS and J.T.M. NEILSON
(1965). Immunological studies on Nippostrongylus
brasiliensis infection in the rat: the "self cure"
phenomenon.
Exp. Parasitol., 16, 341-347.
NEWBALL, H.H., LM. LICHTENSTEIN and R.C. TALAMO (1975a).
Basophil kallikrein of anaphylaxis (BK-A).
Fed. Proc., 34, 1045.
NEWBALL, H.H., L.M. LICHTENSTEIN and R.C. TALAMO (1975b).
Leukocyte arginine esterase - a potential new mediator of
allergic reactions.
J. Allergy, 55, 72.
NEWSHOLME, E.A. and C. START (1973). Regulation in
Metabolism; pp 60-61 (John Wiley and Sons, London).
NORMAN, P.S. (1975). The clinical significance of IgE.
Hosp. Pract., 10, 41-49.
NORN, S. (1971). Anaphylactic histamine release and
influence of antirheumatics.
Acta Pharmacol. Tox., 30, Suppl. 1.
291
NORTON, S» and E.J, DeBEER (1955). Effects of some anti¬
biotics on rat mast cells in vitro.
Arch. Int. Pharmacol., 102, 352-358.
OGILVIE, B.M. (1974). Immunity to parasites (helminths and
arthropods). In Progress in Immunology II; vol. 4; pp 127-
135 (L. Brent and E.J. Holborow, eds.; North Holland,
Amsterdam).
OGILVIE, B,M. and V.E. JONES (1971). Nippostrongylus
brasiliensis: A review of immunity and the host/parasite
relationship in the rat.
Exp. Parasitol., 29, 138-177.
OLSSON, I. (1971). Mucopolysaccharides of rabbit bone
marrow cells.
Exp. Cell Res., 67, 416-426.
OLSSON, I., S. GARDELL and S. THUNELL (1968). Biosynthesis
of glycosaminoglyeans (mucopolysaccharides) in human
leukocytes.
Biochem. Biophys. Acta, 165, 309-323.
OLSSON, I., P. VENGE, J.K. SPITZNAGEL and R.I. LEHRER (1977).
Arginine-rich cationic proteins of human eosinophil granules.
Comparison of the constituents of eosinophilic and
neutrophilic leukocytes.
Lab. Invest., 36, 493-500.
ORANGE, R.P. and K.F. AUSTEN (1969). Slow reacting substance
of anaphylaxis.
Adv. Immunol., 1(3, 106-144.
ORANGE, R.P. and E.G. MOORE (1976). Functional characteri¬
zation of rat mast cell arylsulfatase activity.
J. Immunol., 117, 2191-2196.
292
ORANGE, R.P., D.J. STECHSCHULTE and K.F. AUSTEN (1969).
Cellular mechanisms involved in the release of slow reacting
substance of anaphylaxis.
Fed. Proc., 28, 1710-1715.
ORANGE, R.P,, W.E. AUSTEN and K.F. AUSTEN (1971). Immuno¬
logical release of histamine and slow reacting substance of
anaphylaxis from human lung. I. Modulation by agents
influencing cellular levels of cyclic 3?,5'-adenosine
monophosphate.
J. Exp. Med., 134, 136S-148S.
ORANGE, R.P., R.C. MURPHY and K.F. AUSTEN (1974). Inactiva-
tion of slow reacting substance of anaphylaxis (SRS-A) by
arylsulfatase.
J. Immunol., 113, 316-322.
ORENSTEIN, N.S., S.J. GALLI, A.M. DVORAK, J.E. SILBERT and
H.F. DVORAK (1978). Sulfated glycosaminoglycans of guinea
pig basophilic leukocytes.
J. Immunol., 121, 586-592.
OXENDER, D.L. and H.N. CHRISTENSEN (1963). Distinct
mediating systems for the transport of neutral amino acids
by the Ehrlich cell.
J. Biol. Chem., 238, 3686-3699.
OXENDER, D.L., M. LEE, P.A. MOORE and G. CECCHINI (1977).
Neutral amino acid transport systems of tissue culture
cells.
J. Biol. Chem., 252, 2675-2679.
PADAWER, J. (1959). A stain for mast cells and its
application in various vertebrates and in a mastocytoma.
J. Histochem. Cytochem., 7, 352-353.
PADAWER, J. (1978). The mast cell and immediate hyper¬
sensitivity. In Immediate Hypersensitivity. Modern
Concepts and Developments; chapt. 13, pp 301-367
(M.K. Bach, ed.; Marcel Dekker, New York).
PARISH, W,E. (1972). Eosinophilia. III. The anaphylactic
release from isolated human basophils of a substance that
selectively attracts eosinophils.
Clin. Allergy, 2, 381-390.
PARK, J.H., B.P. MERIWETHER, P. CLODFELDER and L.W.
CUNNINGHAM (1961). The hydrolysis of p-nitrophenyl
acetate catalysed by 3-phosphoglyceraldehyde dehydrogenase.
J. Biol. Chem., 236, 136-141.
PARSONS, M.E., D.A.A, OWEN, C.R. GANELLIN and G.J. DURANT
(1977). Dimaprit -(s-[3-(N,N-dimethylamino) propyl J
isothiourea^J - a highly specific histamine H2-receptor
agonist. Part 1. Pharmacology..
Agents and Actions, 7, 31-37.
PASTAN, IoH., G.S. JOHNSON and W.B. ANDERSON (1975). Role
of cyclic nucleotides in growth control.
Ann. Rev. Biochem., 44, 491-522.
PEARCE, F.L., H. BEHRENDT, U. BLUM, G. POBLETE-FREUND,
P. PULT, C. STRANG VOSS and W. SCHMUTZLER (1977).
Isolation and study of functional mast cells from lung and
mesentery of the guinea pig.
Agents and Actions, 7, 45-56.
PETERS, R0A., Mo SHORTHOUSE and L.R. MURRAY (1964).
Enolase and fluorophosphate.
Nature, 202, 1331-1332.
PINCUS, S„H. (1978). Production of eosinophil-rich
guinea pig peritoneal exudates.
Blood, 52, 127-134.
PIPER, P. and J.L. WALKER (1973). The release of
spasmogenic substances from human chopped lung tissue and
its inhibition.
Br. J. Pharmacol., 47, 291-304.
PLAUT, M., L.M. LICHTENSTEIN, E. GILLESPIE and C.S. HENNEY
(1973). Studies on the mechanism of lymphocyte-mediated
cytolysis. IV. Specificity of the histamine receptor on
effector T cells.
J. Immunol., Ill, 380-394.
PRAUSNITZ, C. (1955). The passive transfer of allergy.
Int. Arch. Allergy, 6, 260-269.
PROUVOST-DANON, A., M. SILVA LIMA and M. QUEIROZ JAVIERRE
(1966). Active anaphylactic reaction in mouse peritoneal
mast cells in vitro.
Life Sci., 5, 289-297.
PRUZANSKY, J.J. and R. PATTERSON (1967). Subcellular
distribution of histamine in human leukocytes.
Proc. Soc. Exp. Biol. Med., 124, 56-59.
PRUZANSKY, J.J. and R. PATTERSON (1970). Decrease in
basophils after incubation with specific antigens of
leukocytes from allergic donors.
Int. Arch. Allergy Appl. Immunol., 38, 522-526.
RANADIVE, N.S. and C.G. COCHRANE (1971). Mechanism of
histamine release from mast cells by cationic protein
(band 2) from neutrophil lysozymes.
J. Immunol., 106, 506-516.
295
REID, J.D0 and D,M. SHEPHERD (1963). Inhibition of
histidine decarboxylase.
Life Sci., 2, 5-8.
RICHERSON, H.B., H.F. DVORAK, S„ LESKOWITZ (1970).
Cutaneous basophil hypersensitivity. I. A new look at the
Jones-Mote reaction, general characteristics.
J. Exp. Med., 132, 546-557.
RIESKE, J.S. and W.S. ZAUGG (1962). The inhibition by
antimycin A of the cleavage of one of the complexes of the
respiratory chain.
Biochem. Biophys. Res. Commun., 8, 421-426.
RINGOEN, AoR. (1923). The mast leucocyte in adult guinea
pigs under experimental conditions.
Am. J. Anat. , 31L, 319-338.
ROBINSON, B. and D.M. SHEPHERD (1962). The inhibition of
the L-histidine decarboxylase of guinea pig kidney and rat
hepatoma.
J. Pharm. Pharmac., ]L4, 9-15.
ROCH e SILVA, M., O. BIER and M. ARONSON (1951). Histamine
release by anaphylatoxin.
Nature, 168, 465-466.
RORSMAN, H. (1962). Normal variation in the count of
circulating basophil leukocytes in man.
Acta Allerg., 17, 49-65.
ROTHSCHILD, A0M. and R.W. SCHAYER (1958). Histidine
decarboxylase from rat peritoneal fluid mast cells.
Fed. Proc., 1/7, 136.
ROTILIO, G. and B. MONDOVI (1966). pH dependence of the
cyclization reaction between histamine and pyridoxal
phosphate.
Arch. Biochem. Biophys., 114, 598-599.
SABIN, F.R. (1923). Studies of living human blood-cells.
Bull. Johns Hopkins Hosp., 34, 277-288.
SAMPTON, D. and G.T. ARCHER (1967). Release of histamine
from human basophils.
Blood, 29, 722-736.
SAMTER, Mo, M.A. KOFOED and W. PIEPER (1953). A factor in
lungs of anaphylactically shocked guinea pigs which can
induce eosinophilia in normal animals.
Blood, 8, 1078-1090.
SAXON, A0, V.D. MORLEDGE and B. BONAVIDA (1977). Histamine-
receptor leucocytes (HRL). Origin and lymphoid sub-
population distribution in man.
Clin. Exp. Immunol., 28, 394-399.
SCHAYER, R.W. (1952). Biogenesis of histamine.
J. Biol. Chem., 199, 245-250.
SCHAYER, R.W. (1956). Formation and binding of histamine
by free mast cells of rat peritoneal fluids.
Am. J. Physiol., 186, 199-202.
SCHAYER, R.W. (1959). Catabolism of physiological
quantities of histamine in vivo.
Physiol. Rev., 39, 116-126.
SCHAYER, R.W. (1962). Role of induced histamine in
tourniquet shock in mice.
Am. J. Physiol., 203, 412-416.
SCHAYER, R.W. and M.A. REILLY (1968). Suppression of
inflammation and histidine decarboxylase by protein
synthesis inhibitors.
Am. J. Physiol., 215, 472-476.
297
SCHAYER, R,W. and MoA. REILLY (1974). Histamine catabolism
in guinea pigs, rats and mice.
Eur. J. Pharmacol., 25, 101-107.
SCHAYER, R.W., Z. ROTHSCHILD and P. BIZONY (1959). Increase
in histidine decarboxylase activity in rat skin following
treatment with compound 48/80.
Am. J. Physiol., 196, 295-298.
SCHILD, H„0„, D.F, HAWKINS, J.L. MONGAR and H. HERXHEIMER
(1951). Reactions of isolated human asthmatic lung and
bronchial tissue to a specific allergen.
Lancet, jLi, 376-382.
SCHMIKE, R.T., E.W. SWEENEY and C.M. BERLIN (1965). The
role of synthesis and degradation in the control of rat liver
tryptophan pyrrolase.
J. Biol. Chem., 240, 322-331.
SCHOTT, H.F. and W.G. CLARK (1952). Dopa decarboxylase
inhibition through the interaction of coenzyme and substrate.
J. Biol. Chem., 196, 449-462.
SCOTT, R.E. (1970). Effects of prostaglandins, epinephrine
and NaF on human leukocyte, platelet and liver adenyl cyclase.
Blood, 35, 514-516.
SHAKIB, F., P. McLAUGHLAN, D.R. STANWORTH, E, SMITH and
E. FAIRBURN (1977). Elevated serum IgE and IgG4 in
patients with atopic dermatitis.
Br. J. Dermatol., 97, 59-63.
fe
SHELLEY, W.Bo and L. JUHLIN (1961). A new test for
detecting anaphylactic sensitivity: the basophil reaction.
Nature, 191, 1056-1058.
293
SHELLEY, W.B„ and H„M. PARNES (1965). The absolute basophil
count.
J. Am. Med. Assoc., 192, 108-110.
SHER, A. (1976). Complement-dependent adherence of mast
cells to schistosomula.
Nature, 263, 334-336.
SIRAGANIAN, R.P. and A.G. OSLER (1971). Destruction of
rabbit-platelets in the allergic response of sensitized
leukocytes. II. Evidence of basophil involvement.
J. Immunol., 106, 1252-1259.
SIRAGANIAN, R.P. and P.A. SIRAGANIAN (1975). Mechanism
of action of concanavalin A on human basophils.
J. Immunol., 114, 886-893.
SJOERDSMA, A., T.P. WAALKES and H. WEISSBACH (1957).
Serotonin and histamine in mast cells.
Science, 125, 1202-1203.
SKOU, J.C. (1965). Enzymatic basis for active transport
of Na+ and K+ across cell membrane.
Physiol. Rev., 45, 596-617.
SLORACH, S.A. and B. UVNAS (1968). Amine formation by rat
mast cells iji vitro.
Acta Physiol. Scand. , 7^3, 457-470.
SMITH, G.L., R.A. JENKINS and J.F. GOUGH (1969). A
fluorescent method for the detection and localization of
zinc in human granulocytes.
J. Histochem. Cytochem. , 17', 749-750.
STECHSCHULTE, D.J. (1978). Non-IgE homocytotropic antibody
in animals. In Immediate Hypersensitivity. Modern Con¬
cepts and Developments; pp 259-276 (M.K. Bach, ed.;
Marcel Dekker, New York).
STEIN, W.D. (1967). Facilitated diffusion - the kinetic
analysis. In The Movement of Molecules across Cell
Membranes; chapt. 4; pp 126-148 (Academic Press, New
York and London).
STONER, J., V.C, MANGANIELLO and M. VAUGHAN (1973).
Effects of bradykinin and indomethacin on cGMP and cAMP in
lung slices.
Proc. Natl. Acad. Sci. USA, 70, 3830-3833.
SULLIVAN, A.L., P.M. GRIMLEY and H. METZGER (1971).
Electron microscopic localization of immunoglobulin E on
the surface membrane of human basophils.
J. Exp. Med., 134. 1403-1416.
SUTHERLAND, E.W. and T.W, RALL (1958). Fractionation and
characterization of a cyclic adenine ribonucleotide formed
by tissue particles.
J. Biol. Chem., 232, 1077-1091.
SUTHERLAND, E.W., I. 0YE and R.W. BUTCHER (1965). The
action of epinephrine and the role of the adenyl cyclase
system in hormone action.
Rec. Prog. Horm. Res., 21, 623-646.
TAUBER, A.I., M. KALINER, D.J. STECHSCHULTE and K.F. AUSTEN
(1973). Immunologic release of histamine and slow reacting
substance of anaphylaxis from human lung. V. Effects of
prostaglandins on release of histamine.
J. Immunol., Ill, 27-32.
TAYLOR, R.B., W.P.H. DUFFUS* M.C„ RAFF and S. de PETRIS (1971).
Redistribution and pinocytosis of lymphocyte surface immuno¬
globulin molecules induced by anti-immunoglobulin antibody.
Nature New Biol., 233, 225-229.
TERRY, R.W,, D.F„ BAINTON and M.G. FARQUHAR (1969).
Formation and structure of specific granules in basophilic
leukocytes of the guinea pig.
Lab. Invest. , 2JL, 65-76.
THOMAS, E.L. and H.N. CHRISTENSEN (1971). Nature of the
cosubstrate action of Na+ and neutral amino acids in a
transport system.
J. Biol. Chem., 246, 1682-1688.
THONNARD-NEUMANN, E. (1963). Studies of basophils,
variations with age and sex.
Acta Haematol., 30, 221-228.
THORN, G.W., P.H. FORSHAM, F.T. GARNET PRUNTY and A. FORMAN
HILLS (1948). A test for adrenal cortical insufficiency.
J. Am. Med. Assoc., 137, 1005-1009.
TRINER, L., Y. VULLIEMOZ, M. VEROSKY and G.G. NAHAS (1972).
Acetylcholine and the cyclic AMP system in smooth muscle.
Biochem. Biophys. Res. Commun., 46, 1866-1873.
TURNBULL, L.W. and A.B. KAY (1976). Eosinophils and
mediators of anaphylaxis. Histamine and imidazole
acetic acid as chemotactic agents for human eosinophil
leucocytes.
Immunology, 31^, 797-802.
TURNBULL, L.S., D.G. JONES and A.B. KAY (1976). Slow
reacting substance as a preformed mediator from human lung.
Immunology, 31, 813-820.
TYRODE, M.V. (1910). The mode of action of some purgative
salts.
Arch. Int. Pharmacol., 20, 205-223.
USSING, H.H. (1949). Transport of ions across cellular
membranes.
Physiol. Rev., 29, 127-155.
UVNAS, B. (1969). Mast cells and inflammation. In
Inflammation Biochemistry and Drug Interactions; pp 221-
227 (A. Bertelli and J.C. Houck, eds.; Excerpta Medica
Foundation, Amsterdam).
UVNAS, B. (1974). Histamine storage and release.
Fed. Proc., 33, 2172-2176.
UVNAS, B. and J. ANTONSSON (1963). Triggering action of
phospholipase A and chymotrypsins on degranulation of rat
mesentery mast cells.
Biochem. Pharmacol., 12, 867-873.
UVNAS, B. and I-L. THON (1959). Isolation of "biologically
intact" mast cells.
Exp. Cell Res., 18, 512-520.
UVNAS, B. and I-L. THON (1961). Evidence for enzymatic
histamine release from isolated rat mast cells.
Exp. Cell Res., 23, 45-57.
VALENTINE, M.D., K.J. BLOCH and K.F. AUSTEN (1967).
Mechanisms of immunologic injury of rat peritoneal mast
cells. III. Cytotoxic histamine release.
J. Immunol., 99, 98-110.
VALENTINE, W.N., J.S. LAWRENCE, M.L. PEARCE and W.S. BECK
(1955). The relation of the basophil to blood histamine
in man.
Blood, 10, 154-159.
VALONE, F.H. and E.J. GOETZL (1978). Immunologic release
ft
in the rat peritoneal cavity of lipid chemotactic and
chemokinetic factors for polymorphonuclear leukocytes.
J. Immunol., 120, 102-108.
502
VANE, J.R. (1971). Inhibition of prostaglandin synthesis as
a mechanism of action for aspirin-like drugs.
Nature New Biol., 231, 232-235.
VAZQUEZ, D. (1974). Inhibitors of protein synthesis.
Febs. Letts., jlO (Suppl.), S63-S84.
VERCAUTEREN, R. (1953). The properties of the isolated
granules from blood eosinophils.
Enzymologia, lfi, 1-13.
VERCAUTEREN, R. and G. PEETERS (1952). On the presence of
an antihistaminicum in isolated eosinophilic granules.
Arch. Int. Pharmacodyn., 89, 10-14.
VIDAVER, G.A. (1964). Transport of glycine by pigeon red
blood cells.
Biochemistry, 3, 622-667.
WALDEYER, W. (1875). Uber Bindegewebszellen.
Arch. f. mikr. Anat., 1^1, 176.
WALDMANN, T.A. (1969). Disorders of immunoglobulin
metabolism.
New Eng. J. Med., 281, 1170-1177.
WARD, P.A., H.F. DVORAK, S. COHEN, T. YOSHIDA, R. DATA and
S.S. SELVAGGIO (1975). Chemotaxis of basophils by
lymphocyte-dependent and lymphocyte-independent mechanisms.
J. Immunol., 114, 1523-1531.
WASSERMAN, S.I., E.J. GOETZL and K.F. AUSTEN (1975).
Inactivation of slow reacting substance of anaphylaxis by
ft
human eosinophil arylsulfatase.
J. Immunol., 114, 645-649.
WATSON, N.G. (1956). Studies on mammalian histidine
decarboxylase.
Br. J. Pharmacol., 11, 119-127.
WEBB, JoLc (1966) Iodoacetate and iodoacetamide. In
Enzyme and Metabolic Inhibitors, Vol. 3; chapt. 1, pp 1-283
(Academic Press, New York and London).
WEIL, R. (1913). Studies in anaphylaxis.
J. Med. Res., 28, 243-285.
WELSH, R.A. and J.C. GEERS (1959). Phagocytosis of mast
cell granule by the eosinophilic leukocyte in the rat.
Am. J. Path., 35, 103-108.
WESSELS, N.K., B.S. SPOONER, J.F. ASH, M.O. BRADLEY,
M.A. LUDUENA, E.L. TAYLOR, J.T. WRENN and K.Mo YAMANDA
(1971). Microfilaments in cellular and developmental
processes. Contractile microfilament machinery of many
cell types is reversibly inhibited by cytochalasin B.
Science, 171, 135-143.
WETZEL, B.K., R.G. HORN and S.S. SPICER (1967). Fine
structural studies on the development of heterophil,
eosinophil and basophil granulocytes in rabbits.
Lab. Invest., 16, 349-382.
WHITEHOUSE, M. (1968). The molecular pharmacology of
anti-inflammatory drugs: some possible mechanisms of action
at the biochemical level.
Biochem. Pharmacol., Suppl. Chemical biology of inflammation,
293-307.
WICK, A.N., D.R. DRURY, H.I. NAKADA and J.B. WOLFE (1957).
Localization of the primary metabolic block produced by
2-deoxyglucose.
J. Biol. Chem., 224, 963-969.
WILSON, A.Bo and R.R.A. COOMBS (1971). Passive sensitization
of tissue cells. IV0 Guinea pig antibodies cytophilic for
basophils and Kurloff cells.
Int. Arch. Allergy Appl. Immunol., 40, 19-46.
504
WILSON, L., J.R. BAMBURG, S.B, MIZEL, L.M. GRISHAMand
K.M. CRESWELL (1974). Interaction of drugs with micro¬
tubule proteins.
Fed. Proc., 33, 158-166.
WINQVIST, G. (1960). Experimental production of basophil
granulocytes in the guinea pig.
Exp. Cell Res., 19, 7-12.
WINQVIST, G. (1963). Electron microscopy of the basophilic
granulocyte.
Ann. N.Y. Acad. Sci., 103, 352-375.
WISE, W.C. (1976a). Maturation of membrane-function:
transport of amino acids by rat erythroid cells.
J. Cell. Physiol., 87, 199-211.
WISE, W.C. (1976b). Amino acid transport in thymus-derived
lymphocytes.
Fed. Proc., 3£5, 605.
WOLF-JURGENSEN, P. (1966). Basophilic Leukocytes in
Delayed Hypersensitivity. (Munksgaard, Copenhagen).
WRIGHT, D.G. and S.E. MALANISTA (1973). Mobilization and
extracellular release of granular enzymes from human
leukocytes during phagocytosis. Inhibition by colchicine
and Cortisol but not by salicylate.
Arthritis Rheum., 16, 749-758.
YOUMAN, J.D., L. TADDEINI and T. COOPER (1973). Histamine
excess symptoms in basophilic chronic granulocytic leukemia.
»
Arch. Int. Med., 131, 560-562.
YURT, R.W., R. WESLEY LEID, J. SPRAGG and K.F. AUSTEN (1977).
Immunologic release of heparin from purified rat peritoneal
mast cells.
J. Immunol., 118, 1201-1207.
505
ZACHARIAE, F„, G. ASBOE-HANSEN and A-W.A. BOSEILA (1958).
Studies on the mechanism of ovulation. Migration of basophil
leucocytes from blood to genital organs at ovulation in the
rabbit.
Acta Endocrinol., 28, 547-552.
ZEIGER, R.S, and HaR. COLTEN (1977). Histaminase release
from human eosinophils.
J. Immunol., 118, 540-543.
ZUCKER-FRANKLIN, D. (1967). Electron microscopic study of
human basophils.
Blood, 29, 878-890.
ZURIER, R0B., G. WEISSMANN, S. HOFFSTEIN, F. KAMMERMAN and
H.H. TAI (1974). Mechanisms of lysosomal enzyme release
from human leukocytes. II. Effects of cAMP and cGMP,
autonomic agonists and agents which affect microtubule
function.
J. Clin. Invest., 5j3, 297-309.
PUBLICATIONS
The following work connected with this thesis has
been published.
STEWART, J., D.G. JONES and A.B. KAY (1979). Metabolic
14 14
studies on the uptake of C-histidine and C-histamine
and histamine synthesis by guinea pig basophils, juri vitro.
Immunology, 36, 539-548.
